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Background: Kenya has made a commitment to virtually eliminate mother to child 
transmission of HIV (MTCT) by 2015. To achieve virtual elimination, the prevention of 
MTCT (PMTCT) programs must achieve high coverage and retain HIV-positive women 
throughout the PMTCT continuum of care.  
Methods: A mixed methods study was conducted in three health facilities in Kenya. To 
quantify retention along the PMTCT care continuum, a retrospective chart review was 
conducted on HIV positive pregnant or recently-delivered women 18 or older presenting 
for antenatal care or delivery between January 2012 and May 2013.  The primary 
outcome was retention at individual and facility levels through 18 months postpartum. 
Logistic regression analysis was performed to determine predictors of retention. Semi-
structured in-depth interviews were conducted with HIV positive women and male 
partners to understand barriers and facilitators of retention in PMTCT care.	  A failure 
mode and effect analysis was conducted to identify potential failures along the PMTCT 
cascade.  
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Results: Across the study sites, only 9%, 10% and 16% of the cohort was fully retained. 
The retention decreased significantly along the PMTCT cascade from antenatal to the 
postnatal phase. Gestational age at first antenatal visit (p= 0.043) and the number of 
antenatal visits attended (p=0.036) were identified as significant predictors of non-
retention in PMTCT care.  The facilitators of retention included acceptance of HIV 
positive status, supportive male partners, disclosure of HIV status to male partners and 
family, peer counseling and psychosocial support, and positive experiences with 
healthcare providers.  Identified barriers were the inverse of the facilitators and were 
reinforced by stigma, financial pressure, and stress. The failure modes identified along 
the cascade included: missed opportunities for HIV testing and delivery of PMTCT 
interventions at antenatal, poor quality of data, loss of infant’s HIV test results, long wait 
times, and poor linkage between health facilities.  
Conclusion: Retention along the PMTCT continuum of care was low at the study 
facilities. The facilitators and barriers of retention comprised an interaction of personal, 
societal and structural dynamics operating simultaneously. The results provide the needed 
context and important considerations in the improvement of PMTCT implementation 
strategies as Kenya transitions to provide lifelong ART.  
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CHAPTER ONE:  





The goal of this study is to develop strategies and policy recommendations that 
improve retention of HIV-positive women in the prevention of mother-to-child 
transmission (PMTCT) care continuum in Kenya. This study contributes to the current 
understanding of retention in PMTCT care in three ways. First, the study quantifies 
retention rates along the PMTCT care continuum. Second, the study seeks to understand 
the factors that facilitate or hinder retention in PMTCT care from the perspective of HIV-
positive women. Third, by employing quality improvement methods, this study seeks to 
identify potential gaps that impede retention in PMTCT care and provide knowledge that 
can be translated into practice to improve the implementation of PMTCT interventions.  
 
1.2 STATEMENT OF THE PROBLEM  
Human immunodeficiency virus (HIV) can be transmitted from an HIV-positive 
woman to her child during pregnancy, labor and delivery, and during breast feeding. (1) 
In the absence of PMTCT interventions, 15–45% of infants will be infected with HIV 
through mother to child transmission (MTCT).(2) In 2011, the HIV prevalence among 
pregnant women aged 15–49 in Kenya was estimated at 7.6%.(2) In 2013, the MTCT rate 
	  	  	  
2 
in Kenya was estimated at 16% and 12,941 children were infected with HIV through 
MTCT.(3,4) In the same year, the total number of children living with HIV was 191,836 
and 10,393 deaths were reported among HIV infected children.(4)  
Kenya is one of the 221 priority countries under The Global Plan that collectively 
account for almost 90% of pregnant women living with HIV, and 90% of new HIV 
infections in children globally.(5) According to the Kenya AIDS Indicator Survey 
(KAIS) 2012, an estimated 92% of pregnant women in Kenya attend at least one 
antenatal care (ANC) visit, while 61.7% attended four or more visits.(6) The 2012 Kenya 
National Guidelines for PMTCT recommend that all pregnant women attending ANC 
clinics with unknown HIV status be offered HIV testing and counseling as standard 
care.(7) Despite the high uptake of HIV testing in ANC settings estimated at 92% Kenya, 
ART coverage for HIV-positive women and HIV-exposed infants in PMTCT settings is 
moderate; 67% and 57% respectively.(8,9)  Poor antenatal care attendance has been 
strongly associated with failure to receive prophylactic treatment of HIV or anti-retroviral 
therapy (ART).(10)  In addition, the 2013 UNAIDS Global report cited a general decline 
in PMTCT coverage among HIV pregnant women in Kenya from 66%  in 2011 to 53% in 
2012.(5) Globally, the scale up of treatment for HIV infected children substantially lags 
behind that of adults with treatment coverage for HIV  infected children  estimated at 
34% in 2012.(5) 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 1. Angola, 2. Botswana, 3. Burundi, 4. Cameroon, 5. Chad, 6. Côte d’Ivoire, 7. DR Congo, 8. 
Ethiopia, 9. Ghana, 10. India, 11. Kenya, 12. Lesotho, 13. Malawi, 14. Mozambique, 15. 
Namibia, 16. Nigeria, 17. South Africa, 18. Swaziland, 19. Tanzania, 20. Uganda, 21. Zambia, 
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The risk of MTCT is highest during labor and delivery with an estimated 35–45% of 
MTCT occurring during this time period.(11). Facility delivery lowers the risk, as it 
increases access to ARV; however a study in Kenya showed that HIV positive women 
were less likely to deliver in health facilities.(12)  HIV positive women who do not 
deliver at a health facility are less likely to access and use ART, thus increasing the 
probability of MTCT.(12, 13) Despite this risk, the 2014 Kenya Demographic Health 
Survey (KDHS) reported that 49% of deliveries in Kenya occurred at home.(15)  
The risk of MTCT is also high during breastfeeding: it is estimated that over half 
of the new HIV infections in children occur during the breastfeeding period when the 
majority of HIV positive lactating women are not on antiretroviral (ARVs).(5) ART 
coverage  is substantially lower during the breastfeeding period (49%) than during 
pregnancy and delivery (62%).(5) The average breastfeeding period in Kenya is 21 
months, and any loss of HIV-positive mothers from PMTCT care during the 
breastfeeding period increases the probability for MTCT. (16)  The HIV transmission risk 
also depends on the feeding method practiced. For example, the 2011 data from Kenya 
showed that MTCT prevalence among mixed-fed babies was 12.7%; compared to 6.3% 
in those exclusively breastfed, and 5.3% in those who did not breastfeed.(17)  
The pathway of events that must be implemented to facilitate delivery of 
interventions to HIV- positive women is called the PMTCT cascade.(18) Retention along 
this cascade is a major challenge for women enrolled in PMTCT programs.(19–21) In 
sub-Saharan Africa, retention in PMTCT programs is estimated to range from 72%–80% 
during ANC phase to between 30%–20% at four and six months postpartum. (21, 22) 
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Data also shows that even though HIV positive women stay in the healthcare system after 
delivery, they often do not receive HIV treatment services further compromising the 
effectiveness of PMTCT interventions. (24) Even though PMTCT interventions have 
been available in Kenya for more than a decade, HIV- positive pregnant women are still 
not fully optimizing the use of these services. A study of two Kenyan hospitals for 
example reported that only 4% of ART eligible HIV-positive women tested in PMTCT 
settings initiated ART within 6 months.(25) Thus, in addition to placing their child at 
risk, the HIV-positive women lost to follow up (LFTU) in this study were those who 
needed ART for their own health and not just for PMTCT prophylactic. These findings 
were unexpected because it is assumed that HIV positive women who are most likely 
symptomatic and in need of ART for their own health would be more aware of the 
necessity and urgency to initiate ART and would thus have the highest probability of 
initiating in HIV care immediately upon diagnosis.  
Studies show that even in the absence of HIV transmission to the child, a 
mother’s death has negative impact on child survival and children born to HIV-positive 
women are generally more vulnerable to poor socio-economic outcomes than those born 
to HIV negative mothers. (26–29). These children have a higher likelihood of been 
orphaned, a greater the probability of being lost to follow up during care, and are at an 
increased risk for child mortality.(26)  
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1.3 IMPORTANCE OF RETAINING HIV POSITIVE WOMEN IN PMTCT CARE 
Kenya has made a commitment to virtually eliminate mother to child transmission 
of HIV (eMTCT) by 2015.(7,30) The virtual elimination of new infant HIV infections is 
defined “as less than 5% of  MTCT, or 90% reduction of HIV among young children by 
2015.”(31) To achieve virtual elimination, PMTCT programs must achieve high coverage 
and retention of HIV-positive women throughout the PMTCT continuum of 
care.(22,23,32) The retention of HIV positive women in PMTCT care allows for the 
provision of prophylactic ART for mother and infant, early infant diagnosis, and prompt 
initiation of ART if needed.(22, 26–28) HIV disease progression is much faster in 
children than adults, and without HIV treatment, half of  the children born with HIV die 
by the age of two, and 80% die by age five.(3,22) Retaining a mother in PMTCT care 
ensures that a child is diagnosed and started on treatment promptly, thus maximizing the 
positive health outcomes for both mothers and babies.(33) 
The World Health Organization (WHO) 2012 PMTCT treatment recommendation 
introduced Option B+ as a PMTCT intervention. Option B+ recommends the provision of 
triple ART to all HIV-positive pregnant and lactating women and the continued use of 
ART for the rest of their lives.(34) The implementation of Option B+ poses additional 
challenges to retention in long term HIV care because HIV positive pregnant women will 
be starting treatment earlier than under the previous policy guidance, often before they 
become symptomatic, and are expected to stay on ART for the rest of their lives.(25) 
The WHO defines retention in HIV care to be “from the moment of initial 
engagement in care, when a person with HIV is linked successfully to services, to 
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assessment for eligibility, initiation on ART and retention in lifelong ART care.”(35) 
This definition encompasses four stages where retention must be achieved as shown in 
Figure 1. Patient loss to follow up  may occur at any step of the continuum and  may be 
attributed to:  death (in care or out of care), informal transfer between clinics, and 
disengagement with the care process.(35)  
 




Retention of HIV positive women in PMTCT care depends on a programs’ ability 
to facilitate: 1) regular ANC attendance where HIV status is determined and HIV-positive 
women are enrolled for PMTCT services, 2) access to effective ART regimens during 
pregnancy, 3) safe labor and delivery, 4) prophylaxis for the HIV exposed infant, 5) safe 
infant feeding practices, and 6) HIV infant diagnosis (early and late).   
It is fundamental that public health programs not only quantify retention of HIV 
positive women along the PMTCT cascade, but also acquire an in-depth understanding of 
the factors that facilitate or hinder this retention. This understanding will provide public 
health programs with insights into the influences on health care-seeking behaviors of 
HIV-positive women and how these impact retention throughout the PMTCT cascade. 
Health seeking behaviors are complex and are an interplay of personal, interpersonal, 
1.	  	  
Positive HIV test to 
enrollment in care  
2.	  	  
Enrolment in care to ART 
eligibility  
3.	  	  
ART eligibility to 
initiation of ART 
4.	  
	  Continuation of lifelong 
ART 
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social, economic, cultural, and health system factors which must be considered if 
PMTCT programs are to achieve optimal retention.(36) In addition, once this 
understanding has been achieved, it is crucial that the knowledge is translated into policy 
and practice to address the gaps that impede successful implementation of PMTCT 
interventions. For the purpose of this study, retention is defined as the continuous 
engagement with the PMTCT services throughout pregnancy, labor and delivery and 
postpartum until the determination of the HIV status of the HIV-exposed infant is made 
at 18 months of age.   
 
1.4  THE LITERATURE GAP  
While there is greater understanding of patient retention in ART programs for the 
general population, few studies in Kenya have sought to understand the facilitators and 
barriers that promote or limit retention of HIV-positive women throughout the PMTCT 
cascade.  The majority of Kenyan based studies on retention in PMTCT care are mainly 
geographically limited to Nyanza and Nairobi Regions. The emphasis of these studies is 
mostly on the barriers that limit retention and not on the facilitators that promote 
retention throughout the PMTCT cascade. Even though studies have sought to understand 
the factors that predict retention in long term PMTCT care, little has been done to 
understand how experiences in PMTCT settings affect subsequent health seeking 
behavior among HIV positive women. The lack of insight on the mechanisms that explain 
retention may be due to the limited use of qualitative methods to explore this 
phenomenon.  Furthermore, few studies employ quality improvement (QI) methodologies 
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to explore the health system factors that positively or negatively affect retention in 
PMTCT care. This study which employed a mixed method approach which: quantified 
retention along the PMTCT cascade; explored barriers and facilitators that 
hinder/promote retention in PMTCT care; and used QI methodologies to identify 
potential failures along the PMTCT cascade and where along the PMTCT cascade they 
occur. A mixed method approach allowed for the triangulation of data which in turn 
provided more comprehensive understanding of retention in PMTCT care.  
 
1.5 BACKGROUND  
1.5.1 The Global HIV and AIDS Epidemic 
Globally in 2012, an estimated 35.3 [32.2–38.8] million people were living with 
HIV and  2.3 [1.9–2.7] million of those were newly infected with HIV.(5) In 2013, an 
estimated 199 000 [170 000–230 000] children were newly infected with HIV 
globally.(3) Since 2001, there has been a 33% and 52%  decline in the number of new 
HIV infections among all adults and children respectively.(5) However, similar trends 
have not been observed among women with  the pace of decline in new HIV infections 
among women slowing down since 2008.(5) Sub- Saharan Africa (SSA) carries the bulk 
of the global HIV infection as shown in Table 1.  	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Table 1: 2012 HIV statistics for Sub Saharan Africa (SSA) 
• 25 million people are living with HIV.  
• 1.6 million newly infected with HIV accounting for 70% of the new HIV infections 
globally.  
• HIV prevalence among adults aged 15–49 was at 4.7% compared to 0.8% global 
HIV prevalence.  
• 1.2 million AIDS deaths among adults and children accounts for 75% of AIDS 





Despite the gloomy statistics, SSA recorded a 34% decline in new HIV infections 
between 2001–2012.(5) The decline in new HIV infections has especially been slower 
among women of child bearing age in SSA.(5) In the period between 2009–2012, 
declines in new HIV infections among children were reported in all the 22 priority 
countries; Malawi reduced new HIV infections among children by 67% while Botswana, 
Ethiopia, Ghana, Mozambique, Namibia, South Africa and Zimbabwe reduced new HIV 
infections among children by 50%.(3)  
 
1.5.2 The HIV and AIDS Epidemic in Kenya 
The first case of HIV in Kenya was recorded in 1984.(37) Twenty eight years 
after, the 2012 Kenya AIDS Indicator Survey (KAIS) estimated the HIV prevalence 
among adults aged 15 to 64 at 5.6%; with an estimated 1,192,000 people were living with 
HIV. (6) The total number of new HIV infections declined by 15% between 2009–
2013.(37)   
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Kenya mostly employs ANC sentinel surveillance data collection method to 
estimate HIV prevalence. Kenya has also conducted two types of national population-
based surveys to estimate HIV prevalence. These are: 1) Demographic and Health Survey 
(KDHS) 2003, 2008–09, 2014 and, 2) the Kenya AIDS Indicator Survey (KAIS) 2007 
and 2012.  These multiple sources complement the ANC sentinel surveillance data and 
generally improve the quality of epidemiological data. 
Sexual transmission is the primary driver (93%) of Kenya’s HIV epidemic, with 
heterosexual transmission accounting for an estimated 77% of new infections.(37)  Kenya 
has both a generalized and a concentrated epidemic.(37)  A generalized HIV epidemic is 
defined as HIV prevalence greater than 1% in the general population while a 
concentrated epidemic is where “HIV prevalence is less than 1% in the general 
population, but  greater than 5% in at least one high-risk subpopulation, such as men who 
have sex with men (MSM), injecting drug users (IDUs) and sex workers (SWs), or their 
clients”.(38)  
Even though Kenya has experienced a 40% decline in the national HIV 
prevalence over the last decade, the number of people living with HIV (PLHIV) during 
this period has increased. This increase can be attributed to the increasing population, the 
extended life spans of PLHIV, and reduced AIDS related mortality due to ART use.(39) 
The epidemiology of HIV in Kenya depends on several factors namely: gender (male or 
female), age, residency (rural or urban), education levels, marital status, wealth and 
geography.  
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Gender: Kenya’s HIV epidemic disproportionately affects women. Adult women 
aged 15–64 account for 59.1% of the PLHIV; and have a higher HIV prevalence (6.9%) 
compared to men in the same age bracket (4.4%).(6,37) HIV prevalence in young women 
aged 20–24 was at least three times higher (4.6%) than that of young men in the same age 
group (1.3%).(6) 
Age: HIV prevalence increases with age, and the odds of being infected with HIV 
increase as individuals’ transition from adolescence to adulthood. In 2012, HIV 
prevalence was highest among women aged 35–39 and among men 45–49; with the HIV 
prevalence peak reported among the 45–49 age group for  both women and men. (6) 
Residency: HIV prevalence is higher in urban areas than rural areas: 6.5% vs. 
5.1% respectively in 2012. (6) Urban females have the highest HIV prevalence. In 2012 
HIV prevalence among urban females was estimated at 8.0% compared to 5.1% in urban 
males; and 6.2% in rural women compared to 3.9% in rural men. (6) The HIV prevalence 
peak differed significantly by residence, with the peak among rural populations reported 
at 9.4% among 45–49 age group compared to a peak of 11.8% among adults aged 35–39 
in the urban areas. (6) 
Education:  In 2012, HIV prevalence was highest among females with secondary 
education and lowest among men with no primary education. As shown in Table 2, HIV 
prevalence among females increased as education levels increased.(6) Table 2 shows the 
distribution of HIV prevalence among men and women by education level.  
	  	  	  
12 
Marital status: HIV prevalence among widowed men (19.2%) and women 
(20.3%) is six times higher than in those individuals that never married or cohabited.(6)  
Table 3 below summarizes HIV prevalence by marital status. (6) 
 
Table 2: HIV prevalence among persons aged 15–64 years by education level: KAIS 2012 
 HIV prevalence  % (95% CI) 
Education Women Men Total 
No primary  4.0 2.4 3.6 
Incomplete primary  6.3 3.2 5.0 
Complete primary  7.1 4.8 6.0 




Table 3: HIV prevalence among persons aged 15–64 years by marital status: KAIS 2012 
 HIV prevalence % (95% CI) 
Marital Status Women Men Total 
Never married/never cohabited 2.7 1.3 1.8 
Currently married/currently cohabiting 5.3 5.3 5.3 
Separated/divorced 14.5 5.4 11 
Ever widowed  20.3 19.2 20 
Source: http://www.nacc.or.ke/attachments/article/403/KAIS_II_2014_Final_Report.pdf  
 
 
Wealth: The 2008/9 KDHS showed that HIV prevalence associated with wealth 
status.(16) As shown in Table 4, women in the highest wealth quintile had the highest 
HIV prevalence while men in the lowest wealth quintile had the lowest HIV 
prevalence.(16) A similar trend was documented in the 2011 Kenya AIDS Epidemic 
update with those in the top wealth quintile recording the highest HIV prevalence, 
estimated at 7.2%.(39) Kenyans in the lowest wealth quintile also had the lowest HIV 
prevalence estimated at 4.6%.(16,39) According to KAIS 2012, the number of household 
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members infected with HIV also increased with wealth. (6)  
Geography:  HIV prevalence in Kenya shows a regional variation with Nyanza 
Province being the most affected (15.1%), and North Eastern Province being least 
affected (2.4%).(6) Annex 1 is a map of Kenya showing HIV prevalence by province 
from the KAIS 2012 report. 
Table 4: HIV prevalence and wealth among persons aged 15–49 KDHS 2008/9 
 HIV prevalence  % (95% CI) 
Wealth  quintile Women Men 
Lowest  6.0 2.3 
Second  8.8 4.5 
Middle  6.6 4.5 
Fourth  7.4 5.6 




1.6 PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV 
(PMTCT)  
Through PMTCT interventions, MTCT can be reduced to 5% in breast feeding 
populations and to 2% in non- breast feeding populations.(1) Starting in the early 1990s, 
high income countries have been able to eliminate MTCT by using combination ART, 
conducting cesarean sections deliveries, and formula feeding babies born to HIV-positive 
women.(40) To date, these interventions, although highly effective, are out of reach for 
many low income countries because of the cost and the demand on their health 
systems.(40)  
The breakthroughs for PMTCT regimens that are affordable in low income 
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countries were made in the mid to late 1990s. In 1994, the ACTG 076 study 
demonstrated that Zidovudine (AZT) taken at 14 weeks gestation, intravenous in labor, 
and given to the infant for six weeks postnatally reduced vertical transmission by 67%. 
(41) Results from two clinical trials conducted among breastfeeding populations in 
Thailand and Côte d’Ivoire (1996 and 1998) demonstrated a 50% reduction in MTCT 
using shorter regimens of AZT starting from 36 weeks gestation with or without dosing 
of the infant.(42,43) In 1999, the HIVNET 012 study conducted in Uganda demonstrated 
that giving a single 200mg tablet of Nevirapine (NVP) to HIV positive women at the 
onset of labor and  single 2mg/kg/dose of NVP syrup to the infant within 72 hours of 
delivery reduced by  MTCT 47% at 6 weeks of age.(44) The simplicity and feasibility of 
the NVP regimen revolutionized the provision and delivery of PMTCT interventions in 
low income countries.(45)  
 
1.6.1 The Four-Pronged Approach to PMTCT and the PMTCT cascade 
The four pronged approach proposed by United Nations (UN) in 2001 is a 
comprehensive strategy where each “prong” represents a step towards the prevention of 
MTCT. Figure 2 below is graphic representation of the four prongs. The provision of 
ART prophylaxis to prevent MTCT happens in the third prong and mostly implemented 
in clinical settings starting at the antenatal phase, through labor and delivery (intra-
partum), and ending in the postnatal phase. 
	  	  	  
15 
Figure 2: The Four -Pronged Approach to PMTCT (UN 2001) 
 
 
The pathway of events that must be implemented for the ART prophylaxis to be 
delivered to the HIV- positive woman is called the PMTCT cascade and is illustrated by 
Figure 3 below.(18) 
 
Figure 3: Illustrative PMTCT cascade 















1.6.2 Treatment Guidelines for PMTCT 
The first WHO treatment guidelines recommending the use of ARV drugs for 
PMTCT intervention were developed in 2001.(46) These guidelines recommended a 
short-course prophylaxis of single dose nevirapine (sdNVP) starting late in pregnancy or 
Prong	  1:	  Primary	  prevention	  of	  	  HIV	  among	  women	  of	  reproductive	  age	  	  
Prong	  2:	  Prevent	  unintended	  pregnancy	  in	  women	  with	  HIV	  
Prong	  3:	  Prevent	  MTCT	  
Prong	  4:	  Provide	  ongoing	  support	  to	  mothers,	  children	  &	  families	  



















Antenatal (9 months) 
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during labor for the mother and NVP syrup for the infant within 72 hours of birth.(46) 
Since then the PMTCT treatment guidelines have evolved considerably with 
recommendations made in 2004, 2006, 2010 and 2012. As evidence about more 
efficacious regimens to prevent MTCT has emerged, the PMTCT recommendations have 
evolved, and have been standardized and simplified in order to accommodate these new 
findings. The recommendation to provide combination ART (cART) to HIV positive 
pregnant women with CD4 cell counts below 200 cells/mm3 for PMTCT prophylaxis at 
28 week of gestation and for the mother’s own  health was first discussed  in the 2006 
PMTCT treatment guidelines.(47)   
The 2010 guidelines provided a unified approach to PMTCT and introduced the 
concept of Option A and Option B to be offered to HIV-positive women during 
pregnancy, labor and delivery, postpartum, and the breastfeeding period.(48) Option A 
allows for the provision of AZT at 14 weeks gestation for HIV-positive pregnant women 
with CD4 cell count greater than 350 cells/mm3; while under Option B, HIV positive 
women with CD4 cell count greater than 350 cells/mm3 receive triple ART starting at 14 
weeks gestation and continued intrapartum and through childbirth.(48) Under both 
Option A and Option B, HIV positive women with CD4 cell count less than 350 
cells/mm3 receive triple ART for life. The 2012 PMTCT guidelines provide a third 
option, Option B+, which recommends the provision of ART to all HIV positive women 
diagnosed during pregnancy, intrapartum and postnatal irrespective of the CD4 count or 
the clinical stage.(34) In 2013, WHO released the “Consolidated guidelines on the use of 
antiretroviral drugs for treating and preventing HIV infection,” which redefined the CD4 
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cell count to receive ARV to ≤500 and recommended that countries currently 
implementing Option A should transition to Option B or Option B+.(49)  
The move towards the provision of Option B+ was informed by evidence showing 
that: 1) the episodic use of ART in non-ART eligible women led to deterioration,  
morbidity and mortality, (50);  and 2) most women who are not eligible for ART during 
pregnancy become eligible within  a two year period.(7)  Option B+ has three 
advantages: 
• Regimen simplicity: ART can be initiated without clinical staging or CD4 testing, 
• Extended protection from MTCT in future pregnancies starting at conception, 
• A prevention benefit against sexual transmission in serodiscordant couples due to 
decreased transmission when viral loads are low.(34) 
The first advantage above has been debated in Kenya; while Option B+ reduces 
dependency on CD4 estimation it adds the need for viral load monitoring which still 
requires significant health system efforts. Table 5 summarizes the three options for ART 
use in PMTCT under the 2012 guidance.  	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Table 5: Programmatic Update on ARV use for PMTCT -2012 
 Woman receives:  Infant receives: 
 Treatment (for 
CD4 count <350 
ells/mm3) 
Prophylaxis (for CD4 count 
>350 cells/ mm3) 
 
Option A Triple ARVs 
starting as soon as 
diagnosed and 
continued for life 
Antepartum: AZT starting 
as early as 14 weeks 
gestation Intrapartum: at 
onset of labor, sdNVP and 
first dose of AZT/3TC  
Postpartum: daily AZT/3TC 
through 7 days postpartum. 
Daily NVP from birth to 
one week beyond 
complete cessation of 
breastfeeding; or, if not 
breastfeeding or if 
mother is on treatment 
through age 4–6 weeks. 
Option B Triple ARVs 
starting as soon as 
diagnosed, 
continued for life 
Triple ARVs starting as 
early as 14 weeks gestation 
and continued intrapartum 
and through childbirth if not 
breastfeeding or until 1 
week after cessation of all 
breastfeeding 
Daily NVP or AZT from 
birth through 4–6 weeks 
regarding of infant 
feeding option. 
Option B+ Regardless of CD4 count, triple ARVs starting as 




1.6.3 The Kenya PMTCT Guidelines  
The first edition of the Kenya National Guidelines for PMTCT was published in 
2002. The Kenya PMTCT guidelines have also evolved considerably over time to 
accommodate international recommendations and the changing dynamics of the HIV 
epidemic in Kenya. Revisions to the national guidelines were made in 2006, 2009, and 
2012. The current — 2012 Kenya PMTCT Guidelines (fourth edition) — applies the 
Four-Pronged approach to PMTCT implementation described in Section 1.6.1 above.(7) 
In line with the WHO 2012 PMTCT guidance, the guidelines recommend that the ART 
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regimen choice should be based on the CD4 cell counts thresholds as shown in Table 5 
above. However, in situations where CD4 testing is not available, the guidelines 
recommend that the WHO clinical staging-Annex 2- be used as baseline to determine 
treatment eligibility. The WHO guidelines are expanded and contextualized to Kenya and 
operationalized to develop a package of services that HIV positive woman enrolled in 
PMTCT settings should receive throughout the PMTCT cascade.(7)  Annex 3 shows this 
package of services.  
           Kenya adopted and began implementing Option A in 2009.(7) The Kenya 2012 
PMTCT guidelines introduced the use of Option B+ but it was not until June 2014 that an 
amendment was issued recommending the scale up of Option B+ to all facilities 
providing PMTCT services.(7,51)  This delayed scale up of Option B+ was due to the 
lack of capacity in many health care facilities (human resources, logistics for delivery and 
infrastructural challenges)  to initiate and monitor triple therapy.(51)  The 2014 
amendment recommends that:  
• adults with CD4 count <500 cells/mm3 irrespective of WHO stage should be 
initiated on ART,  
• all HIV-infected children aged 10 years and below, regardless of WHO stage or 
CD4 count should be initiated on ART,  
•  all pregnant and breastfeeding women irrespective of CD4 count, WHO stage or 
age should be started on ART to be continued for life (Option B+). (51) 
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1.6.4 Current State of the Kenya PMTCT Program 
The Kenya National PMTCT Program launched in 2002 aimed at reducing the 
proportion of infants infected with HIV by 20% and 50% in 2005 and 2010 
respectively.(52) Kenya has made significant achievements in scaling up PMTCT 
services and creating demand for the services. A 2010 PMTCT Technical Review 
reported that 90% of the 4,400 facilities with maternal child health services in Kenya 
were offering PMTCT services.(53) Kenya has adopted the “opt out” approach to HIV 
testing in ANC settings; HIV testing is routinely offered and pregnant women who do not 
want the HIV test have the option to “opt out” and not take the test.(7) This has resulted 
to high uptake of HIV testing in ANC settings. For example, the KAIS 2012 report 
showed that between 2007 and 2012, 92% of pregnant women aged 15–54 were tested 
for HIV in ANC settings compared to 65% of pregnant women in the 2002–2007 period 
(KAIS 2007).(6,54) 
As discussed earlier in Section 1.2, despite the high uptake in HIV testing in ANC 
settings, maternal ART coverage is estimated is at 67%; 53% of exposed infants are 
receiving ART, and only 38% of the infected children are receiving ARVs. (37,55) The 
Kenya PMTCT guidelines discourage the use of sdNVP in PMTCT prophylaxis due to 
emergence of drug resistance among mothers and children exposed to sdNVP, as well as 
the availability of more efficacious triple ARV regimens.(56–58) Data from 2011 
however showed that 33% of pregnant women with HIV still received sdNVP for 
PMTCT prophylaxis. (55) Table 6 summarizes the challenges to the effective scale up of 
quality PMTCT services in Kenya. 
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Table 6: Challenges to the affective scale up of quality PMTCT services in Kenya. 
Prong A summary of challenges to provision of quality PMTCT In Kenya.  
Prong 1 • 46,000 new infections among women aged 15–49.  
• Low male partner-involvement in PMTCT programs with less than 30% 
couple testing. 
Prong 2 • Unintended pregnancies among women aged 15–49: 18% married 
women have an unmet need for family planning; and 18% of teenagers 
aged 15–19 have begun child bearing.  
• Limited integration of PMTCT services with reproductive health and 
family planning services. 
Prong 3 • Underutilization of ANC services with 58% adhering to the 
recommended four ANC visits and a late enrolment for ANC with 
median gestational at first ANC visit estimated at 20 weeks. 
• Underutilization of health facilities for deliveries estimated at 62%. 
• Use of inefficacious regimes for PMTCT an estimated 33% of HIV-
positive pregnant mothers using sdNVP only for PMTCT prophylaxis. 
Prong 4 • Lack of integration of early infant diagnosis in maternal child health 
(MCH) continuum. 
• 24% of children in need are on treatment. 
• Gaps in data quality of data for PMTCT service delivery at facility level. 
• Cotrimoxazole prophylaxis coverage estimated at 7% among infants  
• 32% of children under six months that are exclusively breastfed. 
 Sources: (8,15,16,37,52,55)  
 
 
1.6.5 Kenya Guidelines for PMTCT Peer Education and Psychosocial Support 
In 2012, Kenya launched the National Guidelines for PMTCT Peer Education and 
Psychosocial Support in Kenya: The Kenya Mentor Mother Program (KMMP). The 
KMMP guidelines provide a  framework that standardizes the integration of peer 
education and psychosocial support services within the national PMTCT program.(59)  
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The KMMP strategy contributes to Kenya’s eMTCT goal by “integrating women living 
with HIV into the health delivery teams that provide PMTCT services.” (59) As with the 
2012 Kenya PMTCT Guidelines, the KMMP guidelines are “aligned with the National 
Health Strategic Plan (NHSSPII), and Kenya National AIDS Strategic Plan (KNASP III 
2009–13) Pillar III, which focuses on strengthening community capacity to contribute to 
universal access and social transformation.”(59) 
The KMMP guidelines provide for a cadre known as Mentor Mothers2 who are 
linked to the Community Health Workers (CHW) and provide psychosocial counseling 
and peer support to HIV positive women in PMTCT settings in order to overcome 
barriers to PMTCT uptake, adherence and retention.(59) The activities of the Mentor 
Mothers are intended to empower the retention of mother-baby pairs in care by increasing 
a mother’s knowledge, promoting confidence and self-efficacy as well as providing 
access to a support network.(59)  The responsibilities of the Mentor Mothers include: 1) 
facilitation of group health education in the MCH waiting areas, 2) facilitation of pre-test 
education sessions, 3) providing one-on-one education and psychosocial support to 
PMTCT clients, 4) couple counseling and couple support sessions, 5) co-facilitate 
support groups for HIV-positive pregnant women and new mothers 6) in collaboration 
with community health workers (CHWs) trace and track PMTCT clients who have 
dropped out of care, and 7) refer and link PMTCT and MCH clients to clinical and 
community services.(59)  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 Mentor mothers is a mother living with HIV who is trained and employed as part of a medical 
team to support, educate, and empower pregnant women and new mothers about their health and 
their babies’ health. 
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In summary, Chapter 1 provides an epidemiological profile of the HIV epidemic 
in Kenya. Chapter 1 shows that HIV prevalence is higher in urban than rural areas and 
the odds of being infected with HIV is four times higher among young females aged 15–
24 than among boys in the same age group.(6) The  rates of condom use at last sex has 
been estimated at only 8.5% among young females aged 15–24 compared to 39.4% 
among young men in the same age group.(6,14) Furthermore, young men are seven times 
more likely to have multiple concurrent partners—a driver of HIV infection—than their 
female peers.(6)  
Though one of the key eMTCT strategies is increased male involvement, 
programmatic data in Kenya estimate male involvement at only 4.5 %.(6) Although HIV 
has no cure, recent scientific discoveries and advocacy have improved access to ART in 
low income countries and encouraged the efforts towards elimination of MTCT 
(eMTCT). Despite the current PMTCT efforts in Kenya, the goal of  eliminating new 
HIV infections among children and halving pregnancy-related deaths caused by AIDS by 
2015 remains elusive.(3, 52) Achieving near perfect retention of HIV positive women 
throughout the PMTCT cascade in Kenya will greatly contribute to the eMTCT goal.   




LITERATURE REVIEW  
 
2.1. RETENTION IN PMTCT  
As discussed in Chapter 1, the majority of literature on retention in PMTCT 
programs from Sub Saharan Africa (SSA) focuses on PMTCT uptake, adherence and 
retention specific to ART use and not to the entire PMTCT cascade. The literature also 
heavily focuses on the barriers that hinder retention and rarely discusses the facilitators 
that promote retention outside of providing recommendations to counter the barriers.   
Three detailed literature reviews specific to PMTCT have recently been 
published: 1) Gourlay et al. 2013 conducted a systematic review which summarized the 
barriers and facilitators to the uptake of ART in PMTCT programs, 2) Nachega et al. 
2012 conducted a systematic review and meta-analysis that estimated the adherence rates 
to ART during and after pregnancy, and 3) a 2012 WHO literature review summarized 
the experiences of women accessing PMTCT services.(60–62) The geographic inclusion 
of the studies was as follows: 1) Gourlay et al. was limited to sub SSA, 2) Nachega et al. 
included low-income, middle-income, and high-income countries, and 3) WHO included 
SSA, Asia and Latin America. I used these three papers as a basis for this literature 
review. The literature review summarizes the factors influencing uptake and retention in 
PMTCT care into eight sub headings: 1) HIV counseling related barriers, 2) personal 
barriers 3) HIV related stigma, 4) disclosure of HIV status, 5) gender related barriers, 6) 
ineligibility for ART, 7) health system factors, and 8) peer counseling and psychosocial 
support. 
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2.2. HIV testing and counseling related barriers 
Pre-test and post-test HIV counseling, confidentiality and informed consent are 
prerequisite for HIV testing. However, even in the presence of national guidelines studies 
show that service delivery related to pre- and post-test counseling, confidentiality and 
informed consent differ within and among facilities.(63,64) A multi-country African 
Testing and Counseling for HIV study (MATCH) conducted in Burkina Faso, Kenya, 
Malawi and Uganda  reported that 89% of the study respondents indicated having a  pre-
test meeting with 75% reporting a complete pre-test index.(63)  Consent, confidentiality  
and overall satisfaction with the pre-test counseling process was reported at 86%,79%, 
and 81%, respectively; and 71% of HIV-positive respondents reported a complete post-
test referral.(63)  
Studies show that the quality and comprehensiveness of HIV pre and post-test 
counseling is often compromised. In many ANC settings including the Kenyan context, 
pre-test HIV counseling occurs in a group setting of between 15–20 women, while post-
test counseling is a one-on-one event. Two Kenyan studies showed that the duration, and 
frequency of pre and post-test counseling was low, with post-test counseling lasting for 
approximately 10 minutes.(65,66) These studies further showed that counselors provided 
a lot of  packed information to women newly tested  HIV positive, and rarely addressed 
the immediate emotional reactions experienced from receiving an HIV positive result.(65, 
66)  
Additional studies showed that little time, if any, was allocated in the ANC to 
prepare the women before they took the test and/or to allow the newly diagnosed 
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individuals to ask questions.(67) Conversely, one of these  studies conducted in Busia, 
Kenya reported that  95% of the women in the study indicated satisfaction with the time 
allotted for questions and answer and the information given  during the pre-test and post-
test counseling sessions.(68) The contradiction in the results could be time sensitive; the 
first two studies were conducted in the early 2000s while the third study was conducted 
in late 2000. Evidence suggest that the adherence to HIV testing guidelines by healthcare 
providers, the shift to a more prescriptive  “opt out” provider initiated HIV testing model, 
and the increase in HIV knowledge  among the general population could account for the 
differences observed among these studies. Having adequate time to process this new 
information and ask questions is a likely prerequisite for retention in PMTCT care.   
The shift to the “opt out” provider initiated HIV testing in ANC settings has led 
some women to perceive HIV testing in ANC settings as mandatory. Obermeyer et al. in 
a four country study—Burkina Faso, Kenya, Malawi, and Uganda—reported that some 
women in ANC settings did not understand that taking the HIV test was optional, and that 
the emphasis by healthcare workers on the benefits of PMTCT pressured some women to 
take the HIV test.(63)  Studies by Njeru et al. and Ujiji et al. conducted in rural Kenya 
with women tested in ANC settings also echoed this;  study subjects did not understand 
that taking the HIV test was optional, and those that understood felt that there was no 
way to “opt out”  of the test.(67,68) For example, none of the 900 pregnant women in the 
Ujiji et al. study opted-out  of the HIV test,  and 83% reported that they had not 
understood that “opting out” of the HIV test was an option.(68)  This study further 
reported that only 20% of the women felt empowered enough to “opt out” of the HIV test 
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while majority did not understand the separation between HIV testing and regular ANC 
services. (68)  The “opt out” decision is further complicated by the imperfect agency 
between the healthcare workers and the pregnant women. Healthcare workers are held in 
high regard, their advice trusted and pregnant women are uncomfortable saying no to the 
benefits of PMTCT as articulated by the healthcare worker. (67–70) Similar perceptions 
where HIV testing was considered mandatory in ANC settings were reported by women 
in rural Malawi with many expressing feelings that PMTCT was about the baby and not 
the mother. (71)  
The value of pre and post HIV counseling in ANC settings cannot be overstated 
given that newly diagnosed women are processing an HIV positive result while pregnant. 
A matched case-control study of the MOH facilities in Nyanza province found that 
MTCT was 2.85 times more likely among women who tested HIV positive during 
pregnancy than those who previously knew their status.(72) This finding points to the 
need to comprehensively counsel pregnant HIV positive women and provide ongoing 
counseling throughout the pregnancy if retention in PMTCT care is to be achieved.  
 
2.3. Personal factors  
Personal factors such as age, level of education, socio-economic status, and 
knowledge regarding HIV and AIDS have been shown to impact uptake of PMTCT 
services including but not limited to HIV testing, ART adherence and facility delivery by 
HIV positive women. The PEARL study conducted in Zambia, Cote d’Ivoire, South 
Africa and Cameroon showed that younger maternal age and fewer antenatal visits were 
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strongly associated with failure to receive sdNVP prophylaxis.(10) Studies with HIV 
positive women in ANC settings in Kenya showed that a woman’s knowledge regarding 
HIV, PMTCT and ART influenced their decisions to test for HIV, seek long term HIV 
care, and the breastfeeding choices made postnatally. (20,73,74) Conversely, age was a 
statistically significant predictor of MTCT in the case –control study of MOH facilities in 
Nyanza province.(72)   
In regard to economic factors, a study conducted in Nairobi, Kenya by Otieno et 
al. among HIV positive women who had participated in a PMTCT research reported that 
19% of the subjects cited the lack of money as a barrier to accessing HIV care. (20) 
Another study conducted by Kinuthia et al. among women attending maternal and child 
health clinics in Nairobi and Nyanza provinces in Kenya, found that women of lower 
socioeconomic status were more likely to refuse HIV testing than those of a higher 
socioeconomic status. (12) In addition, 30% of the study subjects in the Kinuthia et al. 
study reported competing time demands as reason for not attending ANC visits while in 
the Ujiji et al study, the required time for counseling was a disincentive for HIV-1 
testing.(12,68) Conversely only 3% of women in the Otieno et al. study indicated time 
demands to affect access to HIV care services.(20) As shown above personal factors can 
be barriers or facilitators to uptake of PMTCT and HIV services and retention further 
along the continuum of care.  
2.3.1. Geography and Distance 
Closely related to a woman’s socioeconomic status is the distance travelled from 
the woman’s home to the health facility, and the costs associated with this travel. In the 
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Kinuthia et al. study, 20% and 16% of the women reported that distance and cost of travel 
respectively influenced uptake of ANC services; while 23% and 17% indicated that 
distance and cost of travel respectively influenced the place of delivery.(12) According to 
KAIS 2012 the distance to the  health facility was cited as the most common reason for 
ANC non-attendance (32.5%), followed by cost (could not afford the service), and lack of 
time (too busy) at 13.4% and 8.8% respectively. (6)  In addition, two studies from  
Malawi showed that the distance walked by the mother during and after delivery 
influenced hospital attendance.(75,76) Conversely, only 5% of the women in the Otieno 
et al. study indicated that inaccessibility to the health centers was a reason for not seeking 
HIV care.(20) Ferguson et al. in a study conducted in Naivasha and Gilgil hospitals in 
Kenya found that there was no association between the distance from the woman’s home, 
the hospital and registration in the HIV clinic. (25)  A 2013 study that analyzed the 
Kenya 2008/2009 DHS for factors that influence place of delivery for women also found 
that distance to the facility was not statistically significant in influencing a woman’s 
place of delivery.(77) Based on this literature, distance may directly influence retention in 
PMTCT care especially in cases distance and inaccessibility to health facilities cause 
women to disengage with care.  
 
2.4. Stigma  
Stigma can be external or internal: external stigma is the “actual experience of 
discrimination”, while internal stigma may be felt or imagined, and is defined as “the 
shame associated with HIV and AIDS and the fear of being discriminated against.”(78) 
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Studies show that HIV related stigma negatively affects health seeking behavior which in 
turn impacts retention in PMTCT care. (19, 78–80) Pregnant HIV positive women have 
been shown to suffer multiple layers of stigma. In most instances a pregnant woman is 
the first person in the family to know the HIV status, and thus she is faced with the 
burden of disclosure. This situation often leads to the woman being blamed and judged 
responsible for infecting the partner.(74) Secondly, the pregnant woman is judged for 
getting pregnant while HIV positive and putting their unborn child at risk for HIV 
infection.(74)  Thirdly, once the baby is born women who choose not to breastfeed  or  
stop breastfeeding early are often stigmatized.(73) 
The MAMA’s study conducted in Nyanza Province, Kenya with women attending 
ANC reported high rates of  anticipated HIV and AIDS stigma with 45%  indicating that 
they anticipated losing friends once their HIV status was known.(79) This study further 
found that  internal stigma expressed by a woman’s “specific fears of stigma and negative 
events for herself” were more important predictors of  HIV testing acceptance than the 
public’s perceptions of PLHIV.(79) In addition, as reported in a qualitative study 
conducted in Nairobi and Busia, Kenya the  experiences of stigma are  different 
depending on location (rural or urban) as well as the type of relationship a HIV positive 
women has with the social networks.(80)  For example, while those in the rural areas 
described the extended family as crucial part of decision making in HIV related care, 
those in urban areas often made these decisions independent of the extended family 
influence. (80) 
Similarly, Kinuthia et al. found that external stigma was not associated with lower 
	  	  	  
31 
HIV testing among mothers or infant HIV infection rates, whereas internal stigma was 
associated with modest decreased antiretroviral uptake.(12) Two Kenyan studies—
MAMA’s study and Kunuthia et al.—found that external stigma defined by the public’s 
perceptions of stigma was not the major reason why women refused HIV testing.(12,79)  
The matched case-control study of  MOH facilities in Nyanza province found that stigma 
experienced from the community or facility did not increase MTCT.(72) Kinuthia et al 
concluded that health system factors were more important predictors of uptake than 
stigma; and they contributed to about 60% of non-testing among mothers who attended 
ANC, and to missed opportunities in offering ART and utilization of facility delivery.(12)  
 
2.5. Disclosure of HIV Status to Male Partners 
The disclosure of HIV status to male partners during the ANC phase has been 
associated with positive behaviors regarding adherence to PMTCT regimens, better 
feeding practices, safer sex, and increased male partner testing. Disclosure has been 
positively associated with living in urban areas, higher education levels, and being male, 
while being negatively associated with membership to support groups.(6,81) Findings 
from a 2004 literature synthesis on rates, barriers and outcomes of HIV status disclosure, 
estimated disclosure rates to range from 16.7% to 86%, with women attending voluntary 
HIV testing and counseling clinics more likely to disclose their HIV status to their male 
partners than women who were tested in the ANC.(82)  
The implementation of HIV testing in ANC settings aimed at preventing MTCT 
has resulted in a situation where more women are likely to be tested than men, and as a 
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result, many women know their HIV status before their male partners do.(6,74) This 
phenomenon has placed the burden of HIV status disclosure on the women given that 
most women indicate not knowing their male partner’s HIV status.(81,83,84) A study 
conducted in Nairobi’s Mathare slums found that 58% of the women who disclosed their 
HIV status already knew their male partners HIV status, concluding that disclosure of 
HIV status was correlated with knowledge of partner’s testing status.(85) 
 In the MATCH study only 33% of women disclosed their HIV status to their 
partners for fear of “being blamed, abused, and/or abandoned.”(69) A study with ANC 
attendees in Eastern Uganda found that the fear of losing material and financial support 
from the male partners was a major consideration on whether an HIV positive woman 
disclosed their status to a male partner or not.(86) In addition to this Eastern Uganda 
study, another study conducted in Tanzania’s Dar es Salaam and Iringa region, found that 
women very carefully evaluated the nature of their relationship (monogamous, 
polygamous, length in the relationship ) and quality (level of communication, trust) 
before disclosing their HIV status. (86,87) 
Evidence suggests that the fear of abandonment and the loss of financial support 
for their child at a time of pregnancy is the reason why fewer women tested HIV positive 
in ANC settings are less likely to disclose their HIV status, directly influencing retention 
in PMTCT care.  
 
2.6. Gender related barriers  
As indicated above, the perceived state of the relationship between a woman and 
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her male partner influences decision-making regarding HIV testing and seeking long term 
care. Studies show that male partners often have the biggest direct impact on the female 
spouse’s  decisions and that fears about negative reactions from influential partners are 
important predictors of PMTCT service uptake.(86–89) The fear of being labeled 
“promiscuous, abandoned, violated, losing financial security, rejected by one’s partner,” 
and the lack of knowledge about male partner HIV testing were the most important 
influences on women’s decision.(86) For example, in  the MAMA’s study, a woman’s  
fear of being labelled “promiscuous, rejected, abandoned, and/or violated” were  
important personal predictors as to whether a pregnant women accepted HIV testing or 
not.(79) Similarly, Otieno et al. reported that 30% of study subjects indicated that the fear 
of violence from partners was a major barrier to accessing HIV care.(20)  
The position that many women occupy in the African society is one of economic 
dependence on male partners and little decision making power greatly influences the 
decisions they make on whether or not to access PMTCT services. (79,86,88,90) Perhaps, 
it is this position of social and financial power that makes men more likely than women 
to disclose their HIV status to spouses.  
 
2.7. Ineligibility for ART 
All previous PMTCT guidelines in Kenya before the release of the June 2014 
amendment set ART eligibility for ARV medications to a CD4 count ≤ 350 cells/mm3 
and/or WHO disease stage 3 or 4. Also, as mentioned in Chapter 1, Kenya has been 
implementing Option A for PMTCT since 2009 which relies on a CD4 count and WHO 
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disease staging to determine eligibility. Evidence shows that approximately 50% of 
individuals testing HIV positive are eligible for ART for their own health (CD4 cell count 
≤350 cells/mm3), with an additional 25% having CD4 cell count between 350 and 500 
cells/mm3. (91–93) The ineligibility to ART has been shown to negatively affect 
retention in long term PMTCT care. For example, in the Otieno et al. study 33% of the 
subjects dropped out of long term care because they were ineligible for ART and did not 
understand the benefits of staying in care if they did not  receive ART for their own 
health.(20)   
A study using program data from The MTCT Plus Initiative in Cameroon, Cote 
d’Ivoire, Kenya, Mozambique, Rwanda, South Africa, Uganda, Zambia, and Thailand 
showed that only 23% of the HIV positive women qualified for ART according to WHO 
clinical stage 3 or 4 of HIV disease, whereas 94% met CD4+ cell count criterion.(92) 
This means that PMTCT sites that rely solely on the WHO clinical staging criteria due to 
a lack of CD4 count testing capacity are likely to be pronouncing ART eligible women as 
ineligible.  
 
2.8. Health system related factors 
The health system is a key component of a successful PMTCT program.  As 
discussed earlier, the Kinuthia et al. found that health systems factors such as the failure 
to test for HIV due to missing test kits or supplies accounted for 60% of the reasons why 
women did not accept HIV testing. (12) The matched case-control study in Nyanza 
province also concluded that health system factors were  more important predictors  of  
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MTCT than psychosocial factors.(72) In this study, six health facility-related factors were 
found to have statistically significant effect in increasing MTCT namely: 1) insufficient 
HIV education; 2) no counseling given to mothers at first contact; 3) lack of disclosure 
assistance,  4)  lack of encouragement to involve male partners;  5) women not receiving 
ART at the first contact in the clinic; and 6) lack of  adherence by the  health providers to 
ART prescription guidelines for mothers and infants.(72)  
A model testing the  effect of variation in performance of the different steps of the 
PMTCT cascade using hypothetical and reported data in South Africa found that 
“improving reliability of the system at all steps to 95% efficiency would result in a fall in 
the transmission rate to 4.1%.”(94) Data from a three year district level PMTCT program 
in South Africa that introduced system changes to “support frontline healthcare workers 
identify and improve performance gaps at each step of the PMTCT cascade;” reported a 
decline in the proportion of infants testing HIV positive, improved ART uptake during 
the ANC phase for both prophylaxis and own health, and   an increase in postnatal HIV 
testing. (95) I will discuss in detail four health system factors that have been shown to 
influence retention.   
Space/long waiting time: HIV positive women generally encounter longer wait 
time in various stages of the PMTCT cascade a factor that influences retention in PMTCT 
programs.(71) The use of HIV rapid tests has ensured that HIV test results are received 
within an hour and those seeking HIV testing do not need make a return trip to collect 
their HIV test results. Individuals who test HIV positive however, have additional steps 
to complete before a decision on ART regimen is made. Figure 4 is a schematic 
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representation of the steps between knowing one’s HIV status, referral to a clinician for 
HIV disease staging, referral by the clinician to a laboratory for CD4 count estimation 
and return for the CD4 count results, before a decision on the ART regimen is made.  
This process involves return trips back and forth home and the health facility. Studies  on 
same-day (point of care) CD4 testing options have shown that same day  CD4  improve 
uptake to ART programs.(96–98)    





Low laboratory capacity for diagnostic tests such CD4 cell counts, viral load in  
many resources poor countries has been shown to negatively contribute to AIDS 
mortality, drug resistance and higher HIV management costs.(99,100)  Early infant 
diagnosis in the first 1–2 years of age for example, is complicated by the presence of 
maternal antibodies which rules out the use of antibody tests and requires molecular 
biologic tests such as the polymerase chain reaction (PCR). (101,102) The PCR machines 
just like the viral load and the CD4 count machines are not always available in health 
facilities offering PMTCT services and where available, they may not be functional due 
to lack of parts or reagents. (100) This creates apathy among PLHIV and often leads to 
drop out from the care.  
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Stock outs (ARVs, HIV test kits, CD4 test supplies): Adherence studies show that 
ARV stock outs and especially pediatric formulations negatively affect adherence to 
ART. (103,104) 
Health provider factors: In addition to the limited number of qualified health care 
workers, heavy work and negative attitudes of health care providers have been shown to 
affect uptake of PMTCT services. (36,75,76,105)  
 
2.9. The role of peer counseling and psychosocial support  
Psychosocial support and peer counseling by non-medical personnel and lay 
counselors is implemented widely and continues to play an important role in addressing 
retention in HIV care.(61) However, the evidence base shows mixed results of success. 
For example, the use of peers to supervise and administer ART and/or provide social 
support has shown success while peer based psycho-educational groups show null 
results.(106) An evaluation on the mothers2mothers (m2m) project in South Africa 
showed that in comparison to non m2m clients, m2m clients “had greater psychosocial 
well-being, greater use of PMTCT services, and better PMTCT outcomes.”(107)  Two 
studies conducted in Nyanza, Kenya  reported that women who lacked social support 
were 2.83 times more likely to have an HIV positive child and  that social factors were 
important predictors of breastfeeding cessation among  HIV positive women.(72,73) 
Reports from the mothers2mothers model which provides psychosocial support and peer 
counseling to HIV positive women in PMTCT settings, have demonstrated that 
beneficiaries of the program are able  to “help themselves and are less overwhelmed” 
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with problems.(108) Similarly, respondents of a qualitative study exploring perceptions 
of the m2m model in Zimbabwe reported improved self-efficacy and motivation, with 
mentor mothers being viewed more approachable than hospital staff.(109)  
In summary, Chapter 2 provides a literature review of the factors that influence 
uptake of services along the PMTCT cascade and retention in PMTCT care. Though 
many of the factors discussed in Chapter 2 directly influence uptake of PMTCT services, 
their effect can be extrapolated to long term engagement in PMTCT care. This study 
explored the connections between stated epidemiologic profiles discussed in Chapter 1 
and factors highlighted in the literature review in Chapter 2, and sought to understand the 
connections and predict how this impacts retention in PMTCT care.  
  




Conceptual Model, Study Setting and Research Questions 
3.1. INFORMATION, MOTIVATION, BEHAVIORAL SKILLS 
The conceptual basis for this study is the Information, Motivation, Behavioral 
Skills (IMB) model. The IMB provides a generalizable, predictable and uncomplicated 
way of thinking about complex health behaviors.(110) The IMB has been  applied across 
a variety of clinical applications such as to HIV prevention, adherence to HIV medication 
and retention in HIV care.(110–114) The IMB model identifies prevention information, 
motivation and behavioral skills as fundamental determinants of HIV preventive 
behavior.(112) The IMB model posits that information is a prerequisite for behavior 
change but by itself is insufficient to achieve the desired change.(112)  Amico et al. 2009 
applied the IMB model for  Highly Active Antiretroviral Therapy (HAART) adherence 
and  listed adherence information and motivation work through adherence-related 
behavioral skills as determinants of adherence to HAART.(111) Smith et al. 2012 
qualitatively tested the application IMB model in retention of people living with HIV and 
AIDS in HIV care and situated the IMB model in social-environmental, structural, 
cognitive- affective, and behavioral demands. (114) The situated IMB model moves 
beyond individual behavior and explores how a person’s context and environment affect 
behaviors that promote retention.  
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Constructs of the IMB Model  
The IMB model is built on three constructs:  Information, motivation and behavioral 
skills.  These are discussed below and presented in a schematic diagram; Figure 5. 
Information as a prerequisite for preventive behavior: This relates to the individual 
having the basic knowledge on HIV transmission, disease progression, HIV prevention 
and the effective strategies for HIV management.(110) 
Motivation to engage in preventive behavior: is assumed to be function of personal 
attitudes towards the HIV prevention, perceived societal acceptance for the preventive 
behavior and the subjective perception on how others with a similar condition 
behave.(110) Additionally, motivation is depends on an individuals’ perception of the 
costs and benefits associated with the HIV preventive behavior, the perceived 
vulnerability to HIV infection, and type of partner (primary vs. secondary). (110) 
Behavioral skills for performing specific HIV-preventive acts:  involve having the 
necessary behavioral tools or strategies to perform the required behavioral act.(111) 
These tools include having the ability to negotiate HIV preventive behavior with a 
partner and the capacity to exit the relationship if negotiation fails. An individual with 
these behavioral skills is assumed to possess self-beliefs in executing the required 
behavior and a sense of self-efficacy.  (111) 
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Applicability of the IMB Model to retention in PMTCT care 
The study applies the IMB model to analyze, organize, explain results, and frame 
policy and programmatic recommendations. The applicability of the IMB Model 
concepts to retention in PMTCT care is discussed below:  
Information: This related to the individual knowledge on HIV and AIDS  in three 
levels: 1) accurate knowledge of HIV disease and in particular PMTCT procedures and 
benefits, HIV treatments and PMTCT prophylaxis in pre/post-natal phases, infant feeding 
options and infant regimen options. In addition, having the ability and perception to 
identify misinformation, myths about HIV disease and the negative cultural beliefs that 
exist within communities, and how they impact care seeking.  2)  Accurate knowledge of 
different types of HIV and AIDS services including PMTCT available within health 
facilities and the community.  3) Knowledge on the importance of staying in PMTCT 
care and adhering to maternal child health (MCH) appointments, namely antenatal, 
maternity and postnatal care.   Also, knowledge about HIV medications for self and 
infant as well as the consequences of disengaging with PMTCT care for both self and 
infant.   
Information	  	  
Motivation	  	  
Behavioral	  Skills	  	   Behavior	  change	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Motivation: The motivational factors can be categorized as: 1) personal attitudes 
towards MCH and  PMTCT care seeking; 2) perceptions about disclosure or HIV positive 
status, health care services provided, the attitudes of others towards people with HIV and 
benefits of staying in PMTCT care; 3) previous negative experiences while seeking care 
(provider attitudes, side effects, inadequate care) and consequences at the domestic level 
as a result of seeking care; 4) perceptions of competing priorities such as work and 
running a business and the opportunity cost associated with long wait times at the health 
facility, economic (transportation costs) and social (stigma) costs of staying in PMTCT 
care.  
Behavioral skills: The behavioral skills include the individuals’ perceived 
abilities as well as the socio-contextual factors that support positive behavior. These 
include: 1) self-efficacy, confidence and perceived ability to live a “normal” life like 
others without HIV and deliver an HIV negative baby; 2) ability to conceptualize the 
importance of keeping appointments, adhering to the PMTCT process, staying in PMTCT 
care, and knowing where to seek help; 3) developing coping strategies to manage HIV, 
address stress that comes from life’s pressures as well as a positive HIV status, and 
overcome internal and external stigma; 4) socio-contextual factors such an individual’s  
acceptance or denial of HIV positive status, the willingness to live as well as having a 
supportive male spouse and family. 
The IMB will be applied in Chapters 5 and 6.  Chapter 5 provide an understanding 
of individual experiences and value placed on retention in PMTCT care by the HIV 
pregnant women and their families, and how these experiences  impacts health seeking 
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behaviors along the PMTCT cascade. The Failure Mode Effect Analysis (FMEA) 
discussed in Chapter 6 identifies failure modes along the PMTCT cascade where along 
the cascade they occur as well as the causes of these failure modes.  Figure 6 illustrates 
the application of the IMB model to the retention of HIV positive women in PMTCT care 
as defined by this study.   
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• Follow up calls by the mentor 
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• Continuous counseling by the 
mentor mothers   
Context and environmental factors  
1. Individual acceptance or denial of HIV 
positive status, willingness to live  








The study was conducted in collaboration with mothers2mothers (m2m)–Kenya. 
M2m-Kenya is a nongovernmental organization (NGO) that provides psychosocial and 
peer support to HIV-positive women in PMTCT settings.(115) M2m-Kenya has been 
operating in Kenya since 2008 and currently implements the Kenya Mentor Mother 
Program (KMMP) in 30 high volume government health facilities across the country, and 
enrolls approximately 11,500 HIV-positive women annually.(115) The m2m-Kenya 
program improves PMTCT service delivery within public institutions using Mentor 
Mothers who are paid staff and whose goal is to assist HIV positive women to adhere to 
the PMTCT process along the cascade. As defined in Section 1.6.5, Mentor Mothers are 
HIV-positive mothers who have completed the PMTCT process at the facilities where 
they work.  
Mentor Mothers are based within the health facilities and are trained to provide 
information on HIV and AIDS, PMTCT, disclosure, breastfeeding and ART among other 
topics. The pre-service training that prepares new Mentor Mothers is two weeks 
long.(116,117) The trainees are introduced to the Mentor Mother role and the 
responsibilities, the KMMP, the standards and codes of practice.  The participants receive 
basic training on HIV transmission and prevention of HIV and AIDS, PMTCT, ART, 
sexual and reproductive health, safe motherhood and early infant care, infant feeding, and 
positive living for the mothers and the families. They also receive skills training in 
	  	  
46 
interpersonal communication, facilitation geared to adult learners, and collection of 
routine data in the ANC and post-natal settings where they work. (116,117) The Mentor 
Mothers maintain three registers namely the: 1) KMMP HIV Positive Logbook which 
captures information about the HIV positive women (clients) who enroll in the KMMP, 
2) the KMMP HIV-Negative Logbook which captures a more limited set of information 
about HIV negative women, and 3) KMMP Defaulter Tracing Register which contains 
the contact information of the client, the missed facility visit date, and the consent 
information on how the client should be followed up and/or contacted. The options 
include: 1) full consent (text message and telephone call), 2) telephone call only, 3) no 
consent for a telephone call, 4) full consent for a home follow up visit,   and 5)  no 
consent for a home follow up visit.(116,117)  
The Mentor Mothers provide health education and lead the group pre-test 
counseling sessions in ANC settings. In addition, following an HIV positive diagnosis the 
Mentor Mothers provide additional post-test education, offer ongoing psychosocial 
support and peer education as well as guide the HIV positive mothers to navigate the 
PMTCT steps and the transition to treatment programs. For example, they will 
accompany an HIV positive woman to the laboratory for CD4 count testing, inform them 
via telephone when their CD4 count results are ready for collection, explain the meaning 
of the results, and the next steps in the PMTCT process. The Mentor Mothers also keep a 
record of the HIV positive women’s clinic appointment and will call them to remind them 
of the visits wherever necessary. Mentor Mothers also link with CHWs to facilitate home 
visits in cases where the client has defaulted  clinic appointments and cannot be reached 
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by phone.(115). In this study, the Mentor Mothers facilitated subject recruitment by 
making initial contact with the participants for the qualitative in-depth interviews 
discussed in Chapter 5.  
Study sites  
 
The study was conducted in three public (government owned) health facility sites 
where m2m-Kenya is active. The study sites were:  
i. Kayole Level II Health Center, Nairobi County: Tier 2.  
ii. Kiambu County Hospital, Kiambu County, Tier 3. 
iii. Nyeri County Hospital, Nyeri County; Tier 3. 3 
The Kenyan health system was previously organized into six levels of care and 
has now transitioned into four tiers of care based on the scope and complexity of the 
services offered: Tier 1 is community units; Tier 2 is primary care health facilities that 
provide basic outpatient health services (previously Level II & Level III); Tier 3 is county 
referral hospitals (previously Level IV & Level V); and Tier 4 is national referral 
facilities (previously Level VI). (118) 
Site selection was purposive rather than random and was influenced by various 
factors discussed below. First, as indicated in Chapter 1, the majority of HIV and AIDS 
studies in Kenya have been conducted in Nyanza and Nairobi regions and fewer have 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 After the promulgation of the Kenya 2010 constitution in 2013, Kenya changed the 
administrative units from districts to counties. Levels of care and health facility names also 
changed. Kiambu County Hospital was previously known as Kiambu District Hospital while 
Nyeri County Hospital was previously Nyeri Provincial Hospital.   
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been conducted in Central region. Selection of the Central region therefore provides a 
unique opportunity to focus on an under-studied population. Second, according to the 
KAIS 2012, Central and Nyanza regions showed an increasing HIV prevalence among 
women aged 15–49 in the five year period  between KAIS 2007 and KAIS 2012, with the 
HIV prevalence in Central region increasing from 4.3% to 5.6% respectively.(6) Third, 
Nairobi region has the second highest prevalence (5.9%)  among women aged 15–49 
after Nyanza region.(6) Fourth, the three sites provide a mix of health care levels (referral 
hospital, county hospital and a health center and a rural, urban and peri-urban mix.  
Kiambu County Hospital is peri-urban, Kayole Health Center is urban serving low 
income populations, and Nyeri County Hospital is an urban referral hospital serving 
mostly rural populations. This mix of health facilities was especially important because it 
allowed the study access to both rural and urban women as well as women with varied 
socio-economic characteristics. Fifth, budgetary, personnel and logistical requirements 
steered the study site selection towards health facilities that are geographically accessible 
from Nairobi City. Sixth, m2m was present in these three health facilities. Finally, at the 
time of the study, the three sites were all offering Option A for PMTCT prophylaxis.   
 
A. Kayole Health Center (Kayole HC) 
Kayole HC is located in Kayole-Soweto which is one of the eight slums that 
make up the Embakasi Sub County in Nairobi County’s Eastlands area and has an 
estimated population of 89,600 distributed in 22,400 households.(119) It is estimated that 
the majority of people living in Kayole earn US$ 150 a month.(119) In 2009, the 
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population of Nairobi County was estimated at 3,138,369 of which 100% were 
urbanized.(120) In 2013, the overall HIV adult prevalence in Nairobi County was 
estimated at 6.8%, with 177,552 people reported to be living with HIV and of these 7.3% 
were children.(4) New adult infections were estimated at 3,098 .(4) In 2013, 4,982 HIV 
positive pregnant women were in need of PMTCT and 316 children were newly infected 
with HIV through MTCT.(4) In 2011, 61% of pregnant women in Nairobi County 
attended four ANC visits and 59% of HIV-positive pregnant women in the County did 
not deliver in a health facility. In 2011, 62% and 35% of those testing HIV positive 
delayed before entering a care and treatment program and a PMTCT program 
respectively.  Nairobi County ART coverage among children is estimated at 48%. (121) 
 
B. Kiambu County Hospital (Kiambu CH) 
Kiambu CH is located in Kiambu County and 17.7 kilometers (11 miles) from 
Nairobi City.(122) In 2009, the population of Kiambu County was estimated at 1,673,785 
of which 61% (1,017,476) are urbanized. (122) In 2013, the overall HIV adult prevalence 
in Kiambu County was estimated at 3.8%, with 46,658 people reported to be living with 
HIV, and of these, 9% were children. (4) New adult infections were estimated at 2,931.  
In 2013, 1,500 HIV positive pregnant women were in need of PMTCT, 96 children were 
newly infected with HIV through MTCT, and 3,041 children were in need of ART. (4) In 
2011, 59% of pregnant women in Kiambu County attended four ANC visits and 48% of 
HIV-positive pregnant women in the County did not deliver in a health facility.(123) In 
the same year, 73% and 45% of those testing HIV positive delayed before entering a care 
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and treatment program and a PMTCT program respectively. Kiambu County ART 
coverage among children is estimated at 57%.(123) 
 
C. Nyeri County Hospital (Nyeri CH)  
 
Nyeri CH is located in Nyeri County4 which is approximately 150 kilometers (94 
miles) north of Nairobi City in the densely populated Central region.(124)  Nyeri County 
has six constituencies5: Tetu, Kieni, Mathira, Othaya, Mukurwe-ini and Nyeri 
Town.(124)  Nyeri CH is located in Nyeri Town and as a referral hospital serves 
populations from all the other constituencies and beyond. In 2009, the population of 
Nyeri County was estimated at 693,558 of which 25% are urbanized. (124) Nyeri 
County’s  urbanization average of 25% is below Kenya’s urbanization average of 
32%.(124) In 2013, the overall HIV adult prevalence in Nyeri County was estimated at 
4.3%, with 20,797 people reported to be living with HIV and of these 9% were children. 
(4) New adult infections were estimated at 1,307.(4)  In 2013, 669 HIV positive pregnant 
women were in need of PMTCT,  43 children were newly infected with HIV through 
MTCT, and 1,355 children were in need of ART.(4)  In 2011, 73% of pregnant women in 
Nyeri County attended the recommended four ANC visits and 51% of HIV positive 
pregnant women in the County did not deliver in a health facility. (125) In the same year, 
80% and 65% of those testing HIV positive delayed before entering HIV care and 
PMTCT programs respectively.(125) Nyeri County ART coverage among children is 
estimated at 67%.(125) 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 County: geographical units provided for in the 2010 Constitution of Kenya as the units of 
devolved government. 




The study has three research questions: 
I. Research Question 1: What is the retention of HIV-positive women along the 
PMTCT cascade?  
II. Research Question # 2: What are the experiences of HIV positive women with 
PMTCT services?  
• What individual, interpersonal, social, cultural, service delivery, 
institutional and policy factors facilitate/hinder HIV positive women from 
“staying” in PMTCT care? 
• How are women’s experiences in PMTCT services affecting their 
subsequent health care-seeking behavior? 
• What are HIV positive women’s perceptions of PMTCT services 
including Option B+?  
 
III. Research question # 3: What are the potential failures along the PMTCT 
cascade and where along the PMTCT cascade are these failures occurring? 
The study was executed to answer Research Question # 1 first, followed by 
Research Question # 2 and lastly Research Question #3. The research methods employed 
to answer each questions were: a retrospective chart review, in-depth one-on-one 
qualitative interviews, and a Failure Mode and Effect Analysis (FMEA) respectively.   
In summary, Chapter 3 provides a detailed description of the IMB model and its 
applicability to this study.  Chapter 3 then describes the study setting including details on 
the collaborating organization and the counties where the study sites are located. Finally, 
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the Chapter outlines the research question and corresponding data collection methods.  
The ethical statement, data collection methods and analysis are presented for each 
approach in the separate chapters 4, 5 and 6. Chapter 7 provides policy and programmatic 








Measuring Retention of HIV Positive Women in the Prevention of Mother to 
Child Transmission of HIV Cascade in Kenya 
 
ABSTRACT  
Objective: To quantify the retention of HIV-positive women along the prevention of 
mother- to- child transmission of HIV (PMTCT) cascade and examine predictors of non-
retention. 
Study hypothesis:   The retention of HIV positive women decreases progressively along 
the PMTCT care continuum from prenatal phase to the postnatal phase. 
Methods: A retrospective chart review was conducted using routine medical data 
collected on HIV positive, pregnant or recently-delivered women aged 18 or older, who 
presented for antenatal care or labor and delivery to one of three facilities from Jan 2012 
to May 2013. The primary outcome of interest was retention in PMTCT care calculated at 
individual and health facility levels through 18 months postpartum when the final HIV 
diagnosis of the exposed infant is made. Logistic regression analysis was performed to 
determine predictors of non-retention. 
Results: Of the 395 women: 88% were married, 87% were diagnosed HIV positive 
during the current pregnancy and over 94% delivered in a health facility. The mean age at 
first antenatal care (ANC) visit was 27.5 years; the mean gestational age at first ANC 
visit was 23.86 weeks; and the mean of the total ANC visits attended was 2.75 visits.  At 
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18 months postpartum, only 9%, 10% and 16% of women were fully retained (completed 
≥80% of the required interventions) in PMTCT care at the three study sites. At all sites, 
retention decreased significantly along the PMTCT cascade from ANC to the postnatal 
phase. Advanced gestational age at first ANC visit (p= 0.043) and fewer ANC visits 
attended (p=0.036) were statistically significant predictors of non-retention.  
Conclusion:  These results demonstrate that retention measured at the individual and 
facility-level is low across the three study sites. The results further illustrate that a 
mother’s gestational age at first ANC visit and the total number of ANC visits attended is 
an important predictor of non-retention in PMTCT care. As Kenya scales up the 
implementation of Option B+ which promotes lifelong ART use among HIV positive 
pregnant and lactating women, innovative strategies to encourage early ANC attendance 
and increase the percentage of women meeting the minimum recommended ANC visits 




4.1. INTRODUCTION  
In 2013, the mother to child transmission rate (MTCT) of HIV in Kenya was 
estimated at 16% and 12,941 children were infected with HIV through MTCT.(3,4) In the 
same year, the total number of children living with HIV was 191,836, and 10,393 deaths 
were reported among HIV infected children.(4) Kenya is one of the 226 priority countries 
identified under the Global Plan Towards the Elimination of New HIV Infections Among 
Children by 2015 and Keeping Their Mothers Alive. (5) The  22 priority countries 
collectively account for almost 90% of pregnant women living with HIV and 90% of new 
HIV infections in children globally.(5) Despite the efforts made to improve prevention on 
mother to child transmission of HIV (PMTCT) coverage, the 2013 UNAIDS Global 
report cited a general decline in PMTCT coverage among HIV pregnant women in Kenya 
from 66% in 2011 to 53% in 2012.(5)  
Kenya’s PMTCT program is based on the four-pronged approach to PMTCT 
strategy developed by the United Nations in 2001 which promotes: 1) primary prevention 
of HIV infection in women, 2) prevention of unintended pregnancies, 3) reduction of 
HIV transmission during pregnancy, labor and breastfeeding, and 4) provision of 
psychosocial support to HIV-positive women and their families.(7) The Kenyan PMTCT 
guidelines recommend four or more antenatal care (ANC) visits as a foundation for the 
delivery of an essential package of integrated antenatal care, immediate postnatal and 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 1. Angola, 2. Botswana, 3. Burundi, 4. Cameroon, 5. Chad, 6. Côte d’Ivoire, 7. DR Congo, 8. 
Ethiopia, 9. Ghana, 10. India, 11. Kenya, 12. Lesotho, 13. Malawi, 14. Mozambique, 15. 
Namibia, 16. Nigeria, 17. South Africa, 18. Swaziland, 19. Tanzania, 20. Uganda, 21. Zambia, 
22. Zimbabwe.  
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neonatal care services with the specific management of HIV positive pregnant women.(7) 
Guidance on the use of antiretroviral (ARV) drugs in pregnancy for HIV treatment and 
PMTCT, the diagnosis of HIV in children, infant feeding options for HIV exposed infants 
and young children, care and follow-up of children of HIV-infected mothers is also 
included.(7) 
Kenya has made a commitment to eliminate MTCT of HIV by 2015. (7,30) The 
virtual elimination of new infant HIV infections is defined “as less than 5% of  MTCT, or 
90% reduction of HIV among young children by 2015.”(31) To achieve virtual 
elimination, PMTCT programs must achieve high coverage and retention of HIV-positive 
women throughout the PMTCT continuum of care, or the “PMTCT cascade.”(22,23,32) 
The PMTCT cascade is defined as a series of steps that must be implemented to facilitate 
delivery of interventions to HIV positive women.(18)  Retention throughout the PMTCT 
cascade maximizes the probability of positive health outcomes for mothers and 
babies.(33) (126,127) 
However, retention along this cascade is a major challenge for HIV positive 
women enrolled in PMTCT programs.(19–21) In sub-Saharan Africa, retention in 
PMTCT programs is estimated to range from 72%–80% during the ANC phase to 
between 30% and 20% at four and six months postpartum. (22,23) Mathematical models 
of the PMTCT cascade demonstrate that in order to reduce MTCT, each step in the 
PMTCT cascade must be delivered (and utilized) with greater than 90% 
reliability.(32,94)  
 Even though PMTCT interventions have been available in Kenya for more than a 
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decade and the uptake of HIV testing in ANC settings (step one of the cascade) has 
increased to 92%, HIV positive pregnant women are still not fully optimizing the use of 
these services. (37) In the 2012–2013 period, the Kenya Ministry of Health (MOH) 
estimated PMTCT coverage defined as a “proportion of HIV-infected women who 
received ARV prophylaxis for PMTCT divided by the number of HIV-infected pregnant 
women” at 65%–70%. (16,17) A study of two Kenyan hospitals reported that only 4% of 
ART eligible HIV-positive women tested in PMTCT settings initiated antiretroviral 
therapy (ART), within 6 months. (25) This is especially worrisome because the HIV-
positive women who did not initiate ART at these two hospitals were those who needed 
ART for their own health and not just for PMTCT prophylactic purposes. (25) 
In 2009 Kenya began to provide zidovudine (AZT) at 14 weeks gestation for 
HIV-positive pregnant women with CD4 cell count greater than 350 cells/mm3 and 
highly active antiretroviral therapy (HAART) for those with a CD4 count ≤350, currently 
referred to as Option A in the national guidelines(7,48) The Kenya 2012 PMTCT 
Guidelines introduced the option of providing ART to all HIV positive women during 
pregnancy, peri-and postpartum periods without regard to CD4 count or clinical 
condition( Option B+), but it was not until June 2014 that guidelines were amended to 
recommend the scale up of Option B+ to all facilities providing PMTCT 
services(7,48,51). The delayed scale up of Option B+ in health facilities in Kenya was 
mostly due to the lack of capacity (human resources, logistics for delivery and 
infrastructural challenges) to initiate and monitor triple therapy.(51)  
Given the current information on the very low retention rates, and the country’s 
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transition to option B+ which requires lifelong ART use, it is critical to understand 
barriers to retention.   This study quantifies retention of HIV-positive women along six 
steps of the PMTCT cascade in three study sites in Kenya. The six steps were: 1) 
antenatal care 2) labor and delivery, 3) postnatal care, 4) antiretroviral therapy 5) HIV 
exposed infant and 6) psychosocial support and peer counseling. The concept of retention 
of HIV positive women in PMTCT care is frequently used to mean adherence to 
antiretroviral therapy (ART) interventions by HIV positive pregnant women. (128) This 
study expands this description and defines retention “as the continuous engagement with 
the PMTCT services throughout pregnancy, labor and delivery and postpartum until the 
determination of the HIV status of the HIV-exposed infant is made at 18 months of age.”  
This expanded definition incorporates coverage, attendance and continuity in PMTCT 
care, and provides a more comprehensive, meaningful indicator of the quality of the 
delivery of PMTCT and related care.  
 
4.2. METHODS  
A retrospective chart review (RCR) of data routinely collected during pregnancy, 
labor and delivery (L&D), postnatal and ART delivery was conducted between October 1 
and November 15, 2014 as part of a mixed methods study. The study cohort size 
determination was based on historical averages of women testing HIV positive during 
first antenatal (ANC) care visits and those positive women presenting for labor and 
delivery at the three study sites.   
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The RCR cohort included all HIV positive, pregnant or recently-delivered women 
aged 18 or older, who presented for ANC, L&D, or postnatal care to one of three 
facilities from January 2012 to May 2013. The maximum observation period for this 
study was 27 months starting at the earliest recorded time of the first ANC visit. The 27 
months comprised: nine months of pregnancy, labor and delivery, and 18 months of 
postpartum including the final determination of the child’s HIV status at 18 months of 
age. In most cases the observation period was shortened due to late ANC attendance and 
the entry of HIV positive women into the study cohort during labor and delivery, and 
postnatal care. Figure 7 illustrates the observation period and the data source.  






4.2.1. MEASURES  
 
There is no gold standard to measure retention in HIV care.(128,129) However, 
Mugavero et al. outline five commonly used measures of retention namely: 1) missed 
visits, 2) appointment adherence, 3) visit constancy, 4) gaps in care and, 5) the Human 
Resources and Services Administration HIV and AIDS Bureau (HRSA HAB) 
Step1 ANC: 
ANC and ART 
registers 
Step 2 L&D: 
 L&D and 
ART registers 
Step 3 PNC : 
PNC and ART 
registers 
Step 4 Infant 
diagnosis:  
HEI register  
Postpartum and infant diagnosis:  
18 months  Birth  
Pregnancy:  
9 months  
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performance measure for retention in HIV care. (130) Appointment adherence is typically 
defined as completed visits/ scheduled visits without regard to the content of the 
encounter, i.e., whether the appropriate services were rendered. (130) In this study, the 
appointment adherence measure was expanded beyond whether the patient showed up for 
an appointment or not, to include interventions received during a given clinic visit. This 
expanded definition allowed the study to measure intended services received as 
recommended by the Kenya PMTCT guidelines and not just planned scheduled 
appointments. Appointment adherence as a measure allows for long observation periods 
and its granular measurement facilitates the assessment of exposure/response 
relationships between retention and outcomes. (130) The appointment adherence formula 
used to measure retention in PMTCT care in this study is below:  
Appointment adherence = completed PMTCT interventions [events] / total 
required as per the Kenya PMTCT guidelines (completed + “no shows”) [trials]  
Appointments for high risk pregnancies, support group meetings, or unplanned 
visits due to sickness were excluded in the retention measure.   
4.2.2. STUDY SETTING  
This study was conducted in three public (government owned) health facility sites 
in Kenya: 1) Kayole Health Center, Nairobi County 2) Kiambu County Hospital, Kiambu 
County, and 3) Nyeri County Hospital, Nyeri County.  In 2012, the overall HIV adult 
prevalence in Nyeri and Kiambu Counties was estimated at 4.4% compared to 8.6% in 
Nairobi County.(37) At the time of the study, the three study sites were all offering 
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Option A [AZT starting at 14 weeks or at first contact in ANC; AZT 600 mg + 3TC 300 
mg + NVP 200 mg at the onset of labor followed by AZT (300 mg BD) and 3TC (150 mg 
BD) seven days post-delivery] for PMTCT interventions as per the Kenya national 
guidelines.(7) In rare cases where the woman did not receive PMTCT prophylaxis during 
pregnancy, the study sites provided single dose Nevirapine, AZT 600mg or AZT 300mg 
BD+ 3TC 150mg BD in labor and delivery as a PMTCT intervention.(7)  
Site selection was purposive rather than random and was influenced by various 
factors: first, the majority of HIV and AIDS studies in Kenya have been conducted in 
Nyanza and Nairobi regions and Central region provided a unique opportunity to focus 
on an under-studied population. Second, according to the KAIS 2012,  HIV prevalence 
among women aged 15–49  in Central region increased from 4.3% to 5.6% in the five 
year period  between KAIS 2007 and KAIS 2012, and Nairobi region has the second 
highest prevalence (5.9%)  among women aged 15–49 after Nyanza region. (6) Third, the 
three sites provided a mix of health care levels serving is peri-urban, rural, and urban 
women with varied socio-economic status. Fourth, budgetary and logistical requirements 
steered the study site selection towards health facilities that are geographically accessible 
from Nairobi City; and fifth, mothers2mothers (m2m) was present in these three health 
facilities.   
This study collaborated with a local organization, mothers2mothers (m2m-Kenya) 
which supports PMTCT in the three study sites. M2m-Kenya is a nongovernmental 
organization (NGO) that provides psychosocial and peer support to HIV-positive women 
in PMTCT settings.(115) M2m-Kenya has been operating in Kenya since 2008 and 
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currently implements the Kenya Mentor Mother Program (KMMP) in 30 high volume 
government health facilities across the country, and enrolls approximately 11,500 HIV-
positive women annually.(115)  
The m2m-Kenya program improves PMTCT service delivery within public 
institutions using Mentor Mothers7 who are paid staff and whose goal is to assist HIV 
positive women to adhere to the PMTCT process.  Mentor mothers are the first point of 
contact for HIV positive women identified at ANC, labor and delivery and postnatal care. 
The mentor mothers provide peer education and psychosocial support, act as PMTCT 
process navigators, encourage the HIV positive women to join support groups, and follow 
up with the HIV positive women to ensure adherence to future appointments. The mentor 
mothers also collect data on select social support indictors outlined in the Kenya Mentor 
Mother Program (KMMP) guidelines and are a source of data in this study. These data 
are recorded in the KMMP HIV Positive Register, and include: knowledge of male 
partner HIV status, disclosure status, and whether or not the male partner accompanied 
the women for ANC and/or PNC appointments. 
 
4.2.3. ETHICAL CONSIDERATIONS.   
Ethical approval to conduct this study was provided by the Boston University 
Medical Campus (BUMC)-USA and Africa Medical Research Institute (AMREF)-Kenya 
Institutional Review Boards (IRB). Approval was also received from the hospital 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7 Mentor mothers is a mother living with HIV who is trained and employed as part of a medical 




superintendents in the three sites and the County Health Departments in Kiambu County 
Hospital and Kayole Health Center. The officers in charge of the maternal neonatal child 
health (MNCH) departments in the three sites provided additional approval.   
 
4.3. DATA COLLECTION  
Six types of registers were reviewed: 1) ANC, 2) L&D, 3) postnatal care (PNC), 
4) HIV Exposed Infant (HEI), 5) ART, and 6) KMMP HIV Positive register. Registers 1–
5 were MOH registers while Register 6 was in the custody of the mentor mothers at each 
study site. The registers were all paper records, not electronic databases, and were 
physically located in the MCH, the L&D departments and the HIV and AIDS 
Comprehensive Care Centers (CCC) in each facility.   
Data abstraction was done using electronic data abstraction tools in MS. Excel. 
The design of the data abstraction instruments adhered to the recommended standards 
where the variables in the abstraction instruments followed the same order as the 
information in each register register.(131) Given that an individual’s data were found in 
different sources- ANC, L&D, PNC, ART, HEI and the KMMP HIV Positive register - a 
different data abstraction instrument was created for each data source. The data 
abstraction instruments were pilot tested using 30 medical charts in Kayole Level II and 
these are not included the final analyses. 
The abstraction instruments did not contain any patient identifiers and subject 
codes, e.g. KY001, KU001, NY001, were used to follow the HIV positive women 
longitudinally along the PMTCT cascade and from one data source to the next. A  master 
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that linked name and date of birth to subject was created in order to allow the study to 
compile a list of eligible study subjects and facilitate access to the patient records from 
one register (date source) to the next without compromising patient confidentiality.   
Two local university graduates performed the data abstraction, while the principal 
investigator (PI) conducted quality control. To reduce bias, the two data abstractors were 
blind to the study hypothesis. An identifying code was used to keep track of the activities 
of each abstractor and intra-rater and inter-rater reliabilities were calculated using 
Cohen’s kappa (κ) coefficient. Kappa coefficient was reported as a value from –1 (perfect 
disagreement) to 1 (perfect agreement). (132)  To achieve intra-rater and inter-rater 
reliabilities and ensure that data abstraction and coding was consistent within or among 
abstractors, each abstractor was required to repeat data abstraction for up to 10% of the 
records they abstracted while 20% of their abstracted records were repeated by a different 
abstractor. The study achieved between 80%–90% intra and inter- rater agreement.  
Decision on conflicting data was reached through discussions between abstractors 
with differences settled by the PI. These occurrences and the decisions made were 
documented. Data that were either missing or undeterminable were recorded as missing 
and reconciled whenever possible.  Reconciliation involved review across different 
registers to find the missing information.  A detailed review of each patient record across 
the six data abstraction instruments was made before a conclusion was made that the 
variable was indeed missing. Even though three of the six registers- ART, HEI and 
KMMP HIV positive Register- had provisions to collect data on the final patient outcome 
(care ended, transferred out or transferred in); the final outcome for the exposed infant 
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(linked to CCC, transferred out or discharged); as well as for the mother (linked to CCC, 
transferred out, discharged, defaulted, on transit or miscarriage) these data were rarely 
recorded by the three study sites.  
 
4.4. ANALYSES 
All cohort data from the medical records was entered into Microsoft Excel 
spreadsheets and exported into R-3.1.2 (2015-06-18) [The R Core Team] for analyses. 
The retention analyses were conducted separately for each study site to account for 
differences in sites characteristics, as the study could not incorporate site-specific 
measures that might be related to retention. Descriptive analyses were performed to 
summarize the demographic, obstetric and clinical characteristics of the HIV positive 
women in the study cohort in each study site. Maternal characteristic were described 
using means and standard deviation for continuous variables and percentages for 
categorical variables.  
In this study, the HIV positive women could enter the cohort during ANC, L&D 
and PNC. By having multiple entry points to the cohort, the study was able to enroll 
women that did not attend ANC at the study sites but delivered and/or attended PNC at 
the study site within the study period.  The study used the L&D register to complete the 
missing ANC history of the HIV positive women that entered the cohort at L&D.  The 
L&D register is designed to collect the mother’s ANC history such as the number of 
ANC visits attended, antepartum HIV status and regimen received.  The PNC register on 
the other hand collects L&D history of the mothers such as date of delivery, place of 
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delivery and intrapartum HIV status. Data from the PNC register data were used to 
complete the missing L&D history for the HIV positive women that entered the cohort at 
ANC, did not deliver at the study sites but returned to study site for PNC.  Linking 
patient information across the three registers enabled the study to reconcile the data from 
the ANC and L&D sources and analyze them as composite (n=395). HIV positive women 
whose initial point of entry into the study cohort was PNC (n=153) were excluded from 
the analyses because the study did not have all of the ANC and L&D data required for the 
analysis. Figure 8 shows the study cohort by site and point of entry.   







The primary exposure of interest was retention analyzed as a categorical variable: 
fully retained; partially retained and not retained. The numerator (events), for the 
retention calculation was the number of interventions received by HIV positive women at 
each step of the PMTCT cascade while the denominator of 17 (trials) was the required 
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  L&D:	  n=49	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interventions listed in the Kenya 2012 PMTCT guidelines.  Table 7 shows these 
“required interventions” for each PMTCT step and the corresponding data source. The 
study analyses defined full retention as the completion of 80% and above of the required 
interventions; partial retention was the completion of 30%–79%, and non-retention was a 
completion of less than 30% of the required interventions. Rollins et al. and Oyeledun et 
al. proposed and applied similar percentage thresholds to measure retention in PMTCT 
care. (128,133).   
Table 7:  Required interventions for each step as outlined in the Kenya 2012 PMTCT 
guidelines 
 Step Interventions along the PMTCT cascade  Source 




1. ANC visits (1, 2, 3, 4) 
2. ART eligibility (WHO or CD4)  
3. Antepartum AZT or HAART  
4. Antepartum Cotrimoxazole (CTX)  
ANC  & 
ART  
register  
Proportion of HIV+ pregnant 
women receiving ≥ 80% of 
these interventions in ANC  
Labor and 
delivery 
1. Antepartum ART Regimen  
2. Intrapartum ART Regimen  
3. Baby Regimen  
4. Place of delivery (facility or home) 
L&D 
register  
Proportion of HIV+ pregnant 
women receiving ≥ 80% of 




1. Nevirapine given to infant at birth  
2. Infant received CTX  
3. Mother on CTX 
PNC  
register 
Proportion of HIV+ pregnant 
women receiving ≥ 80% of 
these interventions in PNC 
Early infant 
diagnosis: 
18 months  
Six weeks:  
1. Infant ARVs received 0– 6 weeks  
2. Infant tested before 8 weeks  
3. CTX received at 6 weeks  
4. Nevirapine received at 6 weeks 
HEI  
register  
Proportion of HIV exposed 
infants receiving ≥ 80% of the 
interventions 6–8 weeks.  
Nine months:  
1. Antibody test done at nine months 
Proportion of HIV exposed 
infants tested at months  
18 months:  
1. Antibody test done at 18 months  
Proportion of HIV exposed 




Retention was calculated at individual and health facility- levels and separately 
for each study site.  To determine the individual-level retention, we followed each 
woman longitudinally through each stage of the PMTCT process and calculated retention 
starting at the earliest point of entry into the PMTCT process through to 18 months 
postpartum. The health facility-level retention provided insight of the extent to which a 
specific health facility adhered to the Kenya PMTCT guidelines and retained women in 
PMTCT care once they were enrolled there. Health facility-level retention was calculated 
for each stage of the PMTCT cascade and then cumulatively to include the all the steps in 
the PMTCT cascade. This cumulative retention was time sensitive depending on point of 
entry into the cohort. To understand the extent to which women were retained in social 
support at each study site, retention was calculated using data collected from the KMMP 
HIV positive register. ANOVA and Pearson’s Chi squared tests were used to test for 
statistical differences in study site means and proportions respectively. Missed 
interventions contributed towards non-retention.  
Logistic regression analyses were performed to determine the predictor variables 
associated with full retention in PMTCT care (>80% vs. less than <80%).  Due to the low 
number of complete cases, the partially retained and not-retained categories were 
combined into one “not retained” category in the logistic regression.  The predictors of 
interest were the demographic, obstetrical and clinical characteristics of the HIV positive 
women. An analysis comparing the demographic, obstetrical and clinical characteristics 
of the women in the partially retained and not-retained categories showed little 
differences in the means, medians and standard deviation and thus allowed the study to 
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combine the two into one (not-retained) category.  
The logistic regression analysis using generalized linear model (GLM) was 
conducted on combined data ANC and L&D subsample (n=395) and from the three study 
sites. A backward stepwise method was applied to logistic regression modeling in which 
all the potential variables were entered into the model, then removed one at a time based 
on significance and subsequently re-entered back into the model. The ten demographic, 
obstetrical and clinical variables modeled into the final logistic regression model are 
below: 
Retention ≤ 80% ~Total ANC visits, Gestation, Age at 1st ANC visit, ANC HIV status, 
time of HIV diagnosis ( newly diagnosed or known positive),  PMTCT intervention 
received during pregnancy (HAART or AZT),  ART regimen type , Partner Tested in 
L&D+ Place of delivery (facility or home), ART Eligibility (CD4 count greater than 
350).    
 
Odds ratios and probabilities were calculated and all reported P-values are exact 
and two-tailed, and p-values less than 0.05 were considered significant. The model was 
controlled for study site, age at first ANC first, time of diagnosis (newly diagnosed in 
current pregnancy or known positive), ART eligibility (CD4 count >350) and regimen 




4.5. RESULTS  
4.5.1. Study Cohort Characteristics  
Of the 395 HIV positive women, the mean age was 27.51 years (standard 
deviation of 5.5). Eighty eight percent (88%) were married, 10% were single and 2% 
were either divorced or widowed. The mean gestational age in weeks at first ANC visit 
was 23.9 (6.2) and the mean of the total ANC visits attended was 2.7 (1.6). Eighty seven 
(87%) were diagnosed with HIV during pregnancy which was studied while 13% were 
known positives. 
 Table 8 below shows the demographic, obstetric and clinical characteristics of 
the cohort stratified by study site. The mean age of the mother at first ANC visit in 
Kayole HC, Kiambu CH, Nyeri CH was 25.5 ( 4.7), 28.4 ( 5.6) and 29.7 ( 5.85) years 
respectively. The mean gestational age at first ANC visit in Kayole HC, Kiambu CH and 
Nyeri CH was 22.7(5.6), 26.6 (5.6) and 24.6(7.2) respectively.  The  mean of the total 
number of  ANC visits completed in Kayole HC, Kiambu CH and Nyeri CH  was 2.4 
(1.6), 2.9(1.3) and 3 (1.8 ) respectively.  The mean CD4 count during pregnancy for the 
cohort was 400 cells/ml; and 492 (282), 449 (190), CH 482(278) in Kayole HC, Kiambu 
CH, and Nyeri CH respectively.  As shown in Table 8 below, statistically significance 
differences among the three sites were observed in: 1) the total number of ANC visits 
attended; 2) timing of HIV diagnosis at ANC; 3) mother’s age at first ANC visit, at 
delivery, and at first ART use; 4) gestational age at first ANC visit; and 5) parity and 
gravida at ANC.   
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Table 8: Demographic, obstetric and clinical characteristics of 395 HIV positive women 














Total ANC visits  2.4 1.6 2.9 1.4 3.1 1.8 <.001 
% at ≤ 2 visits  89 (59)  53 (40)  28 (26)    % at 3 visits  24 (16)  27 (20)  15 (14)    % at ≥ 4 visits 29 (19)  46 (34)  28 (26)    % Missing 9  (6)  9 (6)  38 (34)    
Place of delivery (%) 
      
  







Home delivery 2  (1) 
 
17  (13) 
 
7  (6) 
 
  







Time of HIV diagnosis in ANC (%) 
      
<.001 







Diagnosed prior to current 




19 (17 ) 
 
  







               
Antenatal Care (ANC) n=101  n=45  n=40    
Mother’s age at first ANC visit   25.5 4.7 28.4 5.6 29.7 5.9 <.001 
Parity 1.3 1.1 1.5 1.2 1.5 1.2 <.001 
Gravida 2.4 1.0 2.6 1.2 2.8 1.3 <.001 
Gestation  at first ANC visit (in 
weeks) 22.7 5.6 26.6 5.6 24.6 7.2 <.001 




























        
ART Eligibility in ANC n=101  n=45  n=40    
Age at first ARV use 25.8 4 29.65 6 29.1 5            <.001 
CD4 count  in ANC  545 282 448 190 500 278              0.04 
% Missing  34 (34)  15 (33)  6 (15)   
                
Labor and Delivery  (L&D) n=50  n=90  n=69    Age at delivery 26.1 4.8 28.3 5.4 29.1 2.0 <.001 
Parity 2.1 1.1 1.6 1.2 1.5 1.3 0.37 
Gravida  2.8 1.1 2.7 1.2 2.7 1.4 0.76 
**Missing data excluded in the mean, standard deviation, Chi-squared and ANOVA calculations 
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Table 9 shows the social demographic characteristics of those individuals in the 
cohort who were enrolled in the KMMP and whose data was available in the KMMP HIV 
Positive Register. The denominator for each characteristic was based on the total that 
self-reported on a given characteristic at the study site. Less than a third reported that 
they accompanied by their male partners during the ANC or PNC visits, and the majority 
reported having disclosed their HIV status to their male partner. In Kiambu CH, 52% 
reported being in discordant relationships compared to 47% and 42% in Nyeri CH and 
Kayole HC respectively. 	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Table 9: Social demographic characteristics of the women enrolled in the KMMP stratified 
by study site. 







         
Accompanied by a male partner at ANC (%) n=100 n=69 n=63 *** 
Yes 27 (27) 29 (42) 19 (30)  
 No  73 (73) 40 (58) 44 (70)  
         
Accompanied by a male partner at PNC (%) n=90 n=72 n=88  
Yes 30 (33) 21 (29) 30 (34)  
No 60 (67) 51 (71) 58 (56)  
         
Disclosure status and to whom (%) n=88 n=72 n=90  
Partner  86 (98) 63 (87) 81 (90)  
Other 2 (2) 9 (13) 8 (9)  
Child 0 0 1 (1)  
         
HIV status of male partner at ANC (%) n=78 n=56 n=72  
Negative  33 (42) 29 (52) 34 (47)  
Positive  45 (57) 27 (48) 38 (53)  
Known Positive  1 (1) 0 0  
         
Seen at another site for ANC (%) n=100 n=73 n=87  
Yes 35 (35) 9 (12) 26 (30)  
No  65 (65) 64 (88) 61 (70)  
         
Seen at another site PNC (%) n=81 n=73 n=87  
Yes 15 (17%) 7 (10) 3 (3)  
No 66 (73) 66 (90) 97 (97)  
***: Not all women engaging in the PMTCT process at a given facility enroll in the KMMP  
 
Table 10 summarizes the exposed infant testing history and the infant’s HIV 
results. Over 99% of the 94, 68 and 89 HIV exposed infants registered in the HIV 
exposed infant (HEI) register in Kayole HC, Kiambu CH and Nyeri CH, respectively, 
received Nevirapine for prophylaxis at 0–6 weeks of life.  Of the total cohort (n=395): 
45%, 16% and 23% presented for the six week early infant diagnosis in Kayole HC, 
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Kiambu CH and Nyeri CH respectively. The mean age in weeks of polymerase chain 
reaction (PCR) testing was seven (7) weeks in Kayole HC and Nyeri CH compared to six 
(6) weeks in Kiambu CH. The HIV prevalence among HIV-exposed infants who were 
tested at six weeks by PCR was 3% in both Kayole HC (n=68) and Kiambu CH (n=36) 
while none of the 52 HIV exposed infants in Nyeri CH was HIV positive.  There was no 
significant difference observed in the age in weeks of first PCR test among the three 
study sites.   
The proportion of  the total cohort (n=395) presenting the HIV exposed infants for 
the nine-month  HIV antibody test was 15%, 22% and 36% in Kayole HC (n=22), 
Kiambu CH (n=29)  and Nyeri CH (n=39)  respectively. The HIV prevalence among HIV 
exposed and tested infants at nine-month HIV antibody test was 6% in Kiambu CH and 
33% in Nyeri CH compared to zero percent in Kayole HC. The proportion of the total 
cohort (n=395) presenting the HIV exposed infants for the 18-month HIV antibody test 
was 17%, 18% and 34% in Kayole HC (n=25), Kiambu CH (n=24) and Nyeri CH (n=37). 
At 18 months postpartum, HIV prevalence among exposed infants tested was 4% in 
Kiambu CH compared to zero percent in Kayole HC and Nyeri CH. The reduction from 
6% and 33% to 0% in Kayole and Nyeri reflect churning in the sample; that is, the infants 
tested at 6 months were not the same infants tested at 9 months due to a lack of consistent 




Table 10: Testing history of the HIV exposed infant and the HIV results. 




(n=109)   
  Mean SD Mean SD Mean SD p values  (ANOVA) 
  n=68  n=67  n=86   
Age in weeks of baby at 
first PCR   6.9 (n=61) 5 6.6 (n=67) 1 7.5 (n=86) 5 0.359 
                
Infant HIV results (% and (n))       
                
PCR results 6 weeks n=68  n=36  n=52   
Positive 2  (3 )  1 (3)  0 (0)   
Negative 66 (97)  35 (97)  52 (100)   
                
Antibody test at 9 
months  n=22  n=29  n=39   
Positive  0 (0)  2 (7)  13 (33)   
Negative 22 (100)  21 (73)  26 (67)   
Discrepant  0 (0)  6 (20)  0 (0)   
                
Antibody test at 18 
months  n=25  n=24  n=37   
Positive  0 (0)  1 (4)  0 (0)   
Negative 25 (100)  23 (96)  37 (100)   
*** Missing data was excluded in the ANOVA tests and the proportions computations. 
 
Table 11 shows retention at individual and facility-levels. Both the individual-
level and facility-level retention was calculated for the 395 HIV positive women in the 
ANC/LD sub sample. At individual-level, only 10%, 9% and 16% of the cohort was fully 
retained (completed ≥80% of the required interventions) in Kayole HC, Kiambu CH and 




Table 11: Individual and facility-level retention proportions along the PMTCT cascade 
(ANC, L&D, PNC and HEI) 





p value ( chi-
square test) 
            
Non retained (<30%) 27 27 18  0.32 
Partially retained (30%–80%) 63 64 66  0.96 
Retained (80% and above) 10 9 16  0.29 
            
 Facility-level retention (%)       
            
Step 1: Antenatal care (ANC) n=101 n=45 n=40    
% receiving PMTCT interventions 63 36 75  0.001 
            
Step 2: Labor and delivery n=151 n=135 n=109    
% receiving PMTCT interventions 13 16 44  <.001 
            
Step 3: Postnatal Care (PNC) n=151 n=135 n=109    
% receiving PMTCT interventions 3 2 1  0.61 
            
Step 4:  Infant testing  at 6 weeks n=151 n=135 n=109    
% tested, receiving ARVs & CTX 32 12 6  <.001 
            
Step 5: Infants testing at 9 months        
% tested 15 22 36  0.01 
            
Step 6: Infants test 18 months        
% tested 17 18 34  0.02 
      
Social support: KMMP HIV 
positive Register (%)  n=151 n=135 n=109   
Non retained (<30%) 19 16 21  0.7 
Partially retained (30%–80%) 36 29 50  0.5 
Retained (80% and above) 45 55 29  0.02 
 
The facility-level retention, which sought to measure the extent to which specific 
facilities retained an individual after they entered the PMTCT cascade, decreased 
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significantly along the PMTCT cascade from ANC to PNC in all the three sites as shown 
in Figure 9.  Statistical significant differences in facility-level retention were observed in 
ANC, L&D and infant testing at six weeks, nine and 18 months.  Retention in the social 
support component of the PMTCT cascade calculated on data from the KMMP HIV 
register was 45%, 55% and 29% for Kayole HC, Kiambu CH and Nyeri CH respectively. 
Figure 9: Facility-level retention along the PMTCT cascade by site 
 
Findings from the logistic regression showed that a mother’s gestational age at 
first ANC visit (p= 0.043: OR: 1.41) and the total number of ANC visits attended 
(p=0.036: OR=0.23) were statistically significant predictors of non-retention. For every 
one unit increase in gestational age measured in weeks the odds of not being retained in 
PMTCT care increased by a factor of 1.41. The average predicted probability for the 
sample was 58.4%.  Additionally, for every one unit decrease in the total number of ANC 




















Study	  Sites	  	  
Facility-­‐Level	  Retention	  	  
ANC	  LD	  PNC	  HEI	  6wks	  HEI	  	  9	  months	  HEI	  18	  months	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predicted probability for the sample was 18.8%. Table 12 below shows the logistic 
regression results.  
Table 12: Logistic regression results (retained vs. not retained) 
 
 I then included a fixed effect to control for study site, gestational age at first ANC visit 
remained statistically significant in the model without Kayole (p=0.049: OR=1.6) 
compared to the models without Kiambu CH (p=0.058: OR=1.2) and Nyeri CH (p=0.61: 
OR=1.1). The total number of ANC visits attended was not statistically significant in any 
of the models that controlled for individual study site: Kayole (p=0.08: OR=2.2), Kiambu 
CH (p=0.06: OR=0.14) and Nyeri CH (p=0.74: OR=21) as shown in Table 13 below. 
Table 13: Logistic regression results (retained vs. not retained) controlled for study site 




Probability  p-value  
Gestational age at 1st ANC visit  
    
 
Kayole  HC 1.6 61% 0.049 * 
 
Kiambu CH  1.2 52% 0.37 
 
Nyeri CH  1.1 53% 0.59 
Total ANC visits  
    
 
Kayole  HC 0.2 19% 0.08 
	  
Kiambu CH  0.2 13% 0.06 
	  
Nyeri CH  0.2 18% 0.07 
 
Combined site data (N=395) Odds ratio 
Predicted 
Probability  % P-value  
Age at 1st ANC visit  1.25 55 0.2 
Gestation 1.41 58 0.043* 
Regimen Category (HAART vs. AZT) 2.61 28 0.69 
Total ANC visits 0.23 19 0.036 * 
Partner Tested for HIV 0.83 45 0.9 
ART Eligibility (CD4 count ≤350) 0.63 38 0.75 
ANC Gravida  0.37 27 0.21 
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Health Facility Characteristics 
The three facilities were run by the government, had functional HIV 
comprehensive care centers (CCC) and they all provided ANC, maternity and PNC 
services. In addition to the main analysis, I qualitatively describe variation in retention 
that could be related to some non-quantifiable, site-specific characteristics. All the 
facilities had at least three mentor mothers present and reported having an active patient 
follow-up mechanism through them. Only Nyeri CH provided free formula for HIV 
exposed infants.  Utilization patterns at ANC, L&D and PNC were different across 
facilities. In Kayole HC, 85% of the 101 HIV positive women that attended the first ANC 
visit at this site did not deliver there, and only 22% (n=101) returned for PNC services. 
On the other hand, 52% (n=50) of those that did not attend ANC in Kayole HC but 
delivered at this site returned for PNC services. A similar trend was observed in Kiambu 
HC, where 64% (n= 46) of ANC attendees did not return for delivery and only 25% 
(n=46) returned for PNC services at this study site. Furthermore, of the 90 HIV positive 
women that did not attend ANC at Kiambu HC but delivered at this site, only 4% 
enrolled for PNC services at the site. In Nyeri HC, 45% (n=40) of the HIV positive 
women that attended the first ANC visit at this site did not deliver there and only 22% 
(n=40) returned for PNC services at this study site. In addition, of the 69 HIV positive 
women that did not attend ANC in Nyeri HC but delivered at this site only 1% enrolled 




4.6.  DISCUSSION  
This analysis shows that the majority (62%, 73% and 60%) of the women are 
presenting for their first ANC visit at 20 weeks gestational age or later in Kayole HC, 
Kiambu CH and Nyeri CH respectively. Antenatal care attendance was also suboptimal 
with 71%, 54% and 72% of the women in Kayole HC, Kiambu CH and Nyeri CH 
attending less than four ANC visits respectively. These results are in concurrence with 
other studies conducted in Kenya and South Africa, that have reported delayed ANC 
attendance at first visit and advanced gestational age as contributing to the fewer women 
completing the four required ANC visits.(25,134–136) This compromises effective 
delivery of PMTCT services because current PMTCT guidance for HIV positive women 
receiving Option A recommend that HIV positive pregnant women be started on AZT 
prophylaxis at 14 weeks gestation. Despite the suboptimal ANC attendance, over 94% of 
the cohort in the three sites delivered in a health facility and with Kiambu CH and Nyeri 
CH recording close to 100% hospital deliveries. This finding is consistent with the 
preliminary results from the Kenya Demographic Health Survey (KDHS) 2014 and with 
a study on retention that was conducted in Kenya, Rwanda, Malawi and Swaziland, 
showing that even with suboptimal ANC attendance and delayed date of first visit, the 
majority of women delivered in a health facility.(15,136) This incongruity between high 
rate of facility births and delayed and irregular ANC attendance  may suggest that women 
do not fully understand the benefits of regular ANC attendance while they do the benefits 
of health facility delivery. 
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The individual-level retention was suboptimal with only 10%, 9% and 16% of the 
women fully retained along the PMTCT cascade in Kayole HC, Kiambu CH and Nyeri 
CH respectively. Decreasing retention along the PMTCT cascade and the lower retention 
in the postpartum period has been reported in previous studies even though they used a 
different definition and measure of retention.(22,23,136,137) Similarly, this study reports 
trends of decreasing facility-level retention from the antenatal to the postnatal period. The 
facility-level retention at the ANC and L&D steps of the cascade was highest in Nyeri 
CH (75% and 44%) and 36% and 34% at nine and 18 months exposed infant testing 
compared with the other two study sites.  Nyeri CH’s facility-level retention rate at the 
L&D stage (44%) though not optimal was significantly higher compared to Kayole HC’s 
13% and Kiambu CH’s 16% retention (p<.001).  The higher retention in Nyeri CH could 
be attributed to the presence of an active follow-up system for all pregnant women with 
high risk conditions including HIV and a separate clinic day for women with high risk 
pregnancies. In addition, the availability of free formula milk for the HIV exposed 
children in Nyeri CH at the time of the study could have contributed to the higher 
facility- retention rate at the PNC compared to the other two sites.  The lowest retention 
was at 18 months postpartum   (Kayole HC = 17%; Kiambu CH =18%; and Nyeri CH 
=34%), was consistent with prior findings from Kenya, reporting retention at 3% between 
11–13 months.(136,138)    
We hypothesized that this low retention in this study could be attributed to three 
factors. First, over 70% of the cohort was diagnosed with HIV during the current 
pregnancy, with a mean CD4 cell count of ≥400 cells/ml during pregnancy, were 
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clinically staged at HIV stage 1 and 2, and over 60% were on ART prophylaxis for 
PMTCT and not HAART. This finding is supported by two recent studies from Malawi 
among Option B+ patients that showed higher loss to follow up among women who were 
on ART prophylaxis for PMTCT compared to those on HAART. (139,140)  Second, 
unlike other PMTCT retention studies that use adherence to ART interventions as a proxy 
for retention, this study estimated retention rate as combined measure and not a single 
intervention. For example, the decision to include Cotrimoxazole use by the mother-
infant pair in the criteria further restricted the likelihood that individual was fully 
retained. Third, over 40% of those enrolled in the KMMP at the study sites self-identified 
as being in discordant relationships a phenomenon that has been documented to limit 
engagement in HIV care. For example, an East Africa study reported considerable delay 
in initiating ART among discordant couples.(141) 
In Kayole HC, the retention for HIV exposed infants progressively decreased 
from the early infant diagnosis conducted at six weeks (45%); through to the mid and 
final tests at nine months (15%) and 18 months (17%) of age. In Kiambu CH and Nyeri 
HC, the percentage of HIV exposed infants testing at nine months increased to 22% and 
36% from 16% and 23% at six weeks respectively, then slightly declined to 18% and 
34% at the 18 months test. The progressive decrease in the proportions of HIV exposed 
children tested at six weeks to those tested at nine and 18 months observed in Kayole HC, 
is hypothesized to be due to the possibility that mothers whose children test HIV negative 
at six weeks do not see reason to bring the infant back for further testing.  Nyeri CH did 
not record any HIV positive result among exposed infants at six weeks but recorded a 
	  	  
83 
33% HIV prevalence at nine months. While this significant increase in HIV prevalence 
among infants could be a result of recording errors, this increase is in concurrence with a 
2013 analysis that showed an increase of MTCT from 7% at six to 16% at the cessation 
of breastfeeding. (3)  Kayole HC reported zero percent HIV prevalence among exposed 
infants at nine and 18-months antibody tests. This was likely attributed to the fact HIV 
positive infants are transferred to the CCC upon diagnosis and thus are no longer in the 
HEI register and thus overestimating non-retention of HIV exposed infants in care. In 
addition, the incompleteness of the HEI register in this study site may account for this 
result.  
Retention in the social support component was estimated at 45%, 55% and 29%, 
in Kayole HC, Kiambu CH and Nyeri HC respectively. The individual-level retention 
based on the KMMP register is higher than the individual-level retention that was based 
on the MOH registers (Kayole =10%; Kiambu =9% and Nyeri=16%). This difference 
could be attributed to the two factors: 1) the completeness of the KMMP register 
compared to the MOH registers; and 2) the KMMP register captures the HIV positive 
women’s self-report on utilization of PMTCT services and this could be overstated.  
The disclosure of HIV status to male partners during the antenatal phase has been 
associated with positive behaviors regarding adherence to PMTCT regimens, better 
feeding practices, safer sex, and increased male partner testing.(24,84,142) In this study, 
over 85% of those enrolled in the KMMP, self-reported that they disclosed their HIV 
status to the male partner, which is in concurrence with two other PMTCT studies from 
Kenya and Zimbabwe.(24,143) This disclosure proportion is much higher than the 65.4% 
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reported in the Kenya AIDS Indicator Survey  (KAIS) 2012 among the general 
population.(6) Despite of this high HIV disclosure rates, less than 43% and 35% of those 
enrolled in the KMMP self-reported being accompanied by their male spouses to the 
health facility for ANC and PNC services respectively. 
The study documented a lot of mobility among the cohort and specific facility 
characteristics affected utilization patterns at ANC, L&D and PNC.  For example, the 
L&D unit in Kayole HC does not provide complete obstetric services, lacking equipment 
and personnel to conduct cesarean sections so the majority (85%) of women who 
attended the first ANC visit at this site did not return for delivery. Kiambu CH and Nyeri 
CH both have well developed L&D units and as a result attract women that attend ANC 
services elsewhere but opt to deliver in these facilities. This may partly explain why the 
majority of women that did not attend ANC services but delivered in Kiambu CH (96%) 
and Nyeri CH (99%) did not return for PNC services at these two sites. These women 
may have opted to start PNC services at the facilities where they received ANC services.  
Paradoxically, in Nyeri CH 40% of the women that delivered here but did not start for 
PNC services at this site, enrolled their infants for follow up care at this site. This 
compares to 18% in Kiambu HC, and could be attributed to the availability of free infant 
formula milk in Nyeri CH. Care seeking at two separate facilities within the postpartum  
period  may explain the low retention rates at PNC, and highlights the difficulty by health 
care system to capture the delivery of services received postpartum. This concurs with a 
retention study conducted in Zimbabwe that showed that HIV-positive women stay 




  Two statistically significant predictors of non-retention emerged. First, advanced 
gestational age at first ANC visit increased the likelihood of non-retention, consistent 
with recent findings from South Africa.(144) We hypothesized that receiving an HIV 
positive result at advanced gestational age is not only overwhelming for the woman but 
leaves little time before delivery for the woman to adjust and prepare mentally to uptake 
PMTCT services and subsequently stay in care. The limited timeframe also affects the 
healthcare provider’s ability to adequately educate women on the PMTCT care plan.  
The second predictor associated with retention in this study was the total number 
of ANC visits attended by a pregnant woman. The more the ANC visits attended, the 
more likely an HIV positive woman would be retained in PMTCT care. This can be 
attributed to the fact that more ANC visits provide HIV positive women the opportunity 
to engage with the health system, eliminate the fear associated with frequent visits to the 
health facility, and allow enough time for the  healthcare providers to educate the woman 
on PMTCT.  Similarly, Woelk et al. identified the number of ANC visits attended as a 
predictor of retention in PMTCT care in Kenya.(136) Additionally, other studies have 
shown that more ANC visits increased maternal ARV use. (10,142)  
 
4.7. STRENGTHS 
This study has two main strengths. First, by using data abstracted from MOH 
registers, this study could assess retention based upon interventions received and not 
simply by attendance or future scheduled appointments. In Kenya, upon enrollment for 
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ANC services, women receive an MCH card which stays in the custody of the patient and 
has information on future appointments. The MOH registers from which data was 
abstracted contain information on the specific interventions the patient received during a 
given visit including dates of testing and result collection. Secondly, the ability to 
compare and reconcile data recorded in the MOH registers with that in the KMMP HIV 
positive register enabled the study to provide a complete record for many women.  
    
4.8. LIMITATIONS  
The biggest limitation of this RCR was the incompleteness of the data largely due 
to partially completed registers. In Kayole HC, the HEI register lacked data on the 
infants’ HIV status at 18 months while the PNC register was not completed for two 
months. In Kiambu CH the ART eligibility information was rarely recorded in the ANC 
register with information only available for 5% of the patients and the nine-month 
antibody test results reported 20% discrepant test results. In Nyeri CH, the PNC register 
did not record if the women were tested for HIV 72 hours before delivery or after, if the 
infant received Nevirapine and Cotrimoxazole as per the protocol, and if the male partner 
was tested for HIV at PNC. In all the three sites, the registers rarely recorded the final 
outcomes of the infant at 18 months post-partum and as such the study could not run 
analyses on the final outcome on the HIV exposed children. In many instances, PMTCT 
interventions were provided but data was not recorded in the relevant registers. For 
example, when this study compared the KMMP register and the MOH registers for an 
individual subject’s clinical data such as CD4 count or infant’s PCR results, the study 
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found that for the same date of visit, data that would be missing in the MOH register but 
would be available in the KMMP register. The poor quality of data has been documented 
by other studies in Sub Saharan Africa and has been attributed to among others the 
inability of healthcare workers to balance the heavy workload with register 
completion.(136,145–147) 
The second challenge was how to effectively estimate retention rates given the 
prolonged time of observation which was a maximum of 27 months or a minimum of 18 
months. By equating full retention in PMTCT care with the time of a child’s final HIV 
status, the study could not account for mother’s own utilization of HIV care postpartum 
because of missing data in the PNC records and as this study showed, over 94% of 
women delivering in the study sites did not enroll for PNC services at the sites.  In 
addition, after delivery the focus shifts to the infant and the mother’s own health is in the 
periphery.  This focus on the exposed child and not the mother introduced bias into the 
measurement.  
Mobility between and within health facilities made it difficult to effectively track 
mother-baby pairs throughout the PMTCT cascade.  Retention calculations were specific 
to a particular health facility and this study did not track women across all health 
facilities attended to ascertain that they indeed received a given service. Therefore, 
women that partially utilized services outside of the three study sites often had a lot of 
gaps in their utilization record. Data from multiple sites may need to be reconciled to 
accurately reflect patterns of attendance. In addition, mobility within facilities which 
mostly occurred when mothers and/or infants transferred from the MCH Department to 
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the CCC also undermined the study’s tracking efforts.  Without a systematic referral and 
tracking process tracing mothers and infants even within a health facility was a challenge.  
Study site selection was purposeful and not random and this could have 
introduced research bias into the study and limited the ability to generalize the sample. In 
addition, the study did not attempt to document facility characteristics such the number of 
doctors and nurses because of budgetary reasons, and thus could not sufficiently explain 
how such factors might have affected retention in PMTCT care.   
Further bias could have been introduced because the study did not account for 
personal characteristics such as educational levels, socioeconomic status, distance to and 
from the health facility, characteristics of the couple, and health beliefs all which could 
have influenced why and how women seek PMTCT care.     
  
4.9. CONCLUSION  
In conclusion, this study shows that the retention in PMTCT care is low across the 
three study sites, and suggests that early ANC attendance and a greater number of ANC 
visits may increase retention in PMTCT care. This data highlights the importance of not 
only promoting four ANC visits but encouraging women to attend ANC earlier on in 
pregnancy. Furthermore more, this study demonstrates considerable challenges in 
measuring retention in PMTCT care due to poor quality of data, and the inability of the 
health system to track women across health facilities.  There is a great need for Kenya to 
expand the current capabilities of the Health Management Information System (HMIS) to 
allow for the longitudinal follow-up of HIV positive women across health facilities.  This 
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would enable Kenya to deliver appropriate services and measure the effectiveness of 





Understanding the Barriers and Facilitators to Retention in the  
Prevention of Mother -to-Child Transmission care:  
a qualitative study of HIV positive women in Kenya  
ABSTRACT  
 
Objective: To understand the experiences of HIV positive women who previously 
participated in prevention of mother-to-child transmission (PMTCT) services and their 
and male partners, and how these experiences influence their retention in PMTCT care.  
Methods: This qualitative research was part of a mixed methods study that examined 
retention in PMTCT care among HIV positive women in three study sites in Central and 
Nairobi regions of Kenya. Forty women were selected for in-depth interviews from a 
sample of 548 HIV positive women identified in the larger retention analysis. In-depth 
interviews were also conducted with husbands of these women. A team-based approach 
was used to develop the codebook and content analysis was used to identify emergent 
themes. The Informational, Motivational, Behavioral (IMB) model was used to structure 
the interview guides, organize, analyze and explain the qualitative results.  
Results: The facilitators of retention in PMTCT care included: supportive male partners; 
acceptance of one’s HIV positive status; disclosure of HIV positive status to spouse, 
family, friends; desire to have an HIV negative baby; psychosocial support and peer 
counseling; and positive provider attitudes. The barriers to retention in PMTCT care 
were: unsupportive male partners; denial of one’s HIV positive status; lack of disclosure 
to spouse, family, friends; internal stigma; financial pressures; negative provider 
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attitudes; waiting and delays; negative perceptions regarding quality of care; stress; and a 
lack of PMTCT knowledge among participants.   
Conclusion: This study demonstrates that the factors that enable or hinder retention in 
PMTCT care are complex and interconnected. As posited by the IMB model, possessing 
just one factor such as correct information of PMTCT, or having a supportive male 
partner, or receiving good quality care does not guarantee that an HIV positive woman 
will be retained in PMTCT care.   
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5.1. INTRODUCTION  
Kenya has made a commitment to virtually eliminate mother -to -child 
transmission of HIV (eMTCT) by 2015.(7,30) The virtual elimination of new infant HIV 
infections is defined “as less than 5% of  MTCT, or 90% reduction of HIV among young 
children by 2015.”(31) To achieve virtual elimination, prevention of mother-to-child 
transmission (PMTCT) programs must achieve high coverage and retention of HIV-
positive women throughout the PMTCT continuum of care. (22,23,32) The PMTCT 
continuum of care, also known as the PMTCT cascade, defines a series of events that 
must be implemented to facilitate delivery of PMTCT intervention and  starts in antenatal 
care where HIV testing occurs through labor and delivery, to postpartum care where the 
HIV exposed infant is tested for HIV  at six weeks, nine and 18 months.(18)  
The retention of HIV positive women in PMTCT care allows for the provision of 
prophylactic antiretroviral therapy (ART) for mother and infant, early infant diagnosis, 
and prompt initiation of ART if needed.(22, 26–28) Given that HIV disease progression 
is much faster in children than adults and without HIV treatment, half of children born 
with HIV die by the age of two, and 80% die by age five, it is important that children are 
diagnosed and started on HIV treatment promptly.(3, 22, 31). Retaining HIV positive 
women throughout the PMTCT continuum of care maximizes the health benefits for both 
the mother and the child. 
In an effort to meet the eMTCT commitment, the Kenya 2012 PMTCT Guidelines 
introduced the use of Option B+ which recommends the initiation of lifelong 
antiretroviral therapy (ART) to all HIV-positive pregnant and lactating women. (7,48) 
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While national guidelines for the scale-up of Option B+ were launched in  June 2014 
(51), there are serious threats to achieve the eMTCT goal in Kenya because retention of 
HIV positive women in PMTCT care under less intensive guidelines (Option A) has been 
suboptimal.(25,136)  Despite a high uptake in HIV testing in ANC settings, (estimated at 
92%), maternal ART coverage was estimated at 70.6% in 2013, and only 55.7% of the 
HIV exposed infants received ARV prophylaxis to reduce MTCT.(37)  The scale up of  
Option B+ poses additional challenges to retention in long term PMTCT care because 
HIV positive pregnant women will now be starting HIV treatment earlier, often before 
they become symptomatic, and will be expected to continue on this treatment for life.(25)  
It is fundamental that public health programs not only quantify retention of HIV 
positive women along the PMTCT cascade, but also acquire an in-depth understanding of 
the factors that facilitate or hinder retention. This understanding will provide public 
health programs with insights into the influences on health care-seeking behaviors of 
HIV-positive women and how these impact retention throughout the PMTCT cascade. 
Health seeking behaviors are complex and are an interplay of individual, interpersonal, 
social, economic, cultural, and health system factors which must be considered if 
PMTCT programs are to achieve optimal retention.(36) Furthermore, while there is 
greater understanding of patient retention in ART programs for the general population, 
few studies in Kenya have sought to understand the facilitators and barriers that influence 
retention of HIV-positive women throughout the PMTCT cascade. In addition, the 
existing studies mostly focus on the barriers that hinder retention and rarely discuss the 




This qualitative study was conducted to understand the experiences of HIV 
positive women and their male partners with PMTCT services and the factors that 




5.2. CONCEPTUAL FRAMEWORK 
 
The Information, Motivation, Behavioral Skills model was used to organize and 
analyze qualitative results. This model allowed the study to structure the restructure the 
research questions, analyze, organize, explain findings, and frame policy and 
programmatic recommendations.  The IMB model identifies information on prevention, 
motivation and behavioral skills as fundamental determinants of HIV preventive 
behavior.(112)The IMB model posits that information is a prerequisite for behavior 
change but by itself is insufficient to achieve the desired change.(112).  A person must 
also have internal and external motivation, and the skills to enact their motivation.  For 
example, awareness of PMTCT and the desire to stay HIV-negative may not be sufficient 
if a person faces stigma for pursuing behaviors that may prevent HIV, such as using 
condoms or taking ART. 
 
 
5.3. METHODS  
Participants, Study setting, Sampling and Study design 
Between October 1 and November 30 2014, 40 HIV positive women and six male 
partners of these women participated in one-on-one semi structured interviews about their 
experiences in PMTCT care. The 40 HIV positive women were a subsample of a cohort 
of 548 identified for a retrospective chart review (RCR) to quantify retention rates along 
the PMTCT cascade.  The study analyses defined full retention as the completion of 80% 
and above of the PMTCT interventions required under the Kenya 2012 PMTCT 
guidelines (7); partial retention was the completion of 30%–79%, and non-retention was 
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a completion of less than 30% of the required interventions. The definition was based on 
prior percentage thresholds used by Rollins et al. and Oyeledun et al. to measure retention 
in PMTCT care (128,133). The RCR cohort included all HIV positive pregnant or 
recently-delivered women 18 or older presenting for antenatal care or delivery between 
January 2012 and May 2013. 
This study was conducted in three public (government-owned) health facility sites 
in Kenya where the non-governmental organization mothers2mothers- (m2m-Kenya), is 
active. The three sites were:  Kayole Health Center, Nairobi County; Kiambu County 
Hospital, Kiambu County; and Nyeri County Hospital, Nyeri County. All the facilities 
had at least three mentor mothers present. The mentor mothers provided peer education 
and psychosocial support to HIV positive women enrolled in PMTCT care and reported 
having an active patient follow-up mechanism. Only Nyeri CH provided free formula 
milk for HIV exposed infants. The PMTCT services in the three study sites are integrated 
within the Maternal and Child Health (MCH) Departments and all sites have an HIV 
comprehensive care center (CCC) within the hospital compound.   
Intensity sampling strategy-a technique that purposively identifies information 
rich cases manifesting the phenomenon of interest, in this case retention in PMTCT care, 
was used to ensure that a range of retention experiences was represented in the sample. 
(148)  To further strengthen the diversity of the sample, the study employed a seven step 
technique described by Trost, 1986 to stratify the sample by retention status, age, marital 
status, and if one was an m2m client or not. (149) The proposed sample size for the in-
depth interviews was 48 HIV positive women (24 fully retained and 24 not-retained in 
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PMTCT care) and 20 male partners of these women distributed equally across the three 
study sites. The sample size was also informed by literature showing that saturation 
(redundancy in themes, or when no new information is forthcoming) is typically reached 
with a sample of 20–50 individuals in depth interviews.(148) 
To identify potential participants, preliminary analysis of the RCR data was 
conducted at each study site to calculate the individual–level retention that was used to 
determine participant selection. Potential female participants were purposively identified 
for those that were fully retained, partially retained or not-retained.  Potential interview 
participants’ medical data in the RCR database was then checked against the Kenya 
Mentor Mother Program’s (KMMP) HIV Positive register kept by the mentor mothers to 
identify the woman’s contact information, to better understand the utilization patterns and 
gain insight on additional information such as availability of consent to be contacted by 
mentor mother after the initial interaction.  
A list of potential interview participants and their contact information was then 
compiled and passed on to the mentor mothers who made the initial contact with the HIV 
positive women at each study site.  The male interview participants were recruited 
through the female participants.  At the end of the female participants interviews, the 
interviewer asked those interviewees who were married or living with a male partner 
about the possibility of interviewing the male partner. If the female participant agreed to 
have her husband/ partner interviewed, the interviewer would ask the woman to discuss 
this with the husband/partner and then follow up with the woman to confirm that the 
discussion had taken place and that the husband/ partner was indeed willing to be 
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interviewed. If still affirmative, the interviewer would then call the husband/partner and 
schedule a location and time for the interview.  
 The interviews were conducted in a private room at each study site. The 
interview process was voluntary and all the participants were informed at the start of the 
interview that they could exit the interview at any time and were at liberty to not answer 
questions that made them uncomfortable. All participants provided consent and signed a 
consent form to this effect. In Kayole HC all interviews were conducted in Kiswahili 
while in Kiambu CH and Nyeri CH the interviews were conducted in either Kiswahili or 
Kikuyu languages. All 46 interviews were audio recorded with the consent of the 
participants and were transcribed into English from either Kiswahili or Kikuyu. Interview 
participants were compensated at an average of US$ 5 to cover transport and lunch cost.  
 
Ethical considerations  
Ethical approval to conduct this study was provided by the Boston University 
Medical Campus (BUMC)-USA and Africa Medical Research Institute (AMREF)-Kenya 
Institutional Review Boards (IRB). Approval was also received from the hospital 
superintendents in the three sites, the local IRB in Nyeri County Hospital and the County 
Health Departments in Kiambu and Nairobi counties. The officers in charge of the MCH 
Departments in the three sites provided additional approval. Written consent was also 





The information-motivation-behavioral skills model (IMB model) was used to 
structure the interview guides, analyze and organize qualitative data. The interview 
guides elicited participants’ experiences with accessing and utilizing PMTCT care 
services through both semi-structured and open-ended questions. The interview questions 
for the female participants explored: 1) why and what influenced women to stay or exit 
PMTCT care; 2) their experiences, opinions, beliefs, and expectations of the PMTCT 
services received; 3) feelings and experiences with disclosure of HIV positive status to 
spouse, family and friends while participating in the PMTCT program; 4) subsequent 
health seeking behaviors after PMTCT; and 5) knowledge and opinions about Option B+. 
The interview questions for the male participants explored: 1) knowledge and 
experiences with the PMTCT program; 2) experiences, opinions and thoughts on the role 
of men in supporting their spouses/partners in participating in PMTCT care; 3) 
observations on subsequent health seeking behaviors among the  partners after PMTCT; 
and 4) knowledge and opinions about Option B+.  The knowledge questions addressed 
the informational construct of the IMB model while the experience, opinion and thoughts 
questions covered both the motivational and behavioral skills constructs. 
   
5.4. ANALYSES 
An inductive data analysis process was used to identify patterns and themes from 
the transcripts. Conventional content analysis techniques were used to review the patterns 
emerging from the transcripts and to interpret meaning from the data. (150)  Three steps 
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were employed to content coding. First, the study’s principal investigator (PI) and two 
research assistants jointly developed a codebook. To develop the codebook each 
individual team member read two transcripts, summarized and presented a list of 
preliminary codes to the team. The team together made decisions on what codes to keep 
in the final codebook. Based on the codebook, the PI coded the transcripts using NVivo 
qualitative data analysis software; QSR International Pty Ltd. Version 10, 2012. Through 
an iterative process, emergent themes were identified by connecting and categorizing the 
codes. Subsequently, a hierarchy of themes were created and prioritized.   
 
5.5. RESULTS  
Participant characteristics 
A total of 40 HIV positive women and six male partners participated in the in-
depth interviews. The interviews with the female participants averaged 43 minutes 
while those with the male participants averaged 30 minutes. The female sample was 
stratified into three categories based on their retention characteristics: 1) retained 
(n=24), 2) re-engaged- or those who dropped out from PMTCT care in a previous 
pregnancy or partly in the most recent one then re-engaged with PMTCT care (n=10), 
and 3) non-retained -or those who dropped out from PMTCT care and not re-engaged 
(n=6). The six male participants interviewed were spouses to the women interviewees 
in the retained and reengaged categories and were not stratified in any way. Figure 10 
is a schematic representation of the interview sample. 
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The median age at the time of interview among the female participants was 32 
with a median age of 29 at the time of entry into the PMTCT program.  At the time of the 
interview 57.5% of the women were married, 20% were single, 15% were separated, and 
7.5% were widowed.  At the time of entry into the PMTCT program, 67.5% of the 
women participants were newly diagnosed with HIV while 32.5% were known positives 
(KP).  Of the married women, 23% were in concordant relationships, 35% in discordant 
relationships and 42% did not know the status of their male partners and/or did not 
respond to this question. Roughly one-third (32.5%) of the single or separated female 
participants were unwilling to discuss the HIV status of their male partners.  More than 
one-third (38%)  of the female participants received all antenatal, maternity and postnatal 
care services at the study sites while 60% received some of these services in facilities 
other than the study sites. The median number of children born to each woman was two. 
At the time of the interview, all the six individuals under the “non-retained” category 
Female	  participants	  ♀	  (n=40):	  Male	  participants	  ♂	  (n=6)	  
Kayole	  HC	  (♀=14:	  
♂=2)	   Nyeri	  PGH	  (♀=14:	  ♂=3)	   Kiambu	  CH	  (♀=12:	  ♂=1)	  
Retained	  (n=10)	  Reengaged	  (n=1)	  Non-­‐retained	  (n=3)	   Retained	  (n=	  9)	  Reengaged	  (n=4)	  Non-­‐	  retained	  (n=1)	   Retained	  (n=	  5)	  Reengaged	  (n=5)	  Non-­‐retained	  (n=2)	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indicated that they were not receiving any HIV care. 
 The six male participants were all married, aged between 32 and 48, with five 
having wives that were fully retained in PMTCT care, and one was in a discordant 
relationship (spouse was HIV positive and he was not).  Annex 4 and 5 summarize the 
demographic characteristics of the female and male participants respectively.  
 
Themes  
The study identified 11 major themes: 1) role of the male partner; 2) acceptance 
or denial of HIV positive status; 3) disclosure of HIV positive status to spouse, family, 
friends; 4) desire to have an HIV negative baby; 5) peer counseling and psychosocial 
support; 6) quality of care; 7) internal stigma; 8) the lack of disclosure to spouse, family, 
friends; 9) financial pressures; 10) stress; and 11) lack of PMTCT knowledge.  These 
themes were then categorized either as barriers or facilitators to retention in PMTCT care 




Table 14: Summary of the themes and subthemes categorized as facilitators or barriers to 
PMTCT care and by the IMB constructs. 
Themes  Informational  Motivational Behavioral 
Facilitators     
Supportive male partner  √  
Acceptance of HIV status   √ 
Disclosure of HIV positive status   √ 
Desire to have an HIV negative baby   √  
Peer counseling and psychosocial support   
a. The role of mentor mothers  
b. The role of formal support groups 
c. Informal support 
√ √ √ 
Quality of care  
a. Positive Provider attitudes  √  
Barriers     
Unsupportive male partners  √  
Denial of HIV status  √ √ 
Lack of disclosure   √ 
Internal Stigma  √ √ 
Financial pressures  √  
Quality of care  
a. Negative Provider attitudes  
a. Waiting and delays  
b. Preconceived negative notions 
regarding quality of care    
 √  
Stress  √ √ 
Lack of PMTCT knowledge   √   
 
 
In applying the IMB model, this study explored: the extent to which participants 
were well informed about HIV and PMTCT in particular; how this information motivated 
them to act; and develop behavioral skills required to uptake PMTCT services and stay in 
PMTCT care. The decision to categorize an identified theme as informational, 
motivational or behavioral skills or a combination was determined by: the participants’ 
narratives showing the information received and how that information was used to 
improve and navigate barriers to PMTCT care; the beliefs, attitudes and social motivators 
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to uptake and stay in care; perceived abilities to uptake PMTCT service, stay in care and 
mobilize support to do so. 
Facilitators 	  
A. The Supportive Male Partner  
The role of male partners emerged as an important theme throughout the 
interviews.   Women felt male partners were important in influencing them to stay with 
the PMTCT program, and male partners provided financial, emotional and tangible 
support at home.  The recurring questions that married women asked themselves after 
receiving an HIV positive  result revolved around the male partner: “how do I tell my 
husband?,” “will he disown me?,” “will this be the end of us?,” and  “how will my 
husband take it?”  The women brought their husbands to be tested or asked them to go by 
themselves because they wanted to know the source of the HIV infection: “I wondered 
where it [HIV] came from?” Women felt very relieved upon disclosing their HIV positive 
status to their male partners because their male partners accepted them; “he accepted me 
as I am.” One woman described how self-stigma, a reported barrier to retention in this 
study, ended when she realized that the “person closest to her,” her husband, still loved 
her regardless of her HIV status:  
Moderator (M): What has motivated you stay in the program for as long as you 
have stayed?   
Respondent (R): “First of all that self-stigma ended and I don’t even face stigma 
from other people now because I realized that the person closest to me, my 
husband, still loves me and we support each other.”  Retained//KF09 
 
Examples of emotional and financial support were also demonstrated in the male 
partners’ interest in the health of their spouses and children. The supportive male partners 
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often jointly made the decisions about the infants’ feeding options (breastfeeding vs. 
replacement feeding), accompanied their partners to the clinic visits and reminded them 
to take their HIV medications as narrated below: 
“At that point my husband said that the child should not breastfeed; he said that 
his child will get the formula milk at the study site and when I come to collect the 
formula milk we will come together... My husband has no problem and even when 
it’s time to pick my drugs he reminds me, have you taken your drugs? He comes 
with me during all my clinic visits; he does not leave me on my own with this 
burden.” Reengaged\\KF01 
  
Supportive male partners acknowledged that the PMTCT program would not only 
help their spouses deliver an HIV negative child but it would also teach them how to take 
care of the baby after birth so that the baby is not infected with HIV. Even in cases where 
the male partner refused to test for HIV or take HIV medication, the woman still 
considered him as a supportive male partner if he continued to encourage her 
participation in the PMTCT program.  This support extended to the decisions that the 
women made on where they wanted to seek ANC, maternity and postnatal care.  
Men and women both saw the role of the male partners in supporting their 
spouses through the PMTCT process. The two quotes below are a description of the role 
of the male spouse as told by the male interviewees:   
“Men have a major role because they are the breadwinners. Should they fail to 
assist in this plan [PMTCT], their women feel abandoned. The [wives] then get 
discouraged so it is good for men to give all their best in support of this plan; it is 
not like if you accompany her [wife] to hospital anything will change…Yes, 
nothing will change, it will not make you less of a man. Instead it will make the 
relationship more lovable. So they should support their women 100%.” UM01 
 
“My roles are to ensure that my wife is in a good state and condition, first I talk 
to her well, then provider her with good nutrition and remind her about taking 
her medication. I also make sure that she is stress free because stress can lead to 
a decrease in the CD4 count.” YM01 
	  	  
106 
The same theme was told by the female participants described similar views:  
“He supported me in that as much as he refused to take medicine, he never told 
me not to take mine. Also in the feeding program, he is the one who decided that I 
would not breastfeed the baby and that has really helped me because I give the 
formula baby milk and then continue with my other work.” Retained\\KF13 
 
  “He [husband] has contributed because he reminded me every time of the 
appointments, time to take drugs etc. Even when I gave birth, the first thing when 
he woke up was to remind me to give the baby the medicine. He told me that I 
should not fail to come to the clinic… In fact when I decided to participate in 
PMTCT my husband was very happy because he was afraid; he was afraid that I 
might have an abortion, or I take off [leave the marriage.]” Retained\\YF14 
 
  
B. Acceptance of HIV positive status 
Many participants in this study said that they did not always immediately accept 
their HIV positive status, but once they did, this helped them stay engaged in PMTCT 
care. Acceptance of one’s HIV positive status was gradual and there are many different 
reasons why newly diagnosed women chose to accept or deny their HIV status. Women 
who were fully retained explained that they viewed themselves as “normal” and no 
different from others without HIV and described this as the initial step of acceptance. 
Women felt that they had to keep on living, and they did so by viewing themselves as just 
any other person. These women felt that their lives must continue: 
“I do not feel like I am sick, I do not feel like I have this dangerous disease, AIDS, 
I just see myself normal like other people because I see myself living; if I continue 
taking my medicine, eating well and keeping myself stress free, I will live.” 
Retained\\YF02  
“When I was told I am positive, I accepted it, I did not deny because I knew I 
would live” Retained\\YF08  
 
By accepting their HIV status, HIV positive women also accepted the 
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responsibilities that came with being HIV positive including: eating a balanced diet, 
decreasing stress and adhering to medication.  Among those not-retained in care and 
those who re-engaged in care, accepting one’s HIV positive status led to behavior change 
including adherence to HIV medications and clinic appointments: 
“Earlier on I would not take those [ARVs] and I did not accept my status. That’s 
the problem, not accepting your status. Even now if I did not accept my status I 
would not be taking medication… I have now accepted my status and every night I 
take the medicines.” Reengaged\\UF12 
 
 
C. Disclosure of HIV positive status to male partners, family and friends.  
The majority of female participants reported that once they disclosed their HIV 
status to male partners and family, the conversation was much easier, and this mostly led 
to increased motivation and support for their participation in PMTCT care in general.  
Those disclosed to alleviated fear and made the woman disclosing feel at ease by 
encouraging and assuring them that: “you have done nothing wrong,” “it’s not the end of 
the world,” and that “ you should be strong for your children.”  The people disclosed to 
not only restored hope but they also pledged support that influenced women to stay in 
PMTCT care. This support included reminders and questions about future scheduled 
clinic visits, adherence to medication, eating habits and simple conversations that asked if 
all was well with the participant. These caring actions encouraged the participants and led 
to positive feelings:  
“I feel that they are still concerned about me a lot. Especially these two [cousins] 
they are usually very concerned and when they call me they ask, are you sick, 
have you eaten?  I tell them am not sick and I have eaten. So that makes me feel 
there is someone somewhere who sees I deserve to be alive” Non Retained\\UF01 
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When some women finally disclosed their status to their spouse and family, the 
benefits were tangible and  extended to practical assistance such as accompanying the 
participants to the health facility for appointments, child care during clinic visits and/or 
when at work, payment of schools fees, and encouragement to find work or start a 
business. Most of the female participants had no regrets about disclosing their HIV status 
but rather regretted not having disclosed earlier.  Women said that the persons they 
disclosed to often asked why the disclosure had not occurred earlier. Even those study 
participants that had not disclosed their HIV status acknowledged the benefits of 
disclosure as regards to getting external support from family. The quotes below explain 
the benefits of disclosure: 
 
“They [those that have been disclosed to] have been encouraging me; they have 
been telling me that it is not the end of everything even if I have the disease 
[HIV]. They advise me to eat well, take medication, and exercise.” 
Retained\\KF11 
 
“If you see a woman going through it [PMTCT] all is because they are not afraid 
to disclose. Even when we are in a crowd you will hear them say, I give mine 
[baby] four spoons of formula milk. Those who keep silent are the ones with the 
problem. Reengaged\\KF04 
 
Furthermore, participants reported that once they disclosed their HIV status they 
could “stop hiding” because the fear associated with disclosure dissipated, and self-
encouragement coupled with the will to live and see their children grow up replaced it. 
Woman who had disclosed to male partners and family reported that they felt “settled” 
and “free” because they no longer had to hide their HIV medication or the ANC cards 
from their spouses or lie about repeated visits to the health facility. In addition, the fear 
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that those closest to the HIV positive woman would find out about the woman’s HIV 
status and “look at them differently” was eased.   
Women who had disclosed to male partners, family and friends felt empowered to 
openly discuss their HIV status with others and even encouraged other pregnant women 
in their neighborhoods to attend antenatal care and get tested for HIV. In some cases the 
female participants reported accompanying these women to the health facility for HIV 
testing and care. By disclosing their HIV status, these women also motivated their friends 
and siblings to be careful and cautious when engaging in sexual relationships, and acted 
as role models for good hygiene practices in their neighborhoods. The freedom brought 
by disclosure is further explained: 
“I am very free. I feel free disclosing because if you keep quiet, I realized when 
you keep quiet you are just hurting yourself.  I wouldn’t like to see someone 
suffering the way I suffered because of my lack of PMTCT knowledge and fear; 
you see where it has led me? Reengaged\\YF13 
 
“I feel relaxed because I told him [husband], because there are others who hide it 
from their husbands, and take the medicine while hiding. So that person has a 
hard time, but I feel happy because I don’t hide any medicine. I take them in his 
presence, so I feel settled” Retained\\UF04 
 
 
D. Desire to have an HIV negative child 
The need to protect the unborn baby from HIV infection was an overwhelming 
factor that influenced women to stay in PMTCT care and in most instances elicited the 
male partners’ support. Having seen other HIV positive women deliver HIV negative 
children also motivated women to aspire for the same goal for themselves.   In some 
cases the male partners would encourage their spouses by saying “try for our child” and 
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nudging the women to call or visit the clinic if they had doubts on how to administer the 
HIV medications. Among those retained in care the decision to protect the unborn child 
was often made during pregnancy. One female participant stated that she “wanted the 
best for her son,” another described it as the “joy of having an HIV negative child,” while 
another said she wanted to contribute to “an AIDS free generation.”  Women narrated 
that having an HIV negative child saved their marriage because it made the male partners 
and the mothers-in-law happy. Women also reported that the negative attitudes or their 
initially unsupportive mothers-in-law changed when the baby tested HIV negative, some 
congratulating their daughters-in-law for choosing not to breastfeed. 
Women who re-engaged with care and those who were not retained in care 
reported that they continued to give their babies the required doses of Nevirapine and 
Cotrimoxazole to protect the child from HIV after birth even though they themselves 
were non-adherent to HIV medications or had altogether defaulted care. When the doses 
they had at home were finished, these women reported that they stopped breastfeeding 
altogether but they did not go back to the clinic for a refill.  Some of the women who re-
engaged and those that were not retained in PMTCT care explained that their male 
partners would be opposed to the woman’s decision to stay in PMTCT care while at the 
same time insisting that the women protect the unborn child from HIV.  In addition, 
positive opinions of the PMTCT program among both the female and male participants 
were mostly biased to the fact that the program contributed to them having an HIV 
negative child. The quotes below demonstrate this theme:  
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“The first benefit I have seen is that I have a child who is not HIV positive. That’s a 
big benefit; I take medicine on my own, I do not have to give the baby.” 
Retained\\YF02  
 
“For him [husband] his main concern was for the baby since I already had it [HIV], 
anything that would prevent the baby from getting HIV so I told him about the 
PMTCT program… if I had any question, he would tell me, take the phone, call them 
[PMTCT providers].’’ Retained\\YF03 
 
   
E. Psychosocial support and peer counseling 
Women in this study reported that psychosocial support and peer counseling 
influenced retention in PMTCT care. Psychosocial support and peer counseling were 
classified into three subthemes: the role of mentor mothers, formal support groups at the 
study sites, and informal relationships. Women reported that mentor mothers and the 
support groups influenced women to the shift from denial to acceptance of their HIV 
status. The ongoing counseling and sharing among peers helped alleviate fear and 
presented positive examples.  Mentor mothers or fellow support group members helped 
those newly tested see the bigger picture beyond one’s HIV positive status. 
i) Mentor Mothers  
When a woman tests positive during ANC, maternity or postnatal care or a child 
tests positive in the pediatric ward, the mentor mothers were the first point of contact and 
they support the women to navigate the various steps of the PMTCT process. The mentor 
mothers were the first people many women newly tested HIV positive meet and many 
women in the study described them as being, “HIV positive like me” or as “colleagues” 
who made the women “not feel all alone.” The women participants described the 
multifaceted role of the mentor mothers to include: the one-on-one counseling that made 
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the participants “see reason,” the encouragement role to test for HIV, adhere to clinic 
visits and medications, accept their HIV status, stay in the program and think about 
practical infant feeding options. The mentor mothers also alleviated the fear and self-
stigma that comes with an HIV positive result. 
The mentor mothers were also seen as mediators by helping talk or break the 
news of an HIV positive test to the male partners and were acknowledged for the 
continuity of marriages especially among discordant couples. The mentor mothers were 
described as: hospitable, “ they look after you nicely”; caring, “they even call you and 
enquire how you are doing”; knowledgeable, “if you have question ask her” and “when 
you call her she answers in good faith”; uplifting , “I feel free even if I was stressed;” and 
motherly, “they talk to you like your mother would.”  Both the female and male 
participants said that the mentor mothers were a major reason why they stayed in PMTCT 
care:  
“Although I had refused PMTCT, I later agreed on seeing my colleagues [mentor 
mothers] who came and talked to me and advised me, they were also HIV 
positive, and they told me to take the medicine, and I should not fear because if I 
refuse to, I will die quicker. Reengaged\\UF06 
“When I started the clinic here, I developed fear, I was thinking should I continue 
or leave? But the people I found [name of mentor mother] and her colleagues 
were very hospitable and tried showing me that the right way was to accept the 
way I am.” Reengaged \\KF10 
“The mentor mothers, they take you as one of their own, they treat you nicely. 
They just talk to you like your people, like my own mother the way she can talk to 
me and hold me. When they tell you to come on a certain day, you come and find 
them, they take you as their own person, they talk to you, you tell them where you 
stay and they also tell you, you talk to each other until when you get out of that 





ii) The role of formal support groups 
Participants in this study described the support groups as safe spaces where HIV 
women met others like themselves to share, learn and encourage each other. The female 
narratives reported that the feelings of “you are not alone,” and ”they know what I am 
going through” were experienced during support group meetings:   
“Like me now I have stayed [in care] because of the group. When you are in a 
group you know you are not alone in this world, there are others just like me and 
life continues, you encourage each other and you learn from each other. You 
know when I was tested positive I felt like this was the end of the world for me, I 
couldn’t work, I  felt as if I was dead but this group helped because when we are 
together I feel am not alone and I feel the love; I have people around me who love 
and care for me. Reengaged \\UF12 
 
Participants also reported feeling “empowered” and “stronger” after participating 
in the support group: 
 
“After you go there [to the support group] if there is anything burning you in the 
heart you talk about it. I would not like to tell another person out there who 
doesn’t know what am going through. I go there [in the support group] to those 
women and we talk. If it is like this or like that, if your husband is refusing to take 
medicine because there are women saying that their husbands refuse medication. 
How will I talk to him so that he can accept these drugs? Those women I come 
and cry to them.  When I ask them for assistance, these women will know how they 
will assist me.” Retained\\UF02 
 
 
iii) Informal Support  
Under this subtheme women explained how the informal bonds that they formed 
with  other HIV positive women in their neighborhoods, villages or at the health facility 
during the support group meeting or when waiting to see the health providers influenced 
their decision to stay in PMTCT care. These bonds and friendships extended beyond the 
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health facility and were founded on women encouraging and supporting each other by 
sharing their personal stories and daily experiences as pertains to the pregnancy, 
medications for the baby, and infant feeding options. 
Women described the informal discussions that come up when they are waiting to 
see the healthcare providers as “normal women stories” or “deep, deep women talk” as a 
motivating factor for them to stay in PMTCT care.  These discussions are in the form of 
stories told by the women as they waited to be served at the health facility and were 
based on women’s own experiences.  These experiences could be positive or negative but 
they were described as encouraging to the women who heard them. Many women in the 
retained category said that after listening to the stories of defaulters who described the 
extent to which: their sickness had worsened, their health deteriorated at time of 
reengagement, or seeing defaulters with HIV positive children motivated them to stay in 
care.  This is narrated below: 
“There is a woman who told us that she was tested when she was four months 
pregnant and she ran away but when she was about to give birth to her baby she 
felt that she should come and be assisted and that’s when she came. She was 
assisted and her baby did not turn HIV positive even though she came two weeks 
before her delivery date. They [study site] helped her and she even accepted to 
start taking medication. This is a story she was telling us while we were sitting 
outside there waiting to be called in by the doctor.” Non Retained\\UF01 
 
“Even now when I was on the queue we were asking each other, how is the baby?  
I said the baby is fine. Do you take medication? Yes, I take. One time, as we were 
waiting in the queue there was a woman who was saying that she will abort [have 
an abortion] because she was HIV positive. We talked to her and I told her that I 
had given birth to two children when I was with this condition [HIV] therefore 
she should not think about an abortion. And she came back and she is now with 
us.” Retained\\UF02 
 
 “In our plot [neighborhood], two ladies were HIV positive, so they knew 
everything about PMTCT and we used to talk, they used to encourage me…they 
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had started the clinic, and they knew if I stayed in the clinic, I will deliver a 
negative child. They were so encouraging to me, every time they would ask me if I 
had started my clinic so as not to get a positive child.” Retained\\UF11 
 
 
F. Quality of care  
The study participants described a good quality PMTCT program to include 
experiences that gave HIV positive women hope, strength and encouragement. Women 
often felt that they owed their lives and that of their child to the PMTCT program: “I 
don’t think I would still be alive,” “I would be dead,” “I would not have a negative 
child.” The experiences that defined good quality of care are described below: 
“I can say their service is high quality, it is excellent because there is no day I 
have come and those ladies talked to me badly or kept me here for long or not 
attended to me; when I ask a question they answer me. I don’t see anything wrong 
with them.” Retained\\KF12 
 
“It [PMTCT program] teaches those who are confused, who don’t have faith, 
those who have lost hope, it gives them strength and one gets motivated… I mean 
they don’t discriminate you based on your HIV status. They take you as a normal 
person” Retained\\YF10 
 
In the female narratives, positive healthcare provider attitudes were the major 
factor that determined whether a woman considered the care to be good quality or not. 
Positive provider attitudes were described as those that: “don’t discriminate,” “answer me 
well,” “give me advice,” “made me feel human,”  “are flexible” and “treat me as human 
and they are not forced to do it.”  This was a motivation to stay in care:  
 R: “The providers serve you well, and they serve without discrimination”  
M: And when you say the serve without discrimination, what to do you mean?  
R: “If you ask a question, they will answer you nicely they don’t answer you in 
bad faith.” Reengaged \\UF06 
 
“The services were good because the doctor had the time to listen to what I was 
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feeling, and then he would tell me how it’s going to be. It makes me feel 
comfortable and I had confidence, that if I follow the instructions I had been 
given, and I will get a HIV negative child.” Retained\\UF11 
 
“When I came to know my status, the first person to test me, the way she handled 
me. I had panicked after being told my status but she calmed me down and made 
me not lose hope and I decided to continue coming to the clinic because they gave 
me good advice…You know when one is pregnant, some women say that they 




A. Unsupportive male partner 
This is a subtheme further develops the theme on the Role of the male partner 
discussed earlier.  The unsupportive male partners hindered retention in PMTCT care by: 
1) abandonment; 2) refusing financial and / or emotional support; 3) refusing to accept 
the woman’s HIV positive status; 4) psychological abuse.  Some unsupportive male 
partners would go to extremes and “throw away” or “hide” the spouse’s HIV 
medications.  In other instances the unsupportive male partners were totally uninvolved 
and refused to accompany the wives to the health facility, did not contribute financially 
and abdicated all responsibilities by telling the woman that “you gave birth please carry 
on.” Some male partners encouraged denial of the HIV status by repeatedly telling the 
wives, “you are not sick,” “do not to take those medicines” or “stop giving the baby 
medicine “and “I don’t believe that you are sick, how can you be when I am healthy?”  
The acceptance of the HIV positive status by the male partner often occurred only when 
the women were symptomatic and/or they themselves fell sick.   
The unsupportive partners refused to get tested for HIV and continued to demand 
	  	  
117 
unprotected sex with their wives and when the woman conceived they accused them of 
being unfaithful since “they have been using condoms.” Women in discordant 
relationships especially reported that some male partners did not practice safe sex with 
the justification that “I have not been infected all those years,” while others accused the 
wives of “not loving them enough” for suggesting protected sex.  Unsupportive male 
partners often accused their wives of “being the source of the HIV” in the home while 
others denied their women permission to work outside of the home and yet they were not 
providing financial or emotional support. Some male partners were reported to be harsh 
and demanded that their wives have an abortion upon disclosure of an HIV positive 
result.  
Women described the above situations as a “source of conflict” in the relationship 
leading to frustration which often led women to default on their clinic appointments and 
not adhere to their medications.	  Sometimes relationship issues resulted in the couples 
separating, though the consequences may or may not improve the woman’s situation.  
Some women described how the male partners became disrespectful, verbally abusive, 
and unfaithful, or overly controlling demanding that their wives spouses should not be 
friends with others from the PMTCT support group. They even went further to demand 
that the HIV positive women should not take their exposed children for follow up visits 
because people will suspect them of being HIV positive.   
Women described themselves as “having a lot on their minds” due to these 
conflicts and as a result they failed to follow up on appointments for themselves and their 
babies. The women that opted to leave their marital homes often disengaged with care 
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because the new living arrangements were either with relatives that they had not 
disclosed to or were in rural homes where they had to start PMTCT care afresh in a new 
health facility. The quotes below demonstrate highlight these different scenarios:    
 
M: When did he [husband] run away?  
R: “The time I told him that I had been tested HIV positive and was pregnant. He 
didn’t want to hear of another baby and I don’t know why but it’s because he 
knew my condition…From what I saw, he felt like there was nothing left and he’d 
rather die and avoid the shame.” Retained\\KF12 
 
“In fact he [husband] is the one who told me not to go back to the clinic because 
he didn’t think I was sick [HIV positive]. He was even asking me, why do you take 
medicine, what for and you are not sick? He made me feel like I was not sick until 
I became really sick and that is when he believed that I was sick. 
“Reengaged\\UF07 
 
“When I went home [from the clinic] I had an issue with my husband because 
whenever he saw the medicines he would throw them away. I got tired and 
decided there was no need of taking medicine… I would look for medicine in the 
house but I would not find them…I would ask him and he would say that he hasn’t 
seen them…I even told him that we come together and get tested but he refused. 
That is why we separated. Reengaged\\UF03 
 
 
B. Denial of HIV positive results 
Refusal to accept one’s HIV positive status directly affected retention in PMTCT 
care because women convinced themselves otherwise, even despite the influence of 
family members to participate in the PMTCT program.  Participation for some mattered 
only after there was acceptance at the individual level.  Denial of HIV status resulted in 
delayed ANC seeking; late initiation of PMTCT interventions during pregnancy or after 
birth and often resulted in negative outcomes as such an HIV positive child. The quotes 
below demonstrate this denial: 
	  	  
119 
“I refused to accept my status and that was my biggest problem, not accepting 
after being told my status… I had already given birth to two children before who 
are okay [not HIV positive], I came to learn when I was breastfeeding the second 
child that I am sick [HIV positive]. I was still having intercourse with my husband 
without using a condom and he is not HIV positive. Then I have HIV; where 
from? That is what was making me not accept my status. “Reengaged\\UF09 
 
“Then they asked me if I would start medication, but I didn’t have the morale. I 
didn’t accept it [HIV positive] so I took it lightly. Now when I was eight months 
pregnant, the illness were severe, and that’s when my father told me, the right 
thing to do is accept because you can’t know, it’s the doctor who tested you and 
found it that way. I told him that I had not accepted; so I just ignored. I did not 
even deliver in the hospital, I delivered in the house and I just breastfed the baby. 
Breastfed the child up to like three months and then decided to start giving him 
other food.” Non-Retained\\UF012 
 
When asked about their experiences with the PMTCT program, some female 
participants began by describing the emotions that emerged immediately after the HIV 
positive result was revealed to them and how these contributed to denial of the HIV 
status. Feelings of pain, fear, shock and confusion often resulted to negative health 
seeking behaviors like non-adherence, defaulting care and gave women a reason deny 
their HIV status and subsequently not seek or stay in PMTCT care. They described 
themselves as: “seeing death,”  “waiting for death,” “seeing the end of me,” “seeing 
darkness in the day time,” and “reaching the end of life. “ Some women even 
contemplated if they should stop taking medications so “they could die faster” or “abort 
the pregnancy.”   Even though these feelings were expressed by all the female 
participants those that were fully retained were more willing to openly talk and share 
their experiences and even laugh about them.  Once the women processed these negative 
feelings two things would happen: 1) some women moved past these negative feelings 
and accepted their HIV status, 2) others continued to deny the HIV status. The quotes 
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highlight the negative emotions that emerged after a HIV test was revealed: 
 “I disappeared [from study site] because I was shocked, I couldn’t believe I have 
this disease. I did not come back. I stayed away for almost two months without 
coming for medicine. Because I did not believe that I had it (HIV).” 
Reengaged\\UF03 
 
“I was shocked, I cried because I did not know what to do; they [nurses] told me 
that when I finish crying they would talk to me. I was in so much pain, they told 
me to go home and come back the following day. I went home, sat, could not eat, I 
was weak, I could not do anything.” Retained\\YF01 
 
Those women that reengaged and those that were not-retained in PMTCT care 
explained that they denied their HIV positive results by convincing themselves that they 
were not HIV positive. The feelings of fear, hopelessness, confusion, depression that 
emerge immediately after receiving an HIV positive result led the female participants to 
question and then internally process their HIV results.  They asked: “where did I get it 
[HIV],” “how can I have it [HIV] if my husband does not so it’s not true,” and “I 
previously had an HIV negative child?” In some cases women outwardly denied their 
HIV positive status, though continued attending ANC related services and further would 
not discuss their HIV status to providers. In other cases, the woman refused HIV 
treatment or PMTCT prophylaxis for herself but consented to the baby receiving 
prophylaxis after birth and followed safe infant feeding recommendation.  
 
  
C. Internal stigma  
Internal stigma contributed to both denial and non-disclosure of HIV status.  The 
fear of stigma and the shame of being found out prevented and delayed women from 
seeking HIV care early and/or disclosing their HIV status. The female participants’ 
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perception was that when people don’t know your HIV status they treat you like one of 
them but when they know, they treat you differently. All the three categories of women 
interviewed  felt that due to stigma one has to be discerning as to whom they disclosed 
their HIV status to because some people will: “spread the news about me,”  “backbite 
me,” “point fingers at me” and ”stop their children from playing with mine.” Some 
women limited their friendships to mostly HIV positive women because it removed the 
burden of feeling stigmatized. Internal stigma also affected how women perceived 
PMTCT services and the quality of care they received. As expressed in the quotes below, 
the fear of being stigmatized led women to constantly worry about what other people 
thought and stopped women from utilizing PMTCT care and/or made them change health 
facilities:  
“You fear because you imagine everyone knows you are HIV positive (laughs). It 
is self, internal. Retained\\KF13 
  
“You hide yourself, you look like you are a coward, you hide yourself completely 
because you are wondering, how will people look at me? In the plot 
[neighborhood], how will people talk? Those are the questions one I asked 
myself.” Reengaged\\UF09 
 
“That’s why I’m telling you that I go for my HIV medicine in [outside facility]. I 
have accepted yes, but I don’t want other people to be pointing fingers at me on 
the streets, I don’t want; that’s what made me not adhere because I used to meet 
with my neighbors here[study site].” Retained\\YF05 
 
 
D. Lack of disclosure to spouses, family and friends  
The lack of disclosure and the fear of being found out as HIV positive were 
reported as barriers to retention in PMTCT care. Many women in this study feared 
abandonment and loss of support from husbands/partners and relatives who help with 
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child care.  These fears often prevented disclosure of HIV status and were experienced by 
all the women in the three study categories.  Women reported having internal 
conversations on disclosure: “how do I tell my husband?”, ”where do I start from?” and 
“how will I be perceived?” Furthermore, the fear of being labeled as a “prostitute” also 
limited some female participants from disclosing their HIV status especially to in-laws. 
Those that had not disclosed to their male partners narrated how they had to hide their 
HIV medications at home and the unending fear of being found out.  Women that had 
done this or those that were currently hiding their HIV medication from their spouses 
reported being non-adherent during that period. 
“I was afraid of telling him [husband] at that time…I knew if I tell him he may 
disown me.” Retained\\YF10 
 
Study participants reported that they understood the benefits of disclosure but 
wanted the choice to decide who to disclose to or not, and did not want to be exposed to 
everyone and in particular extended relatives, neighbors and church members. The fear of 
having one’s HIV status known by relatives or neighbors often stopped women from 
seeking HIV care in health facilities that were close to their home or waiting in line or in 
an open area to be seen by a healthcare provider.  Some women considered their HIV 
status as “top secret” because of previous experience within the family where an HIV 
infected relative or sibling was discriminated and as such even when seriously ill and 
admitted in hospital these women were not willing to disclose their HIV status to family 
members. The quotes below demonstrate the fears women associate with disclosure:   
 R: “I haven’t told those [neighbors] my HIV status.”  
M: Why?         
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R: “Because some will discriminate you, some will despise you, some won’t want 
you to visit them, and maybe they won’t share a hanging line or a washing 
basin… The children of the those [neighbors] I have not disclosed to come to my 
house, even they themselves also visit and take tea and eat the “chapatis” that I 
have prepared, some undo my hair. But if they know your status they won’t touch 
you. “Retained\\YF12 
 
R:  “You see I don’t like going to my local facility.” 
M: Why?                                
R: “Because even my biological mother doesn’t know that I am sick [HIV 
positive]. That’s my secret with my husband only. So going there [local health 
facility] close to my home every now and then, I will meet with people from my 
home area, or my neighborhood and I will be exposed there.” Reengaged \\KF10 
 
“My mother also goes there [study site CCC], and I wouldn’t like her to know. 
She comes there [study site CCC] and I was wondering, what if my appointment 
is the same dates as hers and she sees me?” Non Retained\\UF05 
 
 
E. Financial Pressures  
Women found financial constraints to be an obstacle to seeking PMTCT services.  
Women explained that the lack of money and worries about where to get it to cover bus 
fare, pay for the clinic visits or buy formula milk (for those that opted for replacement 
feeding and were in a study site that did not provide) arose. Some women reported that 
even the free formula milk (a very expensive commodity —$10 per tin— for many 
women), the transportation costs to the site estimated at less than a dollar per visit were 
too great, so they had forgone replacement feeding as an option. Some women talked 
about how the lack of money had led them to seek vouchers from the chief’s office to 
enable them access antenatal and maternity care where PMTCT services were also 
provided.  
Women also faced opportunity costs: in going for appointments they gave up 
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other income producing uses of their time. Most HIV positive women had to make at 
least one visit to the health facility per month while others made two visits each month. 
Those women with appointments every two weeks in particular talked about how these 
return visits posed financial pressures when it came to bus fares costs. Some of the 
women were sole breadwinners, and having to fend for themselves or run businesses 
conflicted with clinic appointments and the medication schedules:   
“The business I started demanded me to be going every day and so on my return 
date I didn’t go back to the clinic.… It’s because I am looking for a livelihood. 
You know when you are alone, everything is on you. So I leave in the morning and 
come back in the evening. So even the return date they [study site] gave me I 
forgot because my focus was just on business. When I left my husband I had to 
fend for myself.” Non Retained\\YF09 
 
“When I come here I use Ksh. 60 ($ 0.70) for transport to get the milk. Some 
women decide they would rather not spend that money and they decide to 
breastfeed their children. Our worry was money because we thought we will be 




F. Poor Quality of Care  
Three subthemes on poor quality of care were identified as barriers to retention in 
PMTCT care.  These are: 1) negative healthcare provider attitudes, 2) waiting and delays, 
3) preconceived negative perceptions regarding quality of care.  
A supply issue identified was the lack of HIV test kits. Women explained how 
they went to a health facility multiple times for ANC services but were not tested for HIV 
due to lack of test kits. In most cases, the women who chose to attend privately owned 
health facilities for ANC services were often referred to public health facilities for HIV 
testing but the providers in the referring health facilities did not track the referrals.  
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A human resource issue that was identified was provider oversight. For example, 
providers sometimes failed to take notice during delivery that the newborn required 
PMTCT interventions immediately after birth even when the mother’s HIV positive 
status was documented in the MCH booklet.  In other cases the healthcare providers 
failed to notice that the woman had defaulted PMTCT care and it was clearly documented 
in the patient booklet and as such these women received only ANC services without any 
reference to PMTCT. Others described experiences where the pharmacist incorrectly 
filled the prescriptions and as such the HIV positive women left the hospitals without the 
correct drugs refills and were forced to buy, and or use the mentor mothers to get the 
correct prescription refill. 
A logistical issue experienced and was a common occurrence from all three study 
sites was the delay and or loss of the baby’s six week virologic results. Women described 
how they made several trips to the health facility to collect the baby’s polymerase chain 
reaction (PCR) results only to find that that the results were missing. This situation led 
mothers to change health facilities or to give up on their baby’s HIV result altogether.   
It was also common knowledge that private health facilities do not routinely test 
for HIV while the public ones do, and so women that were avoiding the HIV test or those 
that were in denial after a previous HIV positive test opted to attend ANC and deliver in 
private health facilities. The reengaged group narrated that their return to the public 
facilities after months of attending private facilities was due to frustration with the poor 
quality of services they received and fact that their health situation did not improve but 
instead continued to deteriorate.  
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These negative experiences with the health system often left women demotivated 
and unwilling to return to that particular health facility for PMTCT care as shown below: 
“I went to a private facility with my ANC book and gave birth to my child without 
difficulty and went home after three days. The doctor there did not ask or say 
anything to me about my HIV positive status. After delivery, I went home 
comfortable with my baby and told myself if these people [healthcare providers] 
said nothing [about HIV] then there is nothing serious about my situation, we 
[infant and mother] are safe.” Non Retained\\UF01  
 
“The only thing that didn’t make me happy there is the PCR. Because the first 
PCR was sent and they said it was spoilt, they drew blood again and the second 
one got lost and so the child was tested at nine months. They draw blood from the 




i) Negative healthcare provider attitudes 
Healthcare providers with negative attitudes were described as those that 
discriminated against HIV positive people, did not maintain confidentiality, were harsh, 
hostile or having “bad manners” because they discussed the patient’s condition in the 
presence of others. In other cases, some healthcare providers refused to attend to pregnant 
mothers who showed up for ANC at advanced gestational age as a punishment for late 
ANC attendance. The female participants felt victimized by the healthcare providers 
because they believed that the MCH booklet is a prerequisite for admission into maternity 
in public health facilities. The female participants also explained that they did not like it 
when the healthcare providers asked too many personal questions as to why they missed a 
scheduled appointment because they expected that the healthcare providers would 
understand the stress that their condition –HIV and pregnancy- caused. The quotes below 
demonstrate these attitudes: 
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“So this doctor became harsh and took my mother's (MCH) booklet and started 
asking me in front of everyone, when did you know your HIV status? He 
interfered to a point that I started hating that doctor.” Reengaged\\YF13 
 
“At times you might find a doctor at the pressure check point and throws words 
on you, God, until you wonder if you will be checked or not, but you just console 
yourself. She shouts at you badly, you think; don’t I know what am doing?” 
Retained\\UF08 
 
Female participants were concerned that some healthcare providers were not 
taking time to explain to them why they were required to continue giving ARVs to babies 
whose PCR test result was HIV negative at six weeks. The lack of explanation around 
treatment led many women to feel a degree of coercion on the part of healthcare 
providers. In some instances, providers assumed that the woman knows what to do in 
regards to PMTCT care protocols and as a result the providers “failed to help.”  These 
experiences with healthcare providers left the women feeling that they and the healthcare 
providers “were not getting each other.” In addition, some female participants felt that 
some healthcare providers did not listen when patients told them about the side effects 
that they (women) were experiencing with the ARVs:    
Moderator: And did you tell the doctor you were reacting negatively to the 
medicines? 
Respondent: “I did, and they talked to me in a group, they really talked to me; by 
then I had not delivered. I tried to explain to them but they really wanted me to 
take them [medicines] so as to help the child.” Non Retained\\UF05 
 
Female participants further described how some changed health facilities because 
they were unhappy with the treatment they or their HIV positive child was receiving and 
when they tried explaining their concerns to the providers they were not listened to.  
Narratives stated how healthcare providers discussed and disagreed among themselves 
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about a diagnosis in the presence of the patient and in her opinion the healthcare 
providers did not involve her because “she did not speak English well.”  
Some women reported that many of the providers were inflexible and lacked 
consideration as to why some were missing appointments. Women that were fully 
retained in PMTCT care in particular felt that they were often punished for missing 
scheduled appointments even by a day, and the healthcare providers were unwilling to 
understand why this was happening.  As regards infant feeding options, some participants 
explained that even though the decision to breastfeed or not was often based on the 
practicability of the individual  woman’s situation, some healthcare providers were not 
understanding of that and insisted that women base their decision making on CD4 cell 
count: 
“My CD4 count was down and when I was sent there [doctor’s room] she knew 
my CD4 count and when I reached there she said; I’d advise you not to breastfeed 
the baby because you will infect the baby, so when I left there, I was crying 
because this woman confused me so much and I didn’t know what to do?” 
Retained\\YF03 
 
ii) Waiting and delays 
Women often had experienced long waiting times for their visits, and these long 
waiting times took them away from their work for extended periods of time. Women 
reported that the length of the wait time often extends to almost five hours as a patient 
moved from one room to the next. This long wait times affected the female interview 
participant’s daily plans with those running businesses in particular reporting that they 
had to close up the business for a full day and they felt this “was a waste of time.” Others 
felt discomfort in waiting in an open area as this led to increase opportunity for stigma, as 
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they could be seen   waiting to go into the “AIDS room.”  The quotes below demonstrate 
this frustration: 
“My problem is queuing. Waiting there for long and I’m from around so people 
know me...while waiting out there people are clearly visible and most people that 
live here come to the hospital here.” Non Retained\\UF05 
 
“You might come here at 8am in the morning and go home at 3pm in the evening 
because the queue is very long. This is what makes people not want to close their 
businesses and come to the hospital; you waste a lot of time because you find 
when you come here you will be here the whole day. That’s why I find it hard to 
come for visits.” Non-Retained\\UF10 
The long wait times also affected the babies’ feeding schedules because the 
mothers could not leave the line to feed themselves or their babies.  The very sick 
patients too have to wait in the long lines without exception. In some cases women 
reported that even after the long wait they often left the health facility without the 
prescribed medicines for themselves and/or the baby because the facility had  stock outs 
at the time. The women narratives however acknowledged that the healthcare providers 
were doing their best but the patients were just too many. Women also reported that too 
many patients resulted in reduced time with the providers and they felt that they did not 
have enough time to talk with the provider:  
“There are problems, for instance drugs, when one brings a child here the drugs 
are not available and you are told to buy them outside. At times we stay in the line 
there up to around 1pm and the baby needs to eat. Even when you are sick you 
are sent to the queue, and you know at that time we are all mixed up with the rest, 
so you end up staying in the queue for long before it’s your turn.” Retained\\YF05 
 
“Now when I had the baby, especially we women with this status [HIV], we have 
to pass through this room, so that if the baby is tested, and then is there another 
room where we collect medicine and another one for weight. Now you have to go 
through all these rooms.” Retained\\YF05 
 
“The doctors try very much to serve you quickly because at times they don’t even 
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take a lunch break, they work throughout. I think the doctors are few because 
most times it’s one doctor there and s/he must attend to all the patients. They are 
working well, but the patients are too many. The patients are just too many.” Non 
Retained\\UF10 
 
iii) Preconceived negative perceptions regarding quality of care 
The female interview participants reported that they expected to be treated poorly 
by healthcare providers for being HIV positive and not be followed up in a positive 
manner and these perceptions hindered them from seeking PMTCT care. In addition, 
preconceptions of stigma and blame discouraged them from seeking care.  For example, 
several women were surprised that the healthcare providers treated them like “normal 
people” and did not discriminate them.  One woman expressed, “they treated me well by 
the way.” Those women that were reengaging in care feared that healthcare providers 
would reprimand them for defaulting care because they were constantly warned of the 
dangers of this behavior. The category that reengaged in care while sick was positively 
surprised that they received  good reception at the health facility and were cured of their 
opportunistic infections because at the time of reengagement they expected to die. The 
women who were known HIV positives and in HIV care expected to be reproached by 
the healthcare providers for conceiving and were surprised when that did not happen. In 
addition, female participants in discordant relationships had a preconceived notion that 
the healthcare providers would treat them negatively because they were “bad”. The 
expression of these fears is shown below: 
“I was imagining that they [healthcare providers] will not make a follow-up on 
me so I had prepared myself psychologically that in case that happened I would 
consider going elsewhere. I had told myself even if the place is close to home and 
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I don’t want to attend the clinic because of stigma, I will be forced to just go there 
in case I am treated badly at [study site].” Reengaged\\KF04 
 
“Sometimes you hear some mothers talking about how badly they were handled at 
the clinic and this made me afraid. They [study site] were so friendly and I felt 
free talking to them, even talking with the doctor.” Retained\\UF11 
 
“Sometimes if you get pregnant when your CD4 is very low, they [providers] just 
start asking you, why did you do this, why did you get pregnant and you know 
your CD4 is very low, but this place [study site], they encourage you, advise on 





Narratives from female participants who reengaged or did not stay in care in 
particular reported experiences with stress during and after pregnancy, a condition that 
led them to not seek and/or to default PMTCT care. Women reported many sources of 
stress beyond their HIV status, including an unwanted pregnancy, conflicts with male 
partners, fear of having an HIV positive child and/or finding out one’s baby is HIV 
positive. The negative emotions that emerge immediately after receiving an HIV positive 
result contributed to the   stress and mental health problems described as: “crazy 
behavior,” and “not in the right state of mind.” Women explained that the fear of telling 
the male partner about their HIV status and maybe subsequently being abandoned by 
them and/or being stigmatized by family members described as “made to eat from 
separate utensils” also added to the stress.  The narratives below demonstrate the sources 
of the stress: 
“I was not coming to the clinic; I was just staying at home because I had stress. I 
had stress because I had a lot of children then to find out that I was pregnant 
again and I did not want to get pregnant again. So I just stayed at home and I 
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kept telling myself that I will come to the clinic but I never did and because of the 
stress I delivered the baby at home.” Reengaged \\KF01 
 
“Before the pregnancy I was experiencing a lot of stress. I could get headaches 
and then I got meningitis and got admitted in the hospital for two weeks. When I 
came back home he [husband] refused me to go back to work so I left him. So 
when I discovered I was pregnant I didn’t know what to do. I was just stressed.” 
Reengaged \\KF04 
 
“You know when one is pregnant I fail to understand where stress comes from, 
sometimes you are unable to eat and sleep. If you are HIV positive and pregnant 
you start imagining you will give birth to a sick child [HIV positive] and you even 
start considering having an abortion.”  Reengaged\\KF04 
 
H. Lack of PMTCT knowledge  
Women narrated how the lack of knowledge on the importance of seeking both 
ANC and PMTCT care and/or staying in care resulted in negative health seeking 
behaviors that made them either not seek, or stay in care. Some women narrated that they 
did not know why they should go to the ANC early in the pregnancy and/or deliver in a 
health facility. Others did not care enough to ask what medicine they were taking and 
what it was for. Lack of PMTCT knowledge was reported to lead to reluctance in seeking 
care, refusal to get tested and/or return to the clinic for subsequent appointments. Before 
their experience with the PMTCT program, the majority of female participants were not 
aware that an HIV positive woman could deliver an HIV negative baby and that they 
could choose to not breastfeed and the baby would still thrive. The quotes below 
demonstrate this lack of knowledge:  
Moderator: Did you go the ANC clinic when you were pregnant?  
Respondent: “No, I did not go. Even with the first born, I found out last minute 
that I was pregnant because I started having a stomachache. I did not know 
anything about clinic or if someone wants to give birth they should go to the 
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hospital. I did not know that, so I was just delivering at home. I did not know 
anyone who would tell me to do this, no one helped me. Reengaged\\UF03 
 
 “They used to give me a white pill and Septrin and at that time I was not even 
interested. They told me to take it because when they even tested my CD4 it was 
very low and they said it was dangerous to be pregnant and have such a low 
CD4…I didn’t even know what that pill was and I didn’t want to ask.” 
Reengaged\\UF12 
 
“I went to a dispensary in [name of location] and I refused to be tested. That is a 
past and I am done with it. It was because I was less informed then. If I did get 
tested my baby would not be infected. I know it happened because of my 
ignorance.” Reengaged\\KF04 
 
Differences in care seeking behavior among female participants 
Several differences in health seeking behaviors were observed among the three 
categories of women (retained, not-retained and reengaged), with more similarities 
observed between the retained and the re-engaged categories. For example, in 
contextualizing my findings, I observed that health behaviors before and after HIV 
diagnosis and as the quotes below show, the care seeking behaviors of the non -retained 
women often remained the same after HIV diagnosis while those of the retained and re-
engaged categories changed positively. The narratives below demonstrate this:  
“Now when I fall sick I go straight to the doctor and I am the one who discloses to 
them my HIV status even before they ask. My attitude has changed totally and it is 
as a result of the advice I got from the PMTCT attendant, from that sister of mine 
and that doctor. That is what has made me change.” Re-engaged \\KF12 
  
“Previously, before I knew my status, when I had malaria or headache I could 
just go to the chemist [pharmacy] and buy medicine. But since I knew my status, 
whenever I fall sick I go straight to the hospital for testing before I take drugs.” 
Retained\\YF09 
 
Respondent: “I used to go to the chemist [pharmacy] and buy medicine.”  
Moderator: And now since you knew your HIV status?  
Respondent: “Even now that’s what I do.” Non Retained\\UF10 
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A second difference observed was the reason for change in behaviors. Those in 
the reengaged category mostly adopted positive health seeking behaviors because of a 
negative lived experience (an HIV positive child, severe illness) while those in the 
retained category were often more willing to consider enrolling in PMTCT care 
immediately after a positive HIV test despite being in emotional turmoil. The non-
retained category on the other hand often justified their current negative behavior even 
when they indicated knowing that it was wrong.  
A third difference among the categories was the feelings about Option B+. The 
women in non-retained category were more skeptical and had negative feelings about 
initiating Option B+.  They did not for example understand why lifelong ART would be 
necessary for someone with a CD4 count greater than 350 cells/mm3. They then 
explained how the negative feelings of confusion, shock, fear and uncertainty that emerge 
after an HIV diagnosis would make starting lifelong ART in a PMTCT setting difficult. 
Those in the retained category expressed similar fears and also brought up the side effects 
of ARVs as a negative and there was an even split about the feelings of Option B+ in this 
category. The re-engaged category on the other hand had positive feelings about Option 
B+ and reported that they would initiate lifelong ART because they would not want a 
repeat of what they had previously experienced as defaulters. The participants currently 
on HAART however stated that change in their health was remarkable and would not 
imagine themselves without the medications.  These different views are expressed in the 
quotes below: 
“I won’t accept [to take ART as per Option B+] because my CD4 count is high. The 
books say that when your count is less than 350 you should start taking the medicine 
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[ARVs], why then should you tell me to start ARVs immediately and my count is not 
there? Non-Retained\\UF07 
 
Respondent: “I am not that happy about it [Option B+].  
Moderator: Why?  
Respondent: Right now I take Septrin and it’s not a bother because Septrin I only 
take it at night and in the morning I perform my chores and leave. But when I think 
of ARVs, maybe I have to take during the day and that timing will bring issues… 
Those drugs [ARVs] I hear that they drain fats in the body, and the fats are 
deposited in the tummy”	  Retained\\YF03 
 
“That initiative [Option B+) is not bad because you know when one has HIV at times 
the health just drops [deteriorates]. Like this woman at the clinic I would see her 
health dropping [deteriorating] and they were not putting her on ARVs so there is a 
lot of need to be put women on medication early, so that somebody is not as weak as 




This study identified factors that enable or hinder retention in PMTCT care are 
complex and comprise an interaction of personal, societal and structural dynamics 
operating simultaneously. As posited by the IMB model, possessing just one standalone 
factor such as correct information of PMTCT, or having a supportive male spouse, or 
receiving good quality did not guarantee a woman’s retention in PMTCT. (110) It is the 
collective mix of these factors that led to positive health seeking behavior that resulted in 
retention in PMTCT care. Consistent with other studies, this study found that possessing 
HIV and PMTCT knowledge in particular empowered women to negotiate with male 
partners, suggesting that they too take an HIV test, and make decisions on whether to 
uptake PMTCT services and subsequently stay in PMTCT care. Additionally, possessing 
PMTCT information positively influenced personal attitudes towards PMTCT care. The 
support of a male partner and family, and what they thought about the woman’s 
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engagement with PMTCT services motivated the women and positively influenced her 
decisions to seek and stay in PMTCT. As women gained knowledge, they became 
empowered and more confident in their ability to make decisions about their own health 
and that of the unborn baby. In addition, categorizing women in just two categories 
(retained or not- retained) could be misleading because as this study’s findings show 
there is a third category, the re-engaged. This describes women that had formerly 
defaulted PMTCT care and then reengaged with the services; and their health seeking 
behaviors were significantly different from those that were fully retained and not-
retained. 
  The facilitators identified in this study  (a supportive male partner, acceptance of 
HIV status, disclosure of HIV positive status, desire to have an HIV negative baby, 
psychosocial support and peer counseling and positive provider attitudes) were 
motivational and behavioral when analyzed in the IMB model. The barriers on the other 
hand (unsupportive male partner, denial of HIV results, internal stigma, the lack of 
disclosure, financial pressures, negative provider attitudes, waiting and delays, negative 
preconceived notions regarding quality of care, stress and lack of PMTCT knowledge) 
cut across the three components of the IMB model.  Even though all female participants 
in the three categories –Retained, Reengaged and Non-retained- encountered the same 
barriers, narratives from those in the Retained category indicated the ability to transcend 
these barriers by prioritizing the need to deliver an HIV negative child. The discourse of 
the women in the Reengaged and Non-retained categories described having delivered an 
HIV negative child as a “miracle” given their non-adherent behavior. The review of 
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literature also found that women’s desire to protect her health and her children’s health 
positively influenced ART initiation, adherence, and retention.(151) 
The role of male partners in either facilitating or hindering their spouses’ retention 
in PMTCT care was distinct and important. The findings of this study are in concurrence 
with findings from other East African studies reporting that male partners often have the 
biggest direct impact in predicting the uptake of PMTCT services.(86–89) Given that 
over 70% of the female participants in this study were married, the role of the male 
partners cannot be overstated, and extends beyond accompanying women to the health 
facility for scheduled appointments. The women’s discourses show that their expectation 
of the male partner was one who created a conductive environment at home to facilitate 
engagement with PMTCT services, supported them financially and emotionally and was 
willing to keep the knowledge about the positive HIV status within the nuclear family. 
The narratives from the male respondents emphasized their role as breadwinners and how 
this was key in keeping their spouses engaged in PMTCT care. The categorization of a 
male partner as supportive or unsupportive is fluid because the behavior often 
transitioned from unsupportive to supportive and vice versa. The female participants’ 
whose male partners had transitioned from a non-supportive to supportive behavior 
attributed the former to the fact that the male partners were shocked and shamed of 
having HIV in the nuclear family. Furthermore, the man’s own HIV status did not 
necessarily mean he would be a supportive spouse; some HIV positive men were reported 
to be unsupportive, while some HIV negative men in discordant relationships were 
extremely supportive. The desire to have an HIV negative child was a major driving force 
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for the male partners to support their spouses in PMTCT care.  
The role of psychosocial support and peer counseling in this study was central and 
extended beyond the health facility. A study conducted with six HIV primary care clinics 
in the USA showed that enhanced contact with HIV patients such as peer counseling 
improved retention in HIV care. (152)  An evaluation on the mothers2mothers (m2m) 
project in South Africa showed that in comparison to non-m2m clients, m2m clients “had 
greater psychosocial well-being, greater use of PMTCT services, and better PMTCT 
outcomes.”(107) In addition to the organized structure in which the mentor mothers 
conducted support groups formally within the health facility, the HIV positive women 
found informal ways to encourage themselves and each other. The role of the mentor 
mothers as navigators, counselors and life guides was especially important following a 
new HIV diagnosis. The mentor mothers allowed women the space to process their 
clinical results and take their individual family situation into consideration before making 
difficult decisions, such as those on infant feeding options. For example, postpartum 
mothers with a low CD4 count had to consider this clinical fact in the context of their 
home environment and financial situation before deciding on an infant feeding option. 
This collaborative process is essential and empowering because the HIV positive women 
are involved in their own decision making and do not feel judged or coerced to making 
the “right” decision, a situation which often occurs in healthcare settings. (67, 68, 70) 
Similar results were found in a qualitative study exploring perceptions of the m2m model 
in Zimbabwe. The Zimbabwe study reported improved self–efficacy and motivation, and 
mentor mothers were viewed more approachable than hospital staff.(109) 
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This study confirmed that internal stigma defined as a woman’s “specific fears of 
stigma and negative events for herself”, (79) was an important predictor of both 
disclosure of HIV positive status and comfort in accessing PMTCT care. Studies show 
that HIV related stigma negatively affects health seeking behavior and pregnant HIV 
positive women in particular have been shown to suffer multiple layers of 
stigma.(20,79,89,153). In this study, the negative influence of internal stigma and the 
resulting lack of disclosure to male partners, family and friends were especially felt 
during the postpartum period when HIV positive mothers had to make infant feeding 
options. Some of the women that had opted to provide replacement feeding to their 
babies often resulted to mixed feeding due to internal stigma and lack of disclosure. The 
dangers of mixed feeding have been documented and similar behaviors were reported in 
qualitative studies with postpartum women.(17,137)  
This study not only showed how disclosure of an HIV positive status can facilitate 
retention in PMTCT, but also the unintended negative consequences that may result from 
this disclosure. While some female participants narrated the benefits of disclosure, others 
described how disclosure led to abandonment by their male partners or family, and/or 
created conflict in the relationship that eventually led to a breakup. Similar findings were 
reported by studies conducted in Southern Africa linking disclosure of HIV positive 
status to intimate partner violence and marital tension.(154,155) The fear of being blamed 
“for bringing HIV into the family” and losing financial and social support limited the 
female participants from disclosing their HIV status to partners and family. This finding 
concurs with other studies conducted in Sub-Saharan Africa documenting fear as a 
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disincentive for disclosure.(74,86,156) A study conducted in Eastern Uganda on non-
disclosure with ANC attendees found that the fear of losing material and financial 
support from male partners was a major consideration on whether or not an HIV positive 
woman disclosed her status to a male partner.(86) 
 Financial pressures which included the lack of money to cover bus fare, pay 
hospital registration costs or buy formula milk for those women who opted to provide 
replacement feeding to their babies were reported as barriers to retention in PMTCT care. 
Closely linked were the competing time needs, where women expressed the interest and 
desire to keep to their PMTCT clinic appointments but could not because they had to 
attend to a business or work. The three health facilities where this study was conducted 
categorized HIV positive women as “high risk” and as such they had to attend additional 
ANC visits and in some cases these women reported having appointments at the facility 
every two weeks. The female discourses indicated that the repeated clinic visits did not 
by themselves bother the study participants but the implications (financial and time) did. 
Two studies conducted in Kenya among HIV positive women reported that the lack of 
money and competing time demands were barriers to accessing HIV care services.(26,30)   
Good quality of care was a motivating factor for HIV positive women to stay in 
PMTCT care while poor quality of care demotivated women from staying in PMTCT 
care. The narratives on quality of care touched on the healthcare provider attitudes, the 
services received, and the extended waiting times experienced while seeking PMTCT 
care. Female participants said that staying in care was not difficult if the healthcare 
providers understood them. By listening to the HIV positive women, healthcare providers 
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made them feel comfortable and confident to follow the instructions that would result in 
an HIV negative baby. The flexibility of healthcare providers allowed the women to ask 
questions which further contributed to their confidence and comfort to make difficult 
decisions. Negative healthcare provider attitudes on the other hand were a barrier to 
retention and included hostility, harshness and the lack of confidentiality. As regards the 
lack of confidentiality some women felt that healthcare providers often asked deeply 
personal questions that were not in any way helpful for their care, and sometimes the 
answers women provided were used outside of the health facility and caused marital and 
family problems.  The lack of HIV test kits, medicines and lost PCR results for the baby 
were reported as reasons why women disengaged in care. A study conducted in Kenya 
found the health systems factors such as the failure to test due to missing test kits or 
supplies accounted for 60% of the reasons why women did not accept HIV testing.(12) 
One matched case-control study in Nyanza province also concluded that health system 
factors were more important predictors of  MTCT than psychosocial factors.(72)  
A 2015 systematic review looking at mistreatment of women during childbirth in 
health facilities found that “physical and verbal abuse, a lack of supportive care, neglect, 
discrimination, and denial of autonomy” were experienced by women while seeking 
MCH care. (157) A Zimbabwean study found that women that delay ANC attendance are 
treated poorly by health care providers and as a result continued to avoid care.(24) In this 
study, negative experiences with the health system or with healthcare providers as well as 
preconceived negative perceptions based on lived or other women’s experience brought 
on fear which hindered women from seeking and/or staying in PMTCT care. Women’s 
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narratives showed how women had to psychologically prepare themselves for a negative 
experience and they would often have second plan in place in case this occurred. Women 
were often surprised when they were treated positively by the healthcare providers 
because this was not what they expected. Women that experienced negative treatment in 
the hands of healthcare providers indicated choosing to stay in care at the current health 
facility for the sake of their baby, switching facilities and defaulting PMTCT care 
altogether.  
The need to pay more attention to the mental health of HIV positive pregnant and 
lactating woman though not commonly discussed in PMTCT retention studies emerged in 
this study.(137) The women narrated how the negative emotions of fear, hopelessness 
and confusion experienced upon learning of their HIV positive status, combined with the 
pregnancy and exacerbated by the fear of infecting the unborn baby brought on stress and 
depression. Women described how they did not eat and sleep for days, almost burned 
down their houses or were close to being run over by motorists while crossing the road. A 
study conducted in Kenya showed that shame was associated with decreased HIV testing, 
incompletion of maternal ART course and infant testing. (158) A qualitative study on 
retention conducted in the USA showed that internal stigma (also identified in this study) 
was related to depression and self-shaming.(114) As Kenya transitions to providing 
Option B+, thoughtful consideration should be given to the mental health of HIV positive 
pregnant and lactating women because the majority of women learn about their HIV 
status for the first time during pregnancy. One study in Kenya showed that the likelihood 
of MTCT was higher among newly diagnosed women than among known positives.(72) 
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In this study for example, over 80% of the women in the retrospective chart review 
cohort were newly diagnosed with HIV during the current pregnancy. The mental health 
of HIV positive pregnant women becomes a key point of consideration because under 
Option B+ many asymptotic women will be started on lifelong ART and newly 
diagnosed HIV positive pregnant women will be expected to make a lifelong decision 
while experiencing this mental turmoil. 
Women’s acceptance of their HIV positive status was a continuous process and 
did not happen at one go. Acceptance of HIV status which occurs at the health facility 
immediately after the HIV result is given was often not sustained and resulted in non-
adherent behaviors. This is because on returning back home from the health facility, the 
HIV positive women found that life’s daily pressures heavily conflicted with the demands 
(medication schedules, dietary needs) placed on them by their HIV positive status, and 
they were often no well prepared to handle these demands. The longer women continued 
to deny their status the more stress they experienced because they worried about infecting 
the unborn baby and about the wasted financial resources moving from one health facility 
to the next.  
 
5.8.  STRENGTHS 
The strength of this study was the mix of female participants interviewed. The 
recruitment of three categories of female interviewees with distinct PMTCT utilization 
patterns Retained, Reengaged and Non-retained, enabled the study to get a diverse range 
of views based on specific engagement patterns. In addition, the Reengaged category in 
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particular provided a unique perspective to not only learn why the women disengage with 
PMTCT care but also to the reasons why they reengage with care and their feelings, 
thoughts and behaviors during the period of disengagement.  
 
5.9.  LIMITATIONS 
These results should be viewed with an understanding of several limitations. First, 
few men participated in the study and this number was not sufficient to reach thematic 
saturation. The projected sample size for the male interviewees was 20 but due to refusal 
to participant by the men and time constraints the study only successfully recruited and 
interviewed six male partners. Secondly, five of the six male interviewees all had wives 
that were fully retained in PMTCT care while the remaining one had reengaged with 
care. This biased our sample because the study did not interview any men whose 
wives/partners were active defaulters.  
 
5.10. CONCLUSION  
This study highlights the barriers and facilitators to PMTCT care in a Kenyan 
context. The complexity and interconnectedness of these factors cannot be overstated in 
influencing the health care seeking behaviors of HIV positive women in PMTCT care. 
The successful implementation of Option B+ assumes that PMTCT programs will attain 
close to 100% retention. Understanding these barriers and facilitators to retention will 
have implications in the design and development of PMTCT policies and programs in 
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order to achieve maximum rates of retention and elimination of mother-to-child 





Using failure modes and effects analysis (FMEA) to identify potential failures 




Objective:  To identify potential failures along the prevention of mother to child 
transmission of HIV (PMTCT) cascade and where along the cascade they occur, in order 
to improve retention of HIV positive women in PMTCT care.  
Methods: Structured failure modes and effects analysis (FMEA) was conducted in three 
health facilities in Kenya as a part of a mixed methods study, whose goal was to 
understand the barriers and facilitators to retention in PMTCT care. The causes and 
effects were identified for each failure mode discussed, and a Risk Priority Number 
(RPN) was calculated based on the likelihood of the failure mode occurrence, detection 
and severity.  The FMEA findings were then triangulated with results from a semi-
structured one-on-one qualitative interview that examined the facilitators and barriers to 
retention in PMTCT care.   
Results:  Nine failure modes were identified and are ranked by RPN: Missed 
opportunities for HIV testing and/or provision of PMTCT interventions at ANC (RPN 
1,000); 2) Late ANC attendance (RPN 900); 3) Poor quality of data (RPN 800); 4) Poor 
linkage between health facilities (RPN 700); 5) Outright refusal of PMTCT interventions 
by HIV positive woman (RPN 600); 6) non-disclosure of pregnancy by  HIV positive 
women currently enrolled in HIV care (RPN 405);  7) Long queues, extended waiting 
times and delays (RPN 360); 8) HIV negative infants seroconvert between the six weeks 
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and nine months tests (RPN 200) and;  9) refusal by women enrolled in PMTCT services  
to disclose illnesses (RPN 162). The causes of the failure modes were a combination of 
health system, personal and societal factors.   
Conclusion: The failure modes identified undermine effective implementation of 
PMTCT programs and provide a basis for quality improvement. The triangulation of the 
FMEA results with qualitative data provides the much needed context in the design of 
PMTCT implementation strategies as Kenya transitions to scale-up the provision of 




6.1. INTRODUCTION  
The pathway of events that must be implemented to facilitate delivery of 
interventions to HIV positive women is called the prevention of mother to child 
transmission of HIV (PMTCT) cascade.(18) Successful retention of HIV positive women 
along the PMTCT cascade is a major challenge for PMTCT programs.(19–21) Retaining 
HIV positive women in PMTCT care depends on a programs’ ability to facilitate the 
following: 1) regular antenatal care (ANC) attendance where HIV status is diagnosed and 
HIV positive women are enrolled for PMTCT services; 2) access to effective 
antiretroviral (ARV) regimens; 3) safe labor and delivery; 4) ARV prophylaxis for the 
HIV exposed infant; 5) safe infant feeding practices; and 6) infant HIV diagnosis at six 
weeks, and nine and 18 months postpartum when the final HIV diagnosis is made.     
Even though the Kenya 2012 PMTCT Guidelines introduced the use of Option 
B+,  it was not until June 2014 that an amendment to the guidelines was issued 
recommending the scale up of Option B+ to all facilities providing PMTCT 
services.(7,51)  Unlike the previous guidance  (Option A and Option B) that 
recommended short term ART regimens for PMTCT, Option B+ endorses the initiation 
of lifelong antiretroviral therapy (ART) to all HIV-positive pregnant and lactating 
women.(48) Option B+ expected to improve access and findings from a 2014 study of 11 
countries that documented lessons learned from early implementation of Option B+ 
reported a 50% increase in ART uptake in ANC.  Kenya based retention studies have 
consistently documented low retention and high attrition rates along the PMTCT cascade 
which is attributed to gaps in the PMTCT process.(25,136) For example, even though 
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92.2% of women were tested for HIV in ANC testing in 2013, 70.6% of those that tested 
HIV positive received ART for PMTCT and only 55.7% of the HIV exposed infants 
received ARV prophylaxis to reduce mother-­‐to-­‐child-­‐ transmission (MTCT).(37) To 
maximize the benefits of Option B+, Kenya must not only address these gaps but also 
initiate interventions that improve the current retention in PMTCT care.   
This study used the Failure Modes and Effect Analysis (FMEA) to understand the 
potential failures along the PMTCT cascade, and where along the cascade they are 
occurring in order to improve retention of HIV positive women in PMTCT care.  
 
6.2. STUDY SETTING 
 
This study was conducted in three public (government owned) health facility sites 
in Kenya namely: 1) Kayole Health Center in Nairobi County, 2) Kiambu County 
Hospital in Kiambu County; and 3) Nyeri County Hospital in Nyeri County. At least 
three mentor mothers from Mothers to mothers (m2m) Kenya were present in the three 
study sites and provided peer counseling and psychosocial support to HIV positive 
women enrolled in PMTCT care.   
 
6.3. ETHICAL CONSIDERATION 
 
Ethical approval to conduct this study was provided by the Boston University 
Medical Campus (BUMC)-USA and Africa Medical Research Institute (AMREF)-Kenya 
Institutional Review Boards (IRB). Approval was also received from the hospital 
superintendents in the three sites and the County Health Departments in Kiambu County 
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Hospital and Kayole Health Center. The officers in charge of the maternal neonatal child 
health (MNCH) departments in the three sites provided additional approval.   Written 
consent was also obtained from all participants. 
 
6.4. METHODS 
Quality improvement (QI) is defined as “systematic and continuous actions that 
lead to measurable improvement in health care services and the health status of targeted 
patient groups.”(159) In healthcare, performance is directly linked to an organization's 
service delivery approach, and includes efficiency, outcome of care, and patient 
satisfaction.(159) The Failure Modes and Effect Analysis (FMEA) like many QI 
methodologies, was a adopted for healthcare from the manufacturing industry and  is a 
prospective risk analysis system which allows for the proactive assessment of potential 
weaknesses in a process before they occur.(160) To execute these QI methodologies, 
implementers must first understand the existing system before initiating improvement 
strategies.(161)  
The FMEA is a stepwise approach to identify potential failures in an existing 
process and the subsequent development of process improvements to eliminate or reduce 
each failure in order of priority.(162) The FMEA was designed to provide answers to 
three sub-questions:  
a. What could go wrong? (Failure modes) 
b. Why would/does the failure happen? (Failure causes) 
c. What would be/are the consequences of each failure? (Failure effects) (162) 
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Steps in the FMEA  
The study adopted the Institute for Healthcare Improvement (IHI) FMEA tool —
Annex 6— for the FMEA process. (163) The FMEA was conducted in a sequence of 
seven steps outlined below:  
Step 1: Defined the scope for the FMEA at each study site based on preliminary 
data collected from a retrospective chart review (RCR) and semi structured in-depth 
qualitative interviews conducted prior to the FMEA as part of this mixed methods study 
design.  The scope of the FMEA was to identify potential gaps in the PMTCT process in 
order to improve the retention of HIV positive women in PMTCT care. 
Step 2: Assembled a multidisciplinary team of at least six people at each study 
site to participate in the FMEA. These teams comprised: a) healthcare providers engaged 
in the PMTCT process, and b) mentor mothers at the study sites. To ensure buy-in by the 
study sites, the study’s principal investigator (PI) conducted orientation visits to each site 
at the start of the study, and initiated discussions with both management and frontline 
healthcare providers.  The FMEA meetings were conducted in rooms within the study 
sites and lasted approximately three hours. The study PI facilitated the discussions and 
audio recorded the discussions. The FMEA tool was used as a working sheet to guide the 
discussions. 
Step 3:  Process mapping started with the teams listing and verifying all the steps 
in the PMTCT process specific to the individual study site. This listing of steps allowed 
the FMEA teams to critically think about the PMTCT process as they created draft 
process maps to serve as a basis for the discussion. The current state process maps were 
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created on flipcharts and during the analysis redrawn using Microsoft Visio 2013. Annex 
7, 8, 9 are the process maps for Kayole Health Center, Kiambu County Hospital and 
Nyeri County Hospital respectively.  
Step 4: Once the process maps were agreed upon, the FMEA team together began 
to identify the failure modes (what could go wrong?) in each step of the PMTCT cascade 
and the causes for these failures. The FMEA discussions began with a presentation of the 
preliminary findings and observations from the RCR and the in-depth qualitative 
interviews by study PI. A discussion where the FMEA teams deliberated the findings, 
identified failures modes and their causes based on their daily experiences implementing 
PMTCT services then followed.   
Step 5:  In a facilitated discussion format, the team conducted hazard analysis 
using a Hazard Scoring Matrix to determine probability of occurrence, probability of 
detection, and the severity of each failure mode. For each failure mode, the team assigned 
a Risk Priority Number (RPN) for the likelihood of occurrence, likelihood of detection 
and severity. The RPN is a numeric score between one and 10 with one being “very 
unlikely” and 10 being “very likely.”  (163) To assign a RPN the team was guided by 
three questions outlined in the FMEA tool: 
i. Likelihood of occurrence: How likely is it that this failure mode will occur?  
ii. Likelihood of detection: If this failure mode occurs, how likely is it that the 
failure will be detected?  




The failure modes were then explored through the results of semi structured in-
depth qualitative interviews conducted prior with HIV positive women (n=40) and male 
partners (n=6). Data from these in-depth interviews were analyzed for emerging themes 
and categorized as either barriers or facilitators to retention in PMTCT care. The barriers 
were further explored for correlations with the failure modes, their causes and effects.  
 
6.5. DATA ANALYSIS 
Data analysis consisted Step 6 and 7 of the FMEA.   
 Step 6: Upon completion of the hazard analysis, the risk priority numbers (RPN) 
for each failure mode were then calculated using the formula below: 
RPN for each value mode = A multiplication of the three scores assigned in Step 
5 (1 to 10 score for each likelihood of occurrence, detection and severity). 
The lowest possible score was 1 and the highest 1,000. The RPN for the entire process 
was also calculated: RPN for the entire process = a sum of all the individual RPNs for 
each failure mode. (163) 
Step 7: defined the plan for quality improvement based on the RPN score values. 







The healthcare providers participating in the FMEA process in the three study 
sites were from the Maternal Child Health department (antenatal and postnatal care), the 
labor and delivery department, the HIV Comprehensive Care Centers (clinical officers, 
nurses, midwives and nutritionists).  The box below shows the composition of the FMEA 
teams by study site: 
 
1. Kayole HC: Seven (7) participants; [3 mentor mothers, ANC nurse, PMTCT 
nurse, midwife (L&D), a community health worker]. 
2. Kiambu CH: 10 participants; [2 MCH nurses, a CCC nurse, PMTCT Clinician, 
PMTCT Counselor, 3 mentor mothers, a midwife (L&D), and medical intern.] 
3. Nyeri CH:  Eight (8) participants; [Midwife (L&D), CCC Nurse, CCC 
Nutritionist, PMTCT Clinician, Nurse MCH, Nutritionist, Mentor mother and 
PMTCT Client.] 
 
Failure Modes by Study Site 
The FMEA systematically identified possible failures along the PMTCT cascade 
and across four PMTCT steps namely: antenatal care (ANC), labor and delivery (L&D) 
postnatal care (PNC) and the HIV comprehensive care centers (CCC).  
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A. Kayole Health Center 
Five (5) failure modes were identified in the PMTCT process in Kayole HC and 
the total risk probability number (RPN) was 2,889. The failure modes are below and the 
highest RPN is listed first:    
i. Poor quality of data especially the postnatal and HIV exposed infant registers. 
(800) 
ii. 18 months antibody test not done and/or not recorded in the HEI or PNC registers. 
(400) 
iii. Missed opportunities for HIV testing at ANC (history of ANC attendance is in 
ANC register but HIV test was not done.) (400) 
iv. HIV positive woman refuses PMTCT intervention. (400) 
v. Long queues, extended waiting times and delays. (360) 
 
For most of the failure modes identified in Kayole HC, the likelihood of 
occurrence ranged between 2 and 8 but the likelihood of detection and the severity of the 
failure mode effects were scored at either 9 or 10. The causes of the failure modes were a 
combination of health system, personal and societal factors.  The health system causes 
were: 1) too many patients vs. few healthcare providers; 2) poor coordination between 
departments providing PMTCT services; 3) back and forth movement within facility, 
different rooms for different procedures; 4) shortage of test kits and; 5) mobility of 
patients across health facilities. The personal factors were: 1) lack of PMTCT knowledge; 
	  	  
156 
2) fear of disclosing HIV positive status; 3) denial of HIV positive status. HIV related 
stigma was identified as a societal cause of the failure modes. Annex 10 shows the results 
of the FMEA process in Kayole HC. 
 
B. Kiambu County Hospital  
Six (6) failure modes were identified in the PMTCT process in Kiambu CH and 
the total risk probability number (RPN) was 2,343. The failure modes are below and the 
highest RPN is listed first:    
i. Late ANC attendance (700) 
ii. Poor linkage between health facilities where women attend ANC and PNC after 
delivery at Kiambu CH (700) 
iii. Missed opportunities for HIV testing and PMTCT interventions at ANC (HIV 
testing not done ANC or HIV positive woman not given PMTCT interventions 
during ANC). (300) 
iv. HIV positive woman currently enrolled in HIV care does not disclose pregnancy 
to the clinicians during routine HIV clinic appointments. (243) 
v. HIV positive woman refuses PMTCT intervention. (200) 
vi. Infants that test HIV negative at six weeks seroconvert and are positive at the 
nine-month antibody test. (200) 
For most of the failure modes identified in Kiambu CH, the likelihood of 
occurrence ranged between 2 and 7 but the likelihood of detection and the severity of the 
failure mode effects were scored at either 9 or 10. The causes of the failure modes were a 
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combination of health system, personal and societal factors.  The health system factors 
included: 1) inadequate counseling; 2) shortage of healthcare providers; 3) missed 
opportunities for HIV testing especially in private health facilities and; 4) lack of 
confidentiality in the current triage set up. The personal factors included: 1) lack of 
adequate information about the PMTCT process; 2) denial of HIV positive results; 3) fear 
of being reprimanded and/ or of disappointing healthcare providers; 4) poor infant 
feeding practices such as mixed feeding and; 5) domestic problems. The societal factors 
included: cultural practices that discourage an early ANC attendance and; 2) stigma. 
Annex 11 shows the results of the FMEA process in Kiambu CH. 
 
C. Nyeri County Hospital  
Four (4) failure modes were identified in the PMTCT process in Nyeri CH and the 
total risk probability number (RPN) was 1,032.   The failure modes are below and the 
highest RPN is listed first:    
i. Missed opportunities for HIV testing during antenatal care. (300) 
ii. Refusal by HIV positive women enrolled in the PMTCT program to disclose 
illnesses to the healthcare providers during routine appointments. (270) 
iii. Poor ANC attendance marked by intermittent attendance. (200)  
iv. HIV positive women currently enrolled in HIV care do not disclose pregnancy 
to the clinicians during routine HIV clinic appointments. (162) 
For most of the failure modes identified in Nyeri CH, the likelihood of occurrence 
ranged between 2–3 but the likelihood of detection and the severity of the failure mode 
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effects were scored at either 9 or 10. The causes of the failure modes were a combination 
of health system, personal and societal factors.  The health system factors included: 1) 
lack of HIV testing kits; 2) shortage of healthcare providers and; 3) negative health 
provider attitudes.  The personal factors included: 1) lack of information; 2) missed 
opportunities for testing and/ or PMTCT interventions; 3) arrival at L&D while in active 
labor and without having received an HIV test and/or PMTCT intervention; 4) refusal to 
test for HIV; 5) fear of being reprimanded or disappointing healthcare providers.   HIV 
related stigma was identified as a societal cause of the failure. Annex 12 shows the results 
of the FMEA process in Nyeri CH.	  Table 15 below is a summary of the failure modes 
identified at each study sites. 	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Table 15: Summary of the failure modes stratified by study site. 
Kayole Health Center Kiambu County Hospital Nyeri County Hospital  
i. Poor quality of data 
especially the 
postnatal and HIV 
exposed infant 
registers.  
ii. 18 months antibody 
test not done and/or 
not recorded in the 
HEI or PNC registers.  
iii. Missed opportunities 
for HIV testing at 
ANC (history of ANC 
attendance is in ANC 
register but HIV test 
was not done.)  
iv. HIV positive woman 
refuses PMTCT 
intervention.  
v. Long queues, 
extended waiting 
times and delays.  
i. Late ANC attendance  
ii. Poor linkage between 
health facilities where 
women attend ANC and 
PNC after delivery at 
Kiambu CH  
iii. Missed opportunities for 
HIV testing and 
PMTCT interventions at 
ANC (HIV testing was 
not done ANC or HIV 
positive woman did not 
receive any PMTCT 
interventions during 
ANC).  
iv. HIV positive woman 
currently enrolled in 
HIV care does not 
disclose pregnancy to 
the clinicians during 
routine HIV clinic 
appointments.  
v. HIV positive woman 
refuses PMTCT 
intervention.  
vi. Infants that test HIV 
negative at six weeks 
seroconvert and are 
positive at the nine-
month antibody test.  
i. Missed opportunities 
for HIV testing during 
antenatal care.  
ii. HIV positive women 
enrolled in PMTCT 
refuse to disclose 
illnesses that they may 
be experiencing to the 
healthcare providers 
during follow up 
appointments.  
iii. Poor ANC attendance 
marked by intermittent 
attendance.  
iv. HIV positive women 
currently enrolled in 
HIV care do not 
disclose pregnancy to 
the clinicians during 






Qualitative interviews   
The failure modes identified in the FMEA and their causes were further explored 
through the in-depth qualitative interviews conducted prior to identify barriers and 
facilitators to retention in PMTCT care.  Just like in this FMEA, the barriers and 
facilitators to retention in PMTCT that emerged from the qualitative interviews were a 
mix of health system, personal, and societal factors. Poor quality of care was identified as 
a barrier to retention in PMTCT care while good quality of care was a facilitator.  The 
causes of the FMEA failure modes were mostly health system related and were 
comparable to the barriers identified under the quality of care theme in the qualitative 
interviews. This quality of care theme was further categorized into two  subthemes: 1) 
healthcare provider attitudes (positive or negative), and 2) waiting and delays.  
The qualitative narratives described healthcare providers with negative attitudes 
as those that discriminated against HIV positive people, did not maintain confidentiality, 
were harsh or hostile, did not follow up with patients, or discussed the patient’s condition 
in the presence of others. In addition, the fear of being reprimanded by healthcare 
providers for late ANC attendance, conceiving while HIV positive or for defaulting care 
was reported to deter HIV positive women  from seeking ANC services late in 
pregnancy, reengaging with HIV care after defaulting, or disclosing pregnancy while 
enrolled in HIV care. Similarly, negative provider attitudes were attributed to four FMEA 
failure modes: refusal of PMTCT interventions by HIV positive women, non-disclosure 
of pregnancy during routine HIV care appointment, non-disclosure of new symptoms 
during follow up PMTCT appointments and missed opportunities for HIV testing during 
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ANC. The quotes below describe these negative provider attitudes:  
  
“There used to be some bad girls [healthcare providers] here [at the study site]. 
If you knock there [nurse’s room] asking for assistance they would talk to you 
badly and one is left wondering whether you will be assisted or not. In fact if I 
had money to buy the baby’s formula milk, I would not have come here. Yes, the 
way they talk to you is bad, or they keep you waiting the whole day. That really 
discouraged us.”  Retained\\PF13 
 
“They [healthcare providers] made a lot of noise and refused to write the ANC 
card for me because I came to the clinic when I was almost giving birth. I 
returned to clinic the following day because I knew that without the ANC card no 
public hospital would admit me for delivery and I did not want to go to the private 
hospital. So I went back to this clinic four days in a row and that’s when that lady 
[healthcare provider] agreed to give me the ANC card but told me never to repeat 
that again.” Non Retained\\UF12 
 
Missed opportunities for HIV testing during ANC were identified as failures 
modes in the PMTCT process, and were mostly experienced by pregnant women who 
sought ANC in private health facilities or low level facilities. The private health facilities 
in particular were reported to often not offer HIV testing, lacked HIV test kits or capacity 
to test and would refer the women to a public health facility for HIV testing. Often times 
women did not follow through with these referrals and neither did the referring health 
facility. The qualitative interviews also identified missed opportunities for HIV testing as 
a barrier to retention in PMTCT care as narrated below:    
“I went to the same private clinic but was not tested for HIV. I went when I was 
six months pregnant until nine months but we were never tested. The private 
hospital I went to asked us to go to a government hospital for HIV testing but I 
did not go. They told us that they did not have the test kits so we should go to a 
government hospital.” Non Retained\\PF01 
 
Missed opportunities also occurred when HIV positive women were not initiated 
on PMTCT interventions during pregnancy and/or did not receive any interventions at 
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labor and delivery even when they delivered in a health facility.  Other times HIV 
exposed infants were not given the required ARVs immediately after birth as 
recommended the PMTCT guidelines. In addition, the healthcare providers were 
dismissive of the patient and did not educate her:   
“I don’t know why my baby was not given Nevirapine after birth. I also asked the 
doctor as I had been told that once you are HIV positive you should not 
breastfeed the baby because you do not know whether the baby is HIV positive or 
not and the virus is present in milk and you can infect the baby from the milk, so I 
asked if I should breastfeed and the doctor said, yes you can breastfeed, so I 
continued breastfeeding.” Non Retained\\PF12 
 
Another FMEA failure mode identified and supported in the qualitative results 
was the delay and/or the loss of the six weeks virologic test results for the HIV exposed 
infant.  As the quotes below show, the loss of the infants six weeks results was identifies 
as a reason why patients exited PMTCT care prematurely: 
“When they removed the baby’s blood at six weeks, the result never came out; I 
came for the results like three times and each time there were no results. I could 
see that the people who were coming after me had collected their results and  it 
reached a point that they [healthcare providers] told me that the baby had to be 
tested again, the baby was tested again, the results never came out again, so I left 
that facility.  Non Retained\\PF06 
 
“The only thing that didn’t make me happy here [study site] is the PCR 
(polymerase chain reaction). Because the first PCR was sent and they said it was 
spoilt, the second one got lost, and so the child was tested at nine months. The 
child’s blood is drawn, but you will never get the results. Only a few people get 
them.” Retained\\PF03 
 
Long queues, lengthy waiting times and the movement from one room to the next 
within the health facilities were identified as barriers to retention as well as potential 
failure modes in the FMEA.  As explained in the quotes below, the patients expected to 
be served within a reasonable timeframe, at one place and did not expect to spend an 
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entire day at the facility with limited access to the healthcare providers:  
“I would come here [study site] at 7:00 am, the [healthcare providers] would 
come at 10:00 am, by the time they collect the patients’ cards and register them 
it’s time for lunch, so the providers would go for lunch and take their time and 
come back at 3:00 pm. Even if someone comes here [study site] at 5:30 am, they 
will be kept waiting until 3:00 pm.” Retained\\KYF03 
 
“At times you may come to the clinic and the providers announce that you are 
more than the required quorum [the allocated number for the day]; and this leads 
to a sort of scramble, and when you get to the doctor’s room you are not even 
given time to say how you are feeling. That and the delay, you wait for long to be 
served.” Reengaged \\NYF10 
 
“I expected when you come here [study site], you are served from one place. 
When you come in, you go pick the file, then come for weight check, you go to the 
doctor, when you are done you go to the pharmacy, I expected to be going into 
one place.” Retained\\KUF08 
 
In addition to the long queues, the lack of medicines at the health facility or 
prescription mistakes by the pharmacists  were identified ad causes of failures modes in 
the FMEA and described as barriers to retention in PMTCT care in the qualitative 
interviews:  
“You see this place now [study site] does not have drugs, when you go to the 
[outside facility] say for my clinic and my child is sick, he will be treated, he will 
be given drugs. When you come here[study site], the baby is sick you will queue 
for long  and  in case you get a good service provider, they will prescribe drugs 
for you but then you have to go and buy them.” Retained\\KYF03 
 
“My opinion of the one who gives us medication [pharmacist] is bad. She should 
at least confirm that she has given you the drugs that are prescribed because 
there was a time, two times in a row that I left without Septrin and had to buy it. I 
came and told [mentor mother] that last time I was not given Septrin, and she 
intervened. The following month again she forgot to give me Septrin and I had to 
buy it.” Retained\\KUF02  
 
Preconceived negative perceptions regarding the expected quality of care were 
identified as a barrier to retention in PMTCT care and a cause for delayed ANC 
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attendance failure mode.  As the two quotes below demonstrate, HIV positive women 
often expected negative attitudes from the providers and were surprised when that was 
the case: 
“I expected to be quarreled [reprimanded] by the providers because of 
conceiving [while HIV positive] but that did not happen.  They instead told me to 
follow the clinic, and I was advised that by so doing I would protect my child from 
HIV. Retained\\KUF04   
 
 
6.7. DISCUSSION  
Quality improvement methods have been used in the scale up on PMTCT 
programs in South Africa, to explore the delivery of ARVs in Swaziland, to improve 
retention of care of mother-baby pairs in Kenya and to maximize effectiveness of 
PMTCT service provision in Côte d’Ivoire, Kenya and Mozambique.(16–20) The 
adoption of QI methods to improve performance, referral linkages and coordination in the 
scale up of South African’s PMTCT program has been cited as one of the factors that led 
to the decrease in MTCT rate to 3%, which is close to transmission rates reported under 
clinical trial conditions.(164–166)  
The total risk priority numbers (RPN) for Kayole HC, Kiambu CH and Nyeri CH 
were 2,289, 2,343 and 1,032 respectively. The differences in the total RPN across the 
sites should be viewed individually for each site because the PMTCT process, the 
population served and the FMEA team composition was different in each site. Missed 
opportunities for HIV testing and/or for the provision of PMTCT interventions at ANC, 
was identified as a common failure across the three study sites and had the highest RPN 
in Nyeri CH and was rated third  highest in Kayole HC and Kiambu CH. The causes of 
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this failure were: the lack of PMTCT knowledge, shortage of HIV test kits, healthcare 
provider shortages, and lack of HIV testing in private health facilities. The hazard risk 
analysis for the failure mode was 300 in Kiambu CH and Nyeri CH compared to 400 in 
Kayole HC. A study conducted in Kenya found that health systems factors such as the 
failure to test due to missing test kits or supplies accounted for 60% of the reasons why 
women did not accept HIV testing. (12) A matched case-control study in Nyanza 
province-Kenya concluded that health system factors were  more important predictors  of  
MTCT than psychosocial factors.(72) 
 In both Kayole HC and Kiambu HC, refusal of PMTCT interventions was 
identified as a failure mode and attributed to lack of adequate information on PMTCT, 
fear of disclosure and stigma. This outright refusal by women to uptake PMTCT 
interventions was highlighted by Bhardwaj et al. as they advocated for the importance of 
considering context in the design of PMTCT strategies.(167) 
Kiambu CH and Nyeri CH identified late/delayed ANC attendance as failure 
mode in the PMTCT process and the causes attributed to this were lack of knowledge, 
fear of being tested for HIV and cultural beliefs that discourage early ANC attendance. 
Even though both Kiambu CH and Nyeri CH located in urban settings, as higher tier 
hospitals they often receive referrals from lower tier health facilities that serve more rural 
populations. Kayole CH which serves majority of urban woman and did not identify this 
as a failure mode.  This difference in ANC attendance patterns between health facilities 
serving mostly rural vs. urban women, is in concurrence with data from two recent 
surveys in Kenya which reported that 51% of rural women attended the recommended 
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four ANC visits compared to 67% of urban woman.  (6,15)  
The non-disclosure of pregnancy by women enrolled in HIV care and the non-
disclosure of symptoms during routine visits by women enrolled in PMTCT services was 
identified in both Kiambu CH and Nyeri CH.   Fear of healthcare providers, patients’ 
perception that she will be viewed as a “bad” patient; stress and stigma were identified as 
causes of this failure mode.  
The study three sites mostly ranked the likelihood of occurrence of a failure low 
to moderate on the RPN score of 1 to 10 while the severity of the consequence – an HIV 
positive child or sickness and/or death for the HIV positive woman – was ranked very 
high. The probability of detecting the failure modes once in the health facility was 
reported to be high ranging between 9 and 10. This high probability of detecting failure 
modes across the three sites shows that improvement in the PMTCT process can be 
successfully achieved without significant changes or investments in the health system.   
The combined use of the FMEA tool with qualitative data allowed the study to 
understand the FMEA results from the perspective of both the healthcare providers and 
the HIV positive women, the context (health facility and community) in which 
implementation occurs, and the interaction between health system factors, personal 
factors and societal factors in influencing retention in PMTCT care. For example, 
healthcare provider attitudes (negative or positive) and the extended wait times at the 
health facilities did not strongly emerge during FMEA process as causes of failures in the 
PMTCT process while the interviews with the women emphasized these as barriers to 
retention.    
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 Implementation science studies have underscored context-sensitivity as an 
important element in enhancing the scalability of PMTCT interventions.(166,167) 
Understanding the context within which the PMTCT interventions are implemented is 
especially important in preparing the environment for change.(166) Following the June 
2014 release of new guidance recommending the scale up of Option B+ in Kenya, the 
majority of health facilities are in the process of transitioning from implementing Option 
A to Option B+ as a PMTCT intervention.(51)  For example, observations from this 
FMEA pointed to the fact that labor and delivery departments were not fully aware of the 
requirements of Option B+ and how the implementation of Option B+ would impact their 
current roles. The lack of clarity as to how the existing PMTCT program and the 
comprehensive care center would relate in the implementation of Option B+ was also 
observed. The success of Option B+ scale-up will depend on how well PMTCT programs 
address the context in which implementation is occurring.  
Furthermore, the multifaceted nature of the causes of the failure modes (personal, 
health system and societal factors) demands that PMTCT implementation strategies are 
designed to address this complex mix. Even though the majority of the personal and 
societal factors are difficult to address in the health facility setting, the awareness of these 
by the healthcare providers is expected to sensitize them as they relate with HIV positive 
women in the PMTCT process.  This enhanced sensitivity is expected to result in positive 
healthcare provider attitudes which were identified as facilitators to retention in PMTCT 
care. In addition, the engagement healthcare providers in a process such as the FMEA has 
been shown provide them with opportunities to think critically about the PMTCT cascade 
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thus creating a strong base for improvement.(167)  
 
6.8. STRENGTHS AND LIMITATIONS  
These results should be viewed with an understanding of the strengths and 
limitations. The major strength of this study was the use of mixed methods and in 
particular the qualitative results to further explain the failure modes identified and their 
successive causes. In addition to explaining the health system factors, the qualitative 
interviews also described the personal and sociocultural elements that contributed the 
failure modes but were not identified in the FMEA. Secondly, conducting a FMEA 
provided the study with the healthcare providers’ perspective on the gaps to retention in 
PMTCT care and showed the feasibility of using the FMEA tool in resource poor settings 
to better engage health care providers in quality improvement. The short time frame 
within which this FMEA was conducted did not allow the study a back and follow-up 
interaction with the FMEA teams to identify actions to address the failure modes.  
 
6.9. CONCLUSION  
As Kenya transitions to scale up the provision of Option B+ at a national level 
these FMEA results provide a context for the design of implementation strategies. This 
study advances the field of implementation research in HIV and AIDs programing by 
providing a wider context that extends beyond the health system to look at personal and 
sociocultural failures in the PMTCT process.  
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CHAPTER SEVEN: 
POLICY AND PROGRAMMATIC RECOMMENDATION 
Introduction  
In efforts to eliminate mother to child transmission of HIV (MTCT), Kenya 
announced the scale up of Option B+ in June 2014. (51) Unlike earlier prevention of 
MTCT (PMTCT) treatment recommendations that provided short antiretroviral therapy 
(ART) regimens, Option B+ recommends that all HIV-positive pregnant and lactating 
women be initiated on lifelong ART.(48) Findings from a 2014 study of 11 countries that 
documented lessons learned from early implementation of Option B+ reported a 50% 
increase in ART uptake in antenatal care (ANC).  Currently, Kenya based retention 
studies have documented low retention and high attrition rates along the PMTCT 
cascade.(25,136)  To maximize the benefits of Option B+, Kenya must initiate 
interventions that improve the current retention in PMTCT care.  Over past couple of 
years, Kenya has employed several strategies to improve retention in PMTCT care.  
These include: mobile Health (mHealth) tools that use text messages reminders, the use 
of mentor mothers in PMTCT settings, and  the development an integrated point-of-care 
electronic maternal and child health register to facilitate longitudinal follow-up of 
mothers and children.(59,147) 
The recommendations presented in this Chapter are based on the findings from 
this study and observations made during the data collection process.  The 
recommendations are at two levels: policy and programmatic. Three policy memos 
tailored to each specific study site are also included in this Chapter.    
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7.1.  Policy recommendations  
Policy Recommendation 1: Greater male partner involvement in Maternal Child Health 
(MCH) initiatives 
Given that over 85% of the HIV women in this study were married or were living 
with male partners, the role of male partners cannot be overstated. Existing PMTCT 
programs have strived to improve male involvement by promoting couple counseling and 
emphasizing the need for male partners to accompany their spouses to the health facility. 
Based on the results from the qualitative interviews, this study argues that the current 
strategies are restrictive and not inclusive of all the different ways in which a male 
partners can support their spouses though pregnancy, delivery and postpartum. It is 
therefore imperative that the PMTCT interventions seek novel ideas for male partner 
engagement. Two recommendations for greater male involvement include:  
i) Adopting a comprehensive definition for male partner involvement; 
ii) Initiating programs that educate men broadly on their role in facilitating 
maternal, neonatal and child health.  
Findings from the qualitative interviews identified male partners as a key factor in 
facilitating or hindering retention in PMTCT care. Narratives from the female interviews 
showed that supportive male partners facilitated retention in PMTCT care while 
unsupportive male partners hindered the same.  Furthermore, the definition of male 
involvement as stated in the qualitative narratives was comprehensive in nature and 
included: the role of male partners in creating a conducive environment at home to allow 
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for disclosure of an HIV positive status; taking an HIV test themselves; encouraging 
spouses with the acceptance process; and providing financial and emotional support. 
Likewise, a study conducted in Mwanza District Malawi, described male partner 
involvement to include men that: “accompanied their wives to  antenatal care (ANC), 
tested for HIV, disclosed their HIV positive results, provided financial support, supported 
the wife to adhere to PMTCT protocols, and participated in decision making regarding 
the use of condoms and the choice of infant feeding method.”(168) The premise of this 
definition is that by adopting a broad and comprehensive definition of male partner 
involvement, the desire to have a healthy family is the motivation for the support. 
Additionally, a comprehensive definition limits the stigma that is often associated with 
male involvement in PMTCT programs.  The current definition limits male partner 
involvement to health facility visits while a comprehensive definition expands this role 
beyond the health facility to the home and community.   
As findings from this study showed, supportive male partners empowered the 
spouses to overcome internal stigma associated with HIV because these women 
understood that the most important person in their lives was on their side. In addition, it 
was easier to correctly adhere to correct infant feeding practices and return to the clinic 
for infant HIV testing when the male partner was supportive.  Strategies to strengthen 
male involvement must be cognizant of the social-cultural, political, policy, healthcare 
provider and communication barriers that have been showed to limit male 
involvement.(169) As suggested by Green et al. these strategies include: 1) assessments 
to understand the root of resistance to male involvement: 2) provide male services at the 
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MCH clinics; 3) promote education on gender equity in relationships; 4) information, 
education and communication materials that are targeted to the male audiences; 5) 
training of healthcare providers to recognize and eliminate bias to male clients; 6) use 
role models to promote male involvement; 8) show the economic benefits of male 
involvement. (169) 
 
Policy Recommendation 2: Integrate mental health into HIV and AIDS services 
including PMTCT  
Findings from this study reported how the negative emotions of fear, hopelessness 
and confusion experienced upon learning of their HIV positive status, combined with the 
pregnancy and exacerbated by the fear of infecting the unborn baby and/or being 
abandoned by the male spouse brought on stress and depression.   
The mental health of people living with HIV and in particular pregnant and 
lactating women should be included into discussions on HIV treatment and care. Mental 
health prevention and management strategies should also be integrated into the next 
edition of the national PMTCT guidelines. Even though Kenya is currently implementing 
the Kenya Mentor Mother Program (KMMP) which uses peer education and 
psychosocial support to motivate behavior change and reduce stigma, this initiative does 
not have specific strategies to address mental health.(59) The guidelines on mentor health 
could include the following strategies: 1) sensitization of healthcare providers offering 
MCH and HIV services to recognize mental health issues and refer appropriately; 2) 
strengthening the counseling component in current  PMTCT programs by training 
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counselors on mental health; 3) expansion of the KMMP guidelines to include activities 
that strengthen mental health; 4) sensitization of communities and families to  recognize 
mental health problems and seek help; 5) integration of mental health education into the 
group education sessions offered during ANC; and 6) drawing on lessons learned to 
design simple self-care fact sheets on mental health and HIV such as those developed by 
the  U.S. Department of Health & Human Services.(170) 
 
7.2. Programmatic recommendations 
Programmatic recommendation 1: Conduct a needs assessment at community and health 
facility levels to explore the understanding of Option B+ and develop new educational 
materials to address gaps identified.   
Findings from this study illustrate that there were mixed feelings about Option B+ 
with the female interview participants individually debating benefits vs. the 
disadvantages based on their current knowledge and experiences. The female 
interviewees explained that they did not understand why an individual with a CD4 count 
greater than 350 cells/mm3 was expected to be on lifelong ART after delivery. They then 
explained how the negative feelings of confusion, shock, fear and uncertainty that emerge 
after an HIV diagnosis would make starting lifelong ART in a PMTCT setting difficult. 
To support this position, they kept referencing prior PMTCT knowledge that based ART 
eligibility on the CD4 count. This quote expresses this interpretation; “I do not want my 
body to get used to the drugs (ART) before my time.”  The possibility of side effects was 
also discussed and the participants also wondered if initiating lifelong ART with a high 
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CD4 count would outweigh the side effects.  
Those that had positive feelings about Option B+ reported that they would initiate 
lifelong ART because: the “doctors said so” and lifelong ART will help them avoid 
onset on sickness by boosting immunity, and in particular after giving birth. The 
participants currently on HAART however stated that change in their health was 
remarkable and would not imagine themselves without the medications.  To address the 
negative feelings about option B+, I recommend: 
i) Conducting rapid assessments to better understand HIV positive women’s 
perception on Option B+, and  
ii) Revising the current PMTCT education materials and/or developing news ones  
to address identified gaps. 
As the scale- up of Option B+ occurs, Kenya should conduct a rapid assessment 
in select counties to better understand perception on Option B+, identify knowledge gaps 
and use the finding to revise the current PMTCT educational materials. Secondly, 
program implementers and healthcare providers should be informed of this knowledge 
gap and adjust their education and counseling sessions appropriately as educational 
material are revised at a national level.  
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Programmatic Recommendation 2:  Utilize existing community structures to sensitize, 
educate and mobilize families on the benefits of early and regular antenatal care 
attendance 
Through the decades, MCH programs have sought innovate ways to improve 
ANC attendance (early attendance and number of visits) with moderate success. Findings 
from this study showed that some women were often indifferent to knowledge about the 
benefits of early and regular ANC attendance. This affected their healthcare seeking 
behaviors and was further reinforced by cultural beliefs that viewed early ANC 
attendance as waste of time and encouraged women to delay and present for ANC once 
the pregnancy was showing. In addition, it was common knowledge that HIV testing is 
offered as part of the ANC package and fear of getting tested for HIV deterred some 
women from seeking ANC early or at all. Predictably, delayed/late ANC attendance 
means that few women are completing the recommended four focused ANC visits. 
Suggested strategies to encourage attendance early in pregnancy and improve the number 
of ANC visits attended include:  
i) Innovative ways to engage the community by effectively using existing community 
structures such as churches/mosques, women groups (chamas) to reach communities;  
ii) Use community health workers beyond the health facility to continue to emphasizing 
the importance of multiple ANC visits, services offered at each visit and why they 
matter; 
iii) Sensitize healthcare providers to change their attitudes from punitive to informative.  
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Programmatic Recommendation 3:  Strengthen the educational component for care of 
HIV exposed infant and initiate teaching during ANC, reinforced at delivery and 
postnatal visits.  
Findings from this study showed low uptake of early infant diagnosis at six 
weeks, nine and 18 months, as well as cases where HIV negative infants seroconverted 
between the six weeks and nine months tests.  Of the cohort delivering or attending either 
ANC or post-natal care at the study sites, less than 57%, 66% and 75% returned to the 
specific sites for the six week, nine and 18 month infant testing. While it would be 
misleading to assume that non–return equates to lack of HIV testing for exposed infants, 
it is important to note that of the infants tested at six weeks, less than 32% and 54% 
returned for the nine and 18 month HIV antibody test respectively. In addition to the low 
uptake of early infant diagnosis, two of the study sites reported an increased in HIV 
prevalence among exposed infants at nine months compared to the six weeks test. This 
points the fact that that HIV exposed infants that test HIV negative at six weeks are 
seroconverting and MTCT is occurring after delivery.  
Narratives from the qualitative interviews highlighted two knowledge gaps 
regarding the care of the HIV exposed infant:  
i. Mothers did not understand why they were required to bring the infant back for 
further testing at nine and 18 months when the polymerase chain reaction (PCR) 
used to test for HIV at six weeks was close to 100% accurate; 
ii.  Mothers also did not understand why they were required to continue administering 
Nevirapine syrup to the infant when the six weeks HIV test was negative.  
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Under Option B+ HIV pregnant and lactating women are encouraged to 
breastfeed their infants at least until 12 months as per the WHO guidance.(171) Under 
Option A, PMTCT guidelines recommended exclusive breastfeeding for the first six 
months of life, then introduce complementary feeding and complete cessation of 
breastfeeding 12 months.(7) This change in regimen and breastfeeding guidance 
increases the knowledge gap in care of the HIV exposed infant. Suggested strategies to 
address this include:  
i) Initiate education on care of the exposed infant earlier in the PMTCT process 
preferably at ANC and reinforce at delivery;  
ii) Tailor the content on care of the exposed infant to a level that mothers understand;  
iii) Immediately after delivery and in subsequent postnatal visits, use the mentor 
mothers to continue educating the HIV positive women on care of the HIV 
exposed infant;  
iv) Use the text messaging platform to create a question and answer database based 
on most frequently asked questions, where HIV positive women can receive/listen 
to simplified messages on when/benefits of infant testing and/or how to 
administer Nevirapine to the exposed infant; 
v) Streamline client tracing and use text messaging to enhance the follow-up process 
for infant diagnosis.  
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Programmatic recommendation 4:  Institute mechanisms to improve documentation of 
dry blood spots (DBS) samples collected at six weeks and effectively communicate the 
status of the test results to mothers.     
One barrier to retention in PMTCT care identified in the qualitative interviews 
was the loss of the HIV exposed infant’s six weeks HIV test results. The majority of 
PMTCT sites do not have the capacity to virologically test for HIV at six week and as 
such the infant’s blood in collected on a dry blood spot (DBS) and sent to an external 
laboratory for PCR testing and results are sent back to the health facility.  Qualitative 
narratives showed frustration by the mothers whenever they returned to collect the results 
and they would be missing. Missing or lost DBS results was reported as a common 
occurrence across the study sites and often happened more than once to the same infant. I 
suggest the following strategies to address this issue: 
i) A mechanism to document the DBS samples sent to the external laboratory and 
compare this to the results received be implemented at health facility level. This 
will allow health facilities to identify if the loss of PCR results is occurring at the 
external laboratory or internally within the facility.  
ii) Health facilities should develop a process to address cases of missing PCR results 
which includes a communication plan on ways to respond to the mothers. 
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Programmatic recommendation 5: Improve linkage among health facilities in order to 
reduce  missed opportunities for HIV testing and for the provision of PMTCT 
interventions during pregnancy.    
Missed opportunities for HIV testing were mostly attributed to the lack of HIV 
test kits at the health facilities while missed opportunities to provide PMTCT 
interventions were due to refusal by the women to uptake the service or healthcare 
provider oversight. Findings from this and other studies showed that HIV positive women 
regularly move between and within health facilities and this mobility often results gaps in 
PMTCT care. (136) Findings from this study further showed that the healthcare providers 
and mentors mothers are aware of the patient mobility dynamic and are often frustrated 
by the fact that errors or gaps in care that occurred at external facilities often reflected 
poorly on them.  
The Failure Modes and Effect Analysis (FMEA) results documented three 
scenarios: women that attended ANC (more than one visit) would present for delivery 
without having been tested for HIV; women who were tested HIV positive at ANC did 
not receive PMTCT interventions; HIV exposed infants do not received ARVs 
immediately at delivery. Based on the findings of this study the following steps can be 
taken to address above gaps in the PMTCT cascade and streamline referral, patient 
follow-up and documentation: 
i) Sensitize healthcare providers on this phenomenon and emphasize the need to be 
vigilant when reviewing a patient’s card at subsequent ANC visits or at delivery. 
ii) Implement HIV retesting for pregnant women whose last test was more than three 
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months ago prior. 
iii) One-on-one counseling conducted to educate the women on the benefits of 
staying in PMTCT care and the services to expect in subsequent visits even if at a 
different facility.  
iv) Institute a referral system that tracks patients and opens communication among 
health facilities. 
v)  Document these occurrences and conduct an audit to identify the health facilities 
where this is occurring. 
vi) Submit the results of the audit in a quarterly report to the MCH department, 
hospital and county level administrators. 
Policy recommendation 6: Adopt quality improvement methodologies to improve 
coordination, and streamline data collection by strengthening feedback loops and periodic 
data quality checks. 
The retrospective chart review conducted on five registers [ANC, L&D, PNC, 
ART and HIV exposed infant (HEI)] showed large gaps in the data collected from 
January 2012–May 2013.  In all the three sites, the registers rarely recorded the final 
outcomes of the mother and infant at 18 months post-partum and as such the study could 
not run analyses on the final outcome on the HIV exposed children.  
Currently, the implementation of PMTCT initiatives in Kenya is a collaborative 
effort between the Ministry of Health (MOH) and external implementing partners [non- 
governmental organizations (NGOs)]. An example of this collaboration is the 
secondment of staff to support data collection by NGOs as was observed in the study 
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sites. Even though quality improvement (QI) has been identified as an essential part of 
healthcare delivery, none of the three study sites reported having a QI process in place at 
the time of this study. I recommend the following: 
i) Borrow from lessons learned and employ QI methodologies that have been 
shown to improve performance of PMTCT programs in South Africa.  
Just like Kenya, South Africa’s PMTCT program is implemented through 
collaboration between the MOH and NGOs. South Africa successfully utilized QI to 
improve performance of PMTCT programs by strengthening  coordination and engaging 
healthcare providers to better understand the components of the health systems and how 
to use data to track performance.(164,166,172) A 2011–2013 initiative implemented in 
South Africa using data-driven participatory processes to address implementation barriers 
and optimize PMTCT implementation recorded improvement on all the indicators along 
the PMTCT cascade.(164) In this initiative, healthcare providers were trained and used a 
simple color coded dashboard to identify and label problem areas in the PMTCT cascade 
and the solutions required.(164)  
ii) Kenya MOH in its negotiations with NGO partners should include QI activities 
as part of the implementation package.  
Quality improvement initiatives do not have to be complicated and could include 
the utilization of the PDSA (Plan –Do-Study-Act) cycle to continually think about the 
success, gaps and identify solutions to these gaps.  
 
iii) NGO partners work with the MCH department heads to design a healthcare 
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provider motivation package to be awarded to those that fully complete the 
registers each month.  
Healthcare providers report being overwhelmed with clinical work and do not 
prioritize record keeping but they could be motivated to view record keeping as an 
important part of their job.  
iv) Improve oversight on data collected and initiate a feedback back loop to identify 
gaps; the former will make the healthcare providers more accountable while the 
later will be a motivator for them to collect data.  
v) Coordinate with the NGOs so the roles of the seconded staff are clear and meet 
the needs to the facility, the data and reports they generate are shared with the 
administration and they are included in the data feedback loop. 
Programmatic recommendation 6:  employ LEAN management principles to improve 
process flow and reduce waste and wait times.  
This study identified long queues and extended wait times as barriers to retention 
in PMTCT care. The reasons for the long delays included: too many patients, too few 
healthcare providers, and the back and movement within the facility. Study participants 
described these long wait times as time wasting, costing them financially and increased 
fear of being identified as HIV positive.   
Option B+ is designed to encourage more women to uptake PMTCT services. 
However, little effort has been put forward to employ more healthcare workers to help 
with the increasing workload. As a result, the healthcare provider patient ratio going to 
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get even wider, the queues longer and wait times are going to increase. Based on this 
premise, this study recommends the use of Lean management principles to improve 
efficiency. Figure 1 below shows the lean management principles applied to the PMTCT 
process. Lean is not expensive and involves improving the current process by reducing 
waste. 	  
Figure 11:  LEAN management principles applied to the PMTCT process 
 
 
Programmatic recommendation 7: Strengthen peer counseling and psychosocial support 
by introducing mentor mothers in all PMTCT sites 
Mentor mothers were present in the three study sites and were identified as a key 
reason why HIV positive women stayed in PMTCT care.  The mentor mothers were the 
first point of contact when women tested HIV positive, assisted the women to navigate 
the PMTCT process and provided peer counseling and psychosocial support.  The mentor 
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mothers and the support groups that they organize were reported as major influencers to 
the shift from denial to acceptance of HIV status. As HIV positive women themselves the 
mentor mothers were viewed as role models and they helped newly tested women 
alleviate fear, self-loath and served as positive examples on the benefits of staying in 
PMTCT care.  
The KMMP has been adopted nationally and guidelines developed. I recommend 
the following strategies to strengthen the implementation of the KMMP nationally:   
i) sensitize the counties on the KMMP program and advocate counties to hire 
mentor mothers in health facilities providing PMTCT services.  
ii) institute a quality control mechanism to ensure that mentor mothers performance 
adheres to the process and quality outlined in the KMMP guidance. 
iii) conduct studies to measure and identify the value added by mentor mothers to 
retention in the PMTCT care.   
 
Programmatic recommendation 8: Employ a double edged strategy to motivate healthcare 
providers while at the same time sensitizing and empowering patients.  
In this study, negative experiences with the system or with healthcare providers as 
well as preconceived negative perceptions based on lived or other women’s experience 
brought on fear which hindered women from seeking and/or staying in PMTCT care. The 
women narratives showed that women often expected to receive bad quality of care at the 
health facility and were surprised when that was not the case. Patients need to be 
sensitized on their rights, what to expect from the health care system, and be provided 
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with an outlet to air grievances. Subsequently, a follow up mechanism to address the 
grievances and close the feedback loop should be implemented. For the healthcare 
providers, incentives such as training opportunities should be put in place to encourage 
positive provider attitudes.   
 
Programmatic Recommendation 9:  Generalized care vs. patient centered care; sensitize 
healthcare providers to understand that context matters, tailor care accordingly.   
Findings from this study showed that women were often frustrated by the “one 
size fits all” attitude to PMTCT care. These frustration was especially expressed when 
women had to make reproductive decisions (get pregnant while HIV positive) and/or 
infant feeding decisions (to exclusively breastfeed or replacement feed). The women 
narratives expressed frustration by the fact that some healthcare providers did not think 
beyond the clinical data such as low CD4 count when discussing the options available to 
the client. For example, the decision to exclusively breastfeed or not was often based on 
the practicability of the individual woman’s home situation (supportive spouse, 
disclosure status and finances); and while a low CD4 count would clinically mean 
replacement feeding is the best the option in this case, the environment dictated 
otherwise. The mentor mothers were reported to be very aware of the environmental 
factors and advised women accordingly while mainstream healthcare providers rarely 
accounted for these factors thus confusing the client.  In the case of infant feeding, 
women then reported that they agreed to replacement feed to please the healthcare 
provider then opted for mixed feeding when they got home.  
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7.3. Policy memos 
A. Kayole Health Center  
To: The Administrator Kayole Health Center  
Cc: MCH In charge, Maternity In charge, Medical Officer of Health, Nairobi 
County  
Introduction:   
In 2013, the overall HIV adult prevalence in Nairobi County was estimated at 
6.8%, with 177,552 people reported to be living with HIV and of these 7.3% were 
children.(4) In the same year, 316 children were newly infected with HIV through mother 
to child transmission (MTCT) and 4,982 HIV positive pregnant women were in need of 
interventions to prevent MTCT (PMTCT).(4) To prevent MTCT and contribute to 
Kenya’s national goal of eliminating MTCT, the PMTCT programs must retain women 
enrolled in PMTCT throughout the care continuum.  Retention along the PMTCT care 
continuum is a major challenge for women enrolled in PMTCT programs.(19–21) In sub-
Saharan Africa, retention in PMTCT programs is estimated to range from 72%–80% 
during ANC phase to between 30%–20% at four and six months postpartum. (21, 22) 
The goal of this study is to develop strategies and policy recommendations that 
improve retention of HIV-positive women in the PMTCT care continuum in Kenya. To 
quantify retention along the PMTCT care continuum, a retrospective chart review (RCR) 
was conducted on HIV positive pregnant or recently-delivered women 18 or older 
presenting for antenatal care or delivery between January 2012 and May 2013.  The 
primary outcome was retention at individual and facility levels through 18 months 
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postpartum. To understand barriers and facilitators of retention in PMTCT care, semi-
structured in-depth interviews were conducted with HIV positive women and male 
partners.  A failure modes and effect analysis (FMEA) was conducted to identify 
potential failures along the PMTCT cascade.   
 
Key findings:  
The RCR cohort in Kayole HC was 200 HIV positive women; 14 HIV positive 
women and two (n=2) male partners participated in the qualitative interviews and; seven 
(n=7) healthcare providers participated in the FMEA.    
 
i. Retrospective chart review (RCR) 
The mean age at first ANC visit in Kayole HC cohort was 25.5, and mean 
gestational age in weeks was 22.7 and the mean of the total number of ANC visits 
attended was 2.4. 
• 20.4% attended four ANC visits and above.  
• 94.4 % of the women delivered in a health facility. 
• 84.7% were diagnosed HIV positive in the current pregnancy.  
• The mean age for early infant diagnosis was seven weeks. 
• 3% of the HIV exposed infants were diagnosed HIV positive at six weeks and no 
babies were diagnosed HIV positive at nine and 18 months.  
• Individual-level retention at 18 months postpartum was: 10% (fully retained); 
63% (partially retained) and 27% not retained.  
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Figure 12 below shows the facility level retention rate in each step of the PMTCT 
cascade namely: antenatal, labor and delivery; postnatal; HIV exposed infant testing at 
six weeks, nine and 18 months.  
Figure 12: Facility-level Retention 
 
 
ii. Qualitative interviews 
This study identified and confirmed that the factors that enable or hinder retention 
in PMTCT care are complex and an interaction of personal, societal and structural 
dynamics working simultaneously. Possessing just one standalone factor such as correct 
information of PMTCT, or having a supportive male spouse, or receiving good quality 
did not guarantee a woman’s retention in PMTCT care. It is the collective mix of these 
factors that led to positive health seeking behavior that resulted in retention in PMTCT 
care. The identified facilitators of retention in PMTCT care included: 1) Supportive male 
partner; 2) Acceptance of HIV status; 3) Disclosure of HIV status; 4) Desire to have an 
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HIV negative baby; 5) Peer counseling and psychosocial support which included the role 
of mentor mothers, the role of formal support groups and informal support and; 6) 
Positive provider attitudes. The quotes below are a sample of the participants’ voices: 
“I do not feel like I am sick, I do not feel like I have this dangerous disease, AIDS, 
I just see myself normal like these other people because I see myself living, if I 
continue taking medicine, I see myself living like the other people. I eat well, keep 
yourself stress free and I don’t feel like I have this disease.” Retained\\KYF02  
 
Moderator: Is there anything else that influenced you to stay in care?  
Response: “The [mentor mothers], they took you as one of their own, they treat 
someone nicely. They just talk to you like your people, like my own mother the 
way she can talk to me and hold me. When they would tell you to come on a 
certain day, you would come and find them, they take you as…..as their own 
person, they talk to you, you tell them where you stay and they also tell you, you 
talk to each other until when you get out of that place you feel free even if you 
were stressed. “Retained\\KYF08 
“When I came to know my status, the first person to test me, the way she handled 
me. I had panicked after being told but she calmed me down and made me not 
lose hope and I decided to continue coming to the clinic because they gave me 
enough advice.” You know when one is pregnant, someone may say she was 
harassed, I wasn’t harassed.”  Reengaged \\KYF13 
 
Ten barriers to retention in PMTCT care were identified and included: 1) 
Unsupportive male partners; 2) Denial of HIV status; 3) Lack of disclosure; 4) Internal 
Stigma; 5) Financial pressures; 6) Negative Provider attitudes; 7) Waiting and delays; 8) 
Negative preconceived notions regarding quality of care; 9) Stress and; 10) Ignorance. 
The quotes below are a sample of the participants’ voices: 
Respondent: “I was afraid of telling him my HIV positive status at that time…  
Moderator: What were you afraid of? “I knew if I tell him he may disown me.” 
Retained\\KYF10 
 
“I told him [husband] that I went to the clinic, I was tested and found to be HIV 
positive. He asked me, “How did they test you?” I told him and told me, “it is a 
lie; it is never tested that way”. He said “You why don’t you listen to me, will you 
listen to them [health workers], or me?  But then when I look at myself, I just see 
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that I am okay[asymptomatic] even my husband  he just looks okay ,so I decided 
not to return to the clinic and just stay away.“ Retained\\KYF02 
“They [health providers] are very hostile.” Retained\\KYF05 
 
“There are problems, for instance drugs, when one brings a child here the drugs 
are not available and you are told to buy them outside. At times we stay in the line 
there up to around 1pm and the baby needs to eat. Even when you sick you are 
sent there, and you know at that time we are all mixed up with the rest, so you end 
up staying in the line before it’s your turn.” Retained\\KYF05 
 
iii. Failure mode and effect analysis (FMEA) 
The FMEA identified five potential failure modes in the PMTCT process as 
outlined below. The risk probability number (RPN) for Kayole HC was 2889; the failure 
mode with the highest RPN should be prioritized for quality improvement and is listed 
first below.    
1. Poor quality of data especially the PNC and HEI infant registers. (800) 
2. 18 months antibody test not done and/or not recorded in the HEI registers. (400) 
3. Missed opportunities for HIV testing at ANC (history of ANC attendance is in 
ANC register but HIV test was not done.) (400) 
4. HIV positive woman refuses PMTCT intervention. (400) 
5. Long queues, extended waiting times and delays. (360) 
Recommendations:  
The recommendations below are based on the key findings above as well as observations 
made during the study.  
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Issue 1: Poor integration of HIV services themselves and within primary health care  
In Kayole HC, all of the services (primary health care, HIV, laboratory, maternal 
neonatal child health, maternity, mentor mothers) are physically located in the one 
building.  Despite this, the HIV services are not fully integrated into the primary health 
care and the implementation of PMTCT services is disjointed from the HIV 
Comprehensive Care Center (CCC).  Even though PMTCT services are fully integrated 
in the antenatal phase, the extent of the integration decreases as one moves to labor and 
delivery and to the postnatal phase. In addition, activities of seconded staff such as data 
entry in the CCC, are disconnected from other health center activities. This gap is likely 
going to widen with the implementation of Option B+. 
 Programmatic recommendation 1: Staff training, team building and quality improvement 
(QI) methodologies to actively integrate HIV services themselves and within PHC.  
With the transition to the provision of Option B+, it is more crucial that HIV 
services are integrated. It important that HIV positive women identified at the ANC, 
L&D not only receive ART but continue to benefit from the current PMTCT activities 
such as psychosocial support, peer counseling, support groups and follow-up calls. I 
recommend the following: 
• A series of training workshops conducted by the health center management to: 1) 
review the current PMTCT process and expected process changes with the 
implementation of Option B+; 2) sensitize the healthcare providers on the 
implementation of Option B+, map out the new PMTCT process and the 
adjustments that the health facility will make to accommodate implementation of 
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Option B+; 3) discuss the changing roles under Option B+ implementation.  
• Conduct team building sessions to assess progress, identify gaps and find 
solutions to the gaps; this can be monthly to start then spread out to every quarter.   
• Initiate QI activities to allow for continuous quality improvement of the integrated 
model.   
Issue 2: Poor quality of data  
The retrospective chart review conducted on five registers in Kayole HC [ANC, 
L&D, PNC, ART and HIV exposed infant (HEI)] showed large gaps in the data collected 
from Jan 2012–May 2013.  For example, the HEI register lacked data on the infants’ HIV 
status at 18 months; the PNC register was not completed for a full two months during the 
study period; and the L&D register missed births that occurred in the facility. The ART 
and HEI registers rarely recorded the final outcomes of the mother- infant pair at 18 
months post-partum and as such studies like this one could not conduct analyses on the 
final outcome of the mother-infant pair.  By comparing a study subject’s data collected in 
the Kenya Mentor Mother Program (KMMP) register with the five MOH registers, it was 
evident that services such as CD4 count testing and/or infant’s PCR results are provided 
but data are not recorded in the relevant MOH registers. The FMEA conducted with 
Kayole HC staff identified the poor quality of data as a failure mode and attributed this to 
healthcare providers workload resulting to non- prioritization of record keeping. Even 
though NGO partners at the site seconded staff to support with data collection and/or 
program monitoring, these NGO staff appeared disconnected from the data collection 
process at the facility. 
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Programmatic recommendation 2: Streamline data collection by introducing a feedback 
loop and period data quality checks.  
• Design a healthcare provider motivation package to be awarded to those 
that fully complete the registers each month. Healthcare providers are 
currently overwhelmed with clinical work and do not prioritize record 
keeping but they can be motivated to view record keeping as an important 
part of their work. 
• Institute oversight mechanisms and a feedback back loop to identify gaps; 
the former will make the healthcare providers more accountable while the 
later will be a motivator for them to collect data. 
• Define the roles of the seconded staff and ensure that they meet the needs 
of the facility. The data and reports they generate should also be shared 
with the health administration and included in the data feedback loop. 
• Introduce QI initiatives such as the PDSA (Plan –Do-Study-Act) cycle to 
continually think about the performance, gaps and solutions to these gaps.  
 
Issue 3: Loss of PCR results  
One barrier to retention identified in the qualitative interviews was the loss of the 
HIV exposed infant’s six weeks HIV test results.  Narratives showed frustration by the 
mothers whenever they returned to collect the results and these would be missing; these 
instances often repeated for the same infant.  
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Programmatic recommendation 3: Institute mechanisms to improve documentation of 
DBS samples sent to external lab vs. results received; and to effectively communicate to 
mothers.    
• Document the DBS samples that were sent to the external laboratory and 
compare this to the results received and document differences.  
• Develop a process to address cases of missing results which includes a 
communication plan on ways to respond to frustrated mothers.  
Issue 4: Long queues, extended waiting times and delays  
The qualitative narratives identified long queues and extended wait times as a 
barrier to retention in PMTCT care. The reasons for the long delays as stated in the 
narratives were: too many patients, too few healthcare providers, and the back and 
movement within the facility.  
Programmatic recommendation:  Use LEAN management strategies to improve the 
process flow and reduce waste and wait times.  
Option B+ is designed to encourage more women to uptake PMTCT services. 
However, little effort has been put forward to employ more healthcare workers to help 
with the increasing workload. As a result, the healthcare provider patient ratio going to 
get even wider and the queues as the queues get longer and wait times are also going to 
increase. Based on this premise, this study recommends the use of Lean management 
principles to improve efficiency. Lean is not expensive and involves improving the 
current process by reducing waste. 
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Issue 5: Missed opportunities for HIV testing and provision of PMTC intervention  
The FMEA results documented three scenarios: women that attended ANC (more 
than one visit) would present for delivery without having been tested for HIV; women 
who were tested HIV positive at ANC did not receive PMTCT interventions; HIV 
exposed infants not given prophylaxis immediately after delivery.  
Programmatic recommendation 5: Streamline referral, patient follow-up and 
documentation  
Based on the findings of this study the following steps can be taken to address these two 
gaps:  
• Sensitize healthcare providers on this phenomenon and emphasize the need to be 
vigilant when reviewing a patient’s card at subsequent ANC visits or at delivery;  
• HIV retesting implemented for pregnant women whose last test was more than 
three months ago prior;  
• One-on-one counseling conducted to educate the women on the benefits of 
staying in PMTCT care and the services to expect during the next visit even if at a 
different facility;  
• Document these occurrences and conduct an audit to identify the health facilities 
where this is occurring; 
• Submit results of the audit in a quarterly report to the MCH department, hospital 
and county level administrators;  
• Institute a referral system that tracks patients and opens communication among 
health facilities.  
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Anticipated challenges: Lack healthcare providers and capacity to implement the 
recommendations.   
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B. Kiambu County Hospital  
To: Medical Superintendent Kiambu County Hospital  
CC: Hospital Matron, MCH In charge, Maternity In charge, Kiambu County   
 
 Introduction:  
In 2013, the overall HIV adult prevalence in Kiambu County was estimated at 
3.8%, with 46,658 people reported to be living with HIV and of these 9% were 
children.(4) In the same year, 96 children were newly infected with HIV through mother 
to child transmission (MTCT) and 1,500 HIV positive pregnant women were in need of 
interventions to prevent MTCT (PMTCT).(4) To prevent MTCT and contribute to 
Kenya’s national goal of eliminating MTCT, the PMTCT programs must retain women 
enrolled in PMTCT throughout the care continuum. Retention along the PMTCT care 
continuum is a major challenge for women enrolled in PMTCT programs.(19–21) In sub-
Saharan Africa, retention in PMTCT programs is estimated to range from 72%–80% 
during ANC phase to between 30%–20% at four and six months postpartum. (21, 22) 
The goal of this study is to develop strategies and policy recommendations that improve 
retention of HIV-positive women in the PMTCT care continuum in Kenya. To quantify 
retention along the PMTCT care continuum, a retrospective chart review (RCR) was 
conducted on HIV positive pregnant or recently-delivered women 18 or older presenting 
for antenatal care or delivery between January 2012 and May 2013.  The primary 
outcome was retention at individual and facility levels through 18 months postpartum. To 
understand barriers and facilitators of retention in PMTCT care, semi-structured in-depth 
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interviews were conducted with HIV positive women and male partners.  A failure modes 
and effect analysis (FMEA) was conducted to identify potential failures along the 
PMTCT cascade. 
Key findings:  
The RCR cohort in Kiambu HC 188 HIV positive women; 12 HIV positive 
women and one (n=1) male partner participated in the qualitative interviews; eleven 
(n=11) healthcare providers participated in the FMEA.  
 
i. Retrospective Chart Review 
The mean age at first ANC visit in Kiambu HC was 28.4; mean gestational age in 
weeks was 26.6; and the mean of the total number of ANC visits attended was 2.9.  
• 36.5% attended four ANC visits and above  
• 97 % of the women delivered in a health facility 
• 93.36% were diagnosed HIV positive in the current pregnancy.  
• The mean age for early infant diagnosis was six weeks 
• 3% of the HIV exposed infants were diagnosed HIV positive at six weeks, 7% 
and 4% were HIV positive at nine and 18 months antibody test respectively.  
• Individual-level retention at 18 months postpartum rate: 9% (fully retained); 64% 
(partially retained) and 27% not retained. 
• Figure 13 below shows the facility level retention rate in each step of the PMTCT 
cascade: ANC, L&D; PNC; HIV exposed infant testing at six weeks, nine and 18 
months. 
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Figure 13: Facility-level Retention  
 
 
ii. Qualitative interviews 
This study identified and confirmed that the factors that enable or hinder retention 
in PMTCT care are complex and an interaction of personal, societal and structural 
dynamics working simultaneously. Possessing just one standalone factor such as correct 
information of PMTCT, or having a supportive male spouse, or receiving good quality 
did not guarantee a woman’s retention in PMTCT. It is the collective mix of these factors 
that led to positive health seeking behavior that resulted in retention in PMTCT care. The 
identified facilitators of retention in PMTCT care included: 1) Supportive male partner; 
2) Acceptance of HIV status; 3) Disclosure of HIV status; 4) Desire to have an HIV 
negative baby; 5) Peer counseling and psychosocial support which included the role of 
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provider attitudes. The quotes below are a sample of the participants’ voices: 
“Although I had refused PMTCT, I later agreed on seeing my colleagues [mentor 
mothers] who came and talked to me and advised me, they were also HIV 
positive, and they told me to take the medicine, and I should not fear because if I 
refuse to, I will die quicker. Reengaged \\KUF06 
M: what influenced you stay with the PMTCT program? “The way they treated 
me…Here [study site], in the morning you ask a lot of questions, sometimes, if my 
CD4 is low, and I want to get a baby, what am I supposed to do? Then they 
[providers] will tell you.  So by the time you are going to see the doctor, you are 
confident with what you are doing.” Retained\\KUF11 
 
The study identified ten barriers to retention in PMTCT care and this included: 1) 
Unsupportive male partners; 2) Denial of HIV status; 3) Lack of disclosure; 4) Internal 
Stigma; 5) Financial pressures; 6) Negative Provider attitudes; 7) Waiting and delays; 8) 
Negative preconceived notions regarding quality of care; 9) Stress and; 10) Ignorance. 
The quotes below are a sample of the participants’ voices:  
“Earlier on I would not take those [ARVs] and I did not accept my status. That’s 
the problem, accepting your status. Even now if I did not accept my status I would 
not be taking medication… I have now accepted my status and every night I have 
to take the medicines.’ Reengaged \\KUF12 
 
“In fact he [husband] is the one who told me not to go back to the clinic because 
he did not believe I was sick. He was even asking me, why do you take medicine, 
what for and you are not sick? He made me feel like I was not sick until I became 
really sick and that is when he believed that I was sick. “Reengaged\\KUF07 
“At times you might find a doctor at the pressure check point and throws words 
on you, God, until you wonder if you will be checked or not, but you just console 
yourself. S/he shout s at you badly, you think I don’t know what I am doing?” 
Retained\\KUF08 
“When one is coming here, you might come here at 8am in the morning and go 
home at 3pm in the evening because the queue is very long. This is what makes 
people feel they won’t close their businesses and come, its feeling you will waste a 
lot of time, because you find when coming here you will waste the whole day.  You 
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iii. Failure modes and Effect Analysis 
 
 The FMEA identified six potential failure modes in the PMTCT process as 
outlined below. The risk probability number for Kiambu CH (RPN) was 2,343; the 
failure mode with the highest RPN should be prioritized for quality improvement and is 
listed first below.    
• Late ANC attendance (700) 
• Poor linkage between health facilities where women attend ANC and PNC after 
delivery at Kiambu CH (700) 
• Missed opportunities for HIV testing and PMTCT interventions at ANC (HIV 
testing was not done ANC or HIV positive woman did not receive any PMTCT 
interventions during ANC). (300) 
• HIV positive woman currently enrolled in HIV care does not disclose pregnancy 
to the clinicians during routine HIV clinic appointments. (243) 
• HIV positive woman refuses PMTCT intervention. (200) 
• Infants that test HIV negative at six weeks seroconvert and are positive at the 
nine-month antibody test. (200) 
Recommendations: In Kiambu County Hospital, PMTCT and most of the outpatient 
services (primary health care, HIV, CCC, laboratory, maternal neonatal child health, 
maternity, mentor mothers) are physically located in the one building.  Kiambu CH 
through an NGO partner has a full time clinical officer who is in charge of PMTCT 
patients. The same NGO is also responsible for the HIV data collection and storage. The 
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recommendations are made in this context and are based on the key findings above as 
well as observations made during the study. 
 
Issue 1: Late ANC attendance 
Data from the study showed that only 36.5% of the Kiambu CH cohort attended 
the required four ANC visits with 21.4% and 23.8% attending three and two visits 
respectively. Narratives from the HIV positive women pointed to three reasons: pressure 
from friends, family and relatives to delay the visits because frequent visits to the clinic 
are viewed as a time waster; fear of being tested for HIV especially because women 
viewed HIV testing as mandatory; fear of being reprimanded by healthcare providers for 
delaying ANC attendance exacerbated  delay.  
Programmatic Recommendation 1: Utilize existing community structures to sensitize, 
educate and mobilize families on the benefits of early antenatal care attendance.   
 Suggested strategies to encourage attendance early in pregnancy and improve the 
number of ANC visits attended include:  
• Innovative ways to engage the community by effectively using existing 
community structures such as churches/mosques, women groups (chamas) to 
reach women. 
• Once at the health facility, group education sessions should continue to emphasize 
the importance multiple ANC visits. 
• Sensitize healthcare providers to change their attitudes from punitive to 
informative. 
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Issue 2: Poor linkage between health facilities where women attend ANC and PNC 
after delivery at Kiambu CH 
In Kiambu CH had an interesting dynamic where over 30% of the women 
presenting for delivery came from outside of Kiambu County namely Nairobi, Machakos, 
and Kajiado counties. Findings from the FMEA showed that tracing previous or future 
locations of care was daunting to the healthcare providers.  The FMEA results 
documented three scenarios: women that attended ANC (more than one visit) were not 
tested for HIV; women who were tested HIV positive at ANC did not receive PMTCT 
interventions; and HIV exposed infants did not received prophylaxis. 
 Programmatic recommendation 2: Streamline referral, patient follow-up and 
documentation  
Based on the findings of this study the following steps can be taken to address these two 
gaps:  
• Sensitize healthcare providers on this phenomenon and emphasize the need to be 
vigilant when reviewing a patient’s card at subsequent ANC visits or at delivery;  
• Implement HIV re-testing for pregnant women whose last test was more than 
three months ago prior;  
• Conduct one-on-one counseling to educate the women on the benefits of staying 
in PMTCT care and the services to expect during the next visit even if at a 
different facility;  
• Document these occurrences and conduct an audit to identify the health facilities 
where this is occurring; 
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• Submit results of the audit in a quarterly report to the MCH department, hospital 
and county level administrators;  
• Institute a referral system that tracks patients and opens communication among 
health facilities. 
Issue 3: HIV positive women currently enrolled in HIV care do not disclose 
pregnancy to the clinicians during routine HIV clinic appointments. 
The reasons why this phenomenon occurred can be healthcare provider or patient 
related. For women enrolled in CCC, the fear of being reprimanded by the healthcare 
providers for being pregnant may limit disclosure. In addition, feelings of 
failure/worthlessness and/or shame/stress also limited disclosure.   
Programmatic recommendation 3: Efforts to change health provider attitudes and 
expand the content of the education sessions conducted at the CCC   
The hospital should create an environment that not only educates HIV positive 
women on their reproductive health options but allows them the opportunity to discuss 
these options honestly. Given the emphasis placed on family planning, many HIV 
positive women view their pregnancy as sign that they are “bad” patients. Providers need 
to change how they approach this topic, and education material tailored to address this 
issue so that women can better understand why they need to disclose their pregnancy to 
the health provider early enough.  
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Issue 4: Infants that test HIV negative at six weeks seroconvert and are positive at 
the nine-month antibody test. 
The retrospective chart review showed increasing prevalence from 3% at six 
weeks to 7% at nine months. This was also identified as a failure during the FMEA 
process and was attributed to poor infant feeding methods and disengagement with the 
PMTCT care during the postnatal phase. The qualitative narratives indicated that some of 
the HIV positive women did not understand why they had to continue administering 
Nevirapine syrup to an HIV negative infant.   
Programmatic Recommendation 4: Strengthen the educational component for care of 
HIV exposed infant and initiate teaching during ANC and reinforce at delivery and 
during postnatal visits.  
Suggested strategies to address this issue include:  
• Initiate education on care of the exposed infant earlier in the PMTCT process 
preferably at ANC and reinforce at delivery and during PNC visits.  
• Tailor the content on care of the exposed infant to a level that mothers understand. 
• Immediately after delivery and in subsequent postnatal visits, use the mentor 
mothers to educate the HIV positive women on care of the exposed infant.  
• Use the text messaging platform to create a question and answer database based 
on most frequently asked questions, where HIV positive women can receive/listen 
to simplified messages on when/benefits of infant testing and/or how to 
administer Nevirapine to the exposed infant; 
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• Streamline client tracing and use text messaging to enhance the follow-up process 
for infant diagnosis. 
Issue 5: Poor data quality  
Of the three study sites, Kiambu CH had relatively good data. However, gaps 
were observed. For example, ART eligibility information was rarely recorded in the ANC 
register with information only available for 5% of the patients, and the nine-month 
antibody test results reported 20% discrepant test results. In addition, by comparing a 
study subject’s data collected in the Kenya Mentor Mother Program (KMMP) register 
with the five MOH registers, it was evident that services such as CD4 count testing 
and/or infant’s PCR results were provided but data were not recorded in the relevant 
MOH registers. 
Programmatic recommendation 5: Streamline data collection by introducing a feedback 
loop and period data quality checks  
• Design a healthcare provider motivation package to be awarded to those that fully 
complete the registers each month. Healthcare providers are currently 
overwhelmed with clinical work and do not prioritize record keeping but they can 
be motivated to improve.  
• Institute oversight mechanisms and a feedback back loop to identify gaps; the 
former will make the healthcare providers more accountable while the later will 
be a motivator for them to collect data. 
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• Define the roles of the seconded staff and ensure that they meet the needs of the 
facility. The data and reports they generate should also be shared with the health 
administration and included in the data feedback loop. 
• Introduce quality improvement initiatives such as the PDSA (Plan-Do-Study-Act) 
cycle to continually identify gaps and solutions. 
Issue 6: Lack of flexibility in the appointment schedules  
Some women reported that many of the providers were inflexible and lacked 
consideration as to why they were delayed for a scheduled appointment. This was 
especially true for women that were retained throughout the PMTCT process and they 
felt punished by the system. Qualitative data showed that HIV positive women once they 
understood the benefits of ANC and PMTCT they were willing to attend as many 
appointments as suggested by the health care providers. However, these individuals felt 
undervalued and disrespected when healthcare providers sent them away or reprimanded 
them when history showed they were good patients.  
Programmatic recommendation 6: Sensitize healthcare providers to understand that 
context matters, tailor care accordingly and respect patients decisions.   
 
Issue 7: Long queues, extended waiting times and delays  
The qualitative narratives identified long queues and extended wait times as a 
barrier to retention in PMTCT care. The reasons for the long delays as stated in the 
narratives were: too many patients, too few healthcare providers, and the back and 
movement within the facility.  
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Programmatic recommendation 7:  Use LEAN to improve the process flow and reduce 
waste 
Option B+ is designed to encourage more women to uptake PMTCT services. 
However, little effort has been put forward to employ more healthcare workers to help 
with the increasing workload. As a result, the healthcare provider patient ratio going to 
get even wider and the queues as the queues get longer and wait times are also going to 
increase. Based on this premise, this study recommends the use of Lean management 
principles to improve efficiency. Lean is not expensive and involves improving the 
current process by reducing waste. 
 
Anticipated challenges: Lack healthcare providers and capacity to implement the 
recommendations. 
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C. Nyeri County Hospital  
To: Medical Superintendent Kiambu County Hospital  
CC: Hospital Matron, MCH In charge, Maternity In charge, Kiambu County  
  
Introduction:  
In 2013, the overall HIV adult prevalence in Nyeri County was estimated at 4.3%, 
with 20,797 people reported to be living with HIV and of these 9% were children.(4) In 
the same year, 1,355 children were newly infected with HIV through mother to child 
transmission (MTCT) and 669 HIV positive pregnant women were in need of 
interventions to prevent MTCT (PMTCT).(4) To prevent MTCT and contribute to 
Kenya’s national goal of eliminating MTCT, the PMTCT programs must retain women 
enrolled in PMTCT throughout the care continuum.  Retention along the PMTCT care 
continuum is a major challenge for women enrolled in PMTCT programs.(19–21) In sub-
Saharan Africa, retention in PMTCT programs is estimated to range from 72%–80% 
during ANC phase to between 30%–20% at four and six months postpartum. (21, 22) 
The goal of this study is to develop strategies and policy recommendations that 
improve retention of HIV-positive women in the PMTCT care continuum in Kenya. To 
quantify retention along the PMTCT care continuum, a retrospective chart review (RCR) 
was conducted on HIV positive pregnant or recently-delivered women 18 or older 
presenting for antenatal care or delivery between January 2012 and May 2013.  The 
primary outcome was retention at individual and facility levels through 18 months 
postpartum. To understand barriers and facilitators of retention in PMTCT care, semi-
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structured in-depth interviews were conducted with HIV positive women and male 
partners.  A failure modes and effect analysis (FMEA) was conducted to identify 
potential failures along the PMTCT cascade.  
 
Key findings:  
The RCR cohort in Nyeri HC consisted of 160 HIV-positive women; 14 HIV-positive 
women and three (n=3) male partners participated in the qualitative interview; seven 
(n=7) healthcare providers participated in the FMEA.    
i. Retrospective Chart Review 
The mean age at first ANC visit in Nyeri CH was 29.7; mean gestational age in weeks 
was 24.6; and the mean of the total number of ANC visits attended was 3.1.  
• 39.4% attended four ANC visits and above  
• 99% of the women delivered in a health facility 
• 82.67% were diagnosed HIV positive in the current pregnancy.  
• The mean age for early infant diagnosis was seven weeks 
• None of the HIV exposed infants were diagnosed HIV positive at six weeks and at 
18 months while 33% were diagnosed HIV positive at nine months.  
• Individual-level retention at 18 months postpartum: 18% (fully retained); 66% 
(partially retained) and 16% (not retained). 
• Figure 14 below shows the facility level retention rate in each step of the PMTCT 
cascade: antenatal, labor and delivery; postnatal; HIV exposed infant testing at six 
weeks, and at nine and 18 months.	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Figure 14: Facility Level retention 
 
 
ii. Qualitative interviews 
This study identified and confirmed that the factors that enable or hinder retention 
in PMTCT care are complex and an interaction of personal, societal and structural 
dynamics working simultaneously. Possessing just one standalone factor such as correct 
information of PMTCT, or having a supportive male spouse, or receiving good quality 
did not guarantee a woman’s retention in PMTCT. It is the collective mix of these factors 
that led to positive health seeking behavior that resulted in retention in PMTCT care. The 
identified facilitators of retention in PMTCT care included: 1)Supportive male partner; 2) 
Acceptance of HIV status; 3) Disclosure of HIV status; 4) Desire to have an HIV 
negative baby; 5) Peer counseling and psychosocial support which included the role of 
mentor mothers, the role of formal support groups and informal support and; 6) Positive 
provider attitudes. The quotes below are a sample of the participants’ voices: 
“If you see a woman going through it [PMTCT] all is because they are not afraid 
to disclose. Even when we are in a crowd you will hear them mention, I give mine 
75%	  
44%	  
1%	   6%	  
36%	   34%	  
0%	  10%	  20%	  
30%	  40%	  50%	  
60%	  70%	  80%	  








PMTCT	  Stage	  	  
Nyeri	  CH	  
	  	  	  
212 
[baby] four spoons of formula milk. Those who keep silent are the ones with the 
problem. Reengaged \\NYF04 
 
“When I started the clinic here, when I came I developed fear, I was thinking 
should I continue or leave? But the people I found [name of mentor mother] and 
her colleagues were very hospitable and tried showing me that the right way was 
to accept the way I am.” Reengaged \\NYF10 
 
“When I was about to give birth, they used to counsel me and there is one nurse 
there who was very friendly and she told me, ‘’ you can save your child, you can 
give birth to your baby and he turns out to be negative.” Retained\\NYF12 
  
The study identified ten barriers to retention in PMTCT care  and this include: 1) 
Unsupportive male partners; 2) Denial of HIV status; 3) Lack of disclosure; 4) Internal 
Stigma; 5) Financial pressures; 6) Negative Provider attitudes; 7) Waiting and delays; 8) 
Negative preconceived notions regarding quality of care; 9) Stress and; 10) Ignorance. 
The quotes below are a sample of the participants’ voices: 
M: When did he [husband] run away? The time I told him that I had been tested 
HIV positive and was pregnant. He didn’t want to hear of another baby and I 
don’t know why but it’s because he knew my condition…From what I saw, he 
used to feel like there is nothing left and he’d rather die and avoid the shame.” 
Retained\\NYF12 
 
“The only thing that didn’t make me happy there is the PCR. Because the first 
PCR was sent and they said it was spoilt, the second one she was done, it got lost, 
and so the child was tested at 9 months. They test after the child is drawn blood, 
but you will never get the results. Only a few people get them. M: And why is 




iii. Failure Modes and Effect Analysis (FMEA) 
The FMEA identified four potential failure modes in the PMTCT process as 
outlined below. The risk probability number for Nyeri CH (RPN) was 1032; the failure 
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mode with the highest RPN should be prioritized for quality improvement and is listed 
first below: 
• Missed opportunities for HIV testing during antenatal care. (300) 
• HIV positive women enrolled in PMTCT refuse to disclose illnesses to the 
healthcare providers during follow up appointments. (270) 
• Poor ANC attendance marked by intermittent attendance. (200)  
• HIV positive women currently enrolled in HIV care do not disclose pregnancy to 
the clinicians during routine HIV clinic appointments. (162) 
Recommendations 
Issue 1: Missed opportunities for HIV testing during ANC and delivery 
Nyeri CH is a referral hospital and the majority of the women presenting for 
delivery are from outside Nyeri Municipality. For example, 99% of the HIV positive 
women that delivered in Nyeri CH did not return for postnatal care at this site. Findings 
from the FMEA showed some of the women who came to deliver in Nyeri CH but 
attended ANC in external locations were often not tested for HIV. This situation was 
often discovered at admission to labor and delivery. Findings from the FMEA further 
showed that tracing previous or future locations of care was daunting to the healthcare 
providers and documented three scenarios: women that attended ANC (more than one 
visit) were not tested for HIV; women who were tested HIV positive at ANC did not 
receive PMTCT interventions; and HIV exposed infants not given prophylaxis 
immediately after birth.  
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Programmatic recommendation 1: Streamline referral, patient follow-up and 
documentation  
Based on the findings of this study the following steps can be taken to address these two 
gaps:  
• Sensitize healthcare providers on this phenomenon and emphasize the need to be 
vigilant when reviewing a patient’s card at subsequent ANC visits or at delivery;  
• HIV retesting implemented for pregnant women whose last test was more than 
three months ago prior;  
• One-on-one counseling conducted to educate the women on the benefits of 
staying in PMTCT care and the services to expect during the next visit even if at a 
different facility;  
• Document these occurrences and conduct an audit to identify the health facilities 
where this is occurring; 
• Submit results of the audit in a quarterly report to the MCH department, hospital 
and county level administrators;  
• Institute a referral system that tracks patients and opens communication among 
health facilities. 
Issue 2: HIV positive women currently enrolled in HIV care do not disclose illness 
and/or pregnancy to the clinicians during routine HIV clinic appointments 
The reasons why this phenomenon occurs can be healthcare provider or patient 
related. For women enrolled in CCC, the fear of being reprimanded by the healthcare 
providers for being pregnant may limit disclosure. In addition, feelings of 
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failure/worthlessness and/or shame/stress also limit disclosure.  Reasons why HIV 
positive women enrolled in PMTCT care did not disclose illness during routine clinic 
visits were: fear of being reprimanded by the healthcare providers; lack of knowledge on 
why this is important; patients’ indifference; and fear that disclosure would result in 
additional time with clinician and/or a return visit.   
Programmatic recommendation 2: Efforts to change health provider attitudes and expand 
the content of the education sessions conducted at the CCC and during routine PMTCT 
clinic visits   
The hospital should create an environment that not only educates HIV positive 
women on their reproductive health options but allows them the opportunity to discuss 
these options honestly. Given the emphasis placed on family planning, many HIV 
positive women view their pregnancy as sign that they are “bad” patients. Providers need 
to change how they approach this topic and education material tailored to address this 
issue so that women can better understand why they need to disclose their pregnancy to 
the health provider early enough. Patients in PMTCT care should be empowered on the 
value of disclosing illnesses.    
 
Issue 3: Late ANC attendance  
Data from the study showed that only 39.4% of the Nyeri CH cohort attended the 
required four ANC visits with 21% and 15.5% attending three and two visits respectively. 
Narratives from the HIV positive women pointed to three reasons: pressure from friends, 
family and relatives to delay the visits because frequent visits to the clinic are viewed as a 
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time waster; the fear of being tested for HIV especially because women viewed HIV 
testing as mandatory; the fear of being reprimanded by healthcare providers for delaying 
ANC attendance made the women even delay further. 
Programmatic Recommendation 3: Utilize existing community structures to sensitize, 
educate and mobilize families on the benefits of early antenatal care attendance.   
 Suggested strategies to encourage attendance early in pregnancy and improve the 
number of ANC visits attended include:  
• Innovative ways to engage the community by effectively using existing 
community structures such as churches/mosques, women groups (chamas) to 
reach communities. 
• Once at the health facility, group education sessions should continue to emphasize 
the importance multiple ANC visits. 
• Sensitize healthcare providers to change their attitudes from punitive to 
informative. 
 
Issue 4: Loss of PCR results  
One barrier to retention identified in the qualitative interviews was the loss of the 
HIV exposed infant’s six weeks HIV test results. Narratives showed frustration by the 
mothers whenever they returned to collect the results and they would be missing; this 
instances often repeated for the same infant.  
Programmatic recommendation 4: Mechanism to improve documentation of DBS 
samples sent vs. results received and communicates with affected mothers.    
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• Document the DBS samples that were sent to the external laboratory and compare 
this to the results received and document differences.  
• Develop a process to address cases of missing results which includes a 
communication plan on ways to respond to frustrated mothers. 
Issue 5: Poor quality of data 
The retrospective chart review conducted on five registers in Nyeri CH [ANC, 
L&D, PNC, ART and HIV exposed infant (HEI)] showed gaps in the data collected from 
January, 2012–May, 2013.  For example, recording in the PNC register was incomplete, 
information on whether women were tested for HIV 72 hours before delivery or after; if 
the infant received Nevirapine and Cotrimoxazole as per the protocol; and if the male 
partner was tested for HIV at PNC was missing.  
Programmatic recommendation 5: Streamline data collection by introducing a feedback 
loop and period data quality checks  
• Design a healthcare provider motivation package to be awarded to those that fully 
complete the registers each month. Healthcare providers are currently 
overwhelmed with clinical work and do not prioritize record keeping but they can 
be motivated to improve. 
• Institute oversight mechanisms and a feedback back loop to identify gaps; the 
former will make the healthcare providers more accountable while the later will 
be a motivator for them to collect data. 
• Define the roles of the seconded staff and ensure that they meet the needs of the 
facility. The data and reports they generate should also be shared with the health 
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administration and included in the data feedback loop. 
• Introduce quality improvement initiatives such as the PDSA (Plan –Do-Study-
Act) cycle to continually identify gaps and solutions to these gaps.   
Issue 6: Long queues, extended waiting times and delays 
 The qualitative narratives identified long queues and extended wait times as a 
barrier to retention in PMTCT care. The reasons for the long delays as stated in the 
narratives were: 1) too many patients, 2) too few healthcare providers and 3) the back and 
movement within the facility. Study participants described these long wait times a time 
wasting, costing them financially and those that had not disclosed feared that they would 
be identified in the long queues.   
Programmatic recommendation 6:  Use LEAN management principles to improve the 
process flow and reduce waste 
Option B+ is designed to encourage more women to uptake PMTCT services. 
However, little effort has been put forward to employ more healthcare workers to help 
with the increasing workload. As a result, the healthcare provider patient ratio going to 
get even wider and the queues as the queues get longer and wait times are also going to 
increase. Based on this premise, this study recommends the use of Lean management 
principles to improve efficiency. Lean is not expensive and involves improving the 
current process by reducing waste. 
Anticipated challenges: Lack healthcare providers and capacity to implement the 
recommendations. 
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ANNEXES 
Annex 1: Map of Kenya, with provincial HIV prevalence among  
all adults aged 15–64 years (2011) 
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Annex 2: Revised WHO clinical staging of HIV/AIDS for adults and adolescents 
 




Acute retroviral syndrome 
Clinical Stage 1 Asymptomatic  
Persistent generalized lymphadenopathy (PGL) 
Clinical Stage 2 Moderate unexplained weight loss (<10% of presumed or measured 
body weight)  
Recurrent respiratory tract infections (RTIs, sinusitis, bronchitis, 
otitis media, pharyngitis) 
Herpes zoster  
Angular cheilitis  
Recurrent oral ulcerations  
Papular pruritic eruptions 
Seborrhoeic dermatitis  
Fungal nail infections of fingers 
Clinical Stage 3 Severe weight loss (>10% of presumed or measured body weight) 
Unexplained chronic diarrhea for longer than one month 
Unexplained persistent fever (intermittent or constant for longer 
than one month)  
Oral candidiasis  
Oral hairy leukoplakia  
Pulmonary tuberculosis (TB) diagnosed in last two years  
Severe presumed bacterial infections (e.g. pneumonia, empyema, 
pyomyositis, bone or joint infection, meningitis, bacteremia) 
Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis 
Unexplained anemia (<8 g/dl), and or neutropenia (<500/mm3) and 
or thrombocytopenia (<50 000/ mm3) for more than one month 
Clinical Stage 4 Conditions where a presumptive diagnosis can be made on the basis 
of clinical signs or simple investigations:  
HIV wasting syndrome  
Pneumocystis pneumonia  
Recurrent severe or radiological bacterial pneumonia  
Chronic herpes simplex infection (orolabial, genital or anorectal 
of more than one month’s  duration) 
Oesophageal candidiasis  
Extrapulmonary TB 
Kaposi’s sarcoma 
Central nervous system (CNS) toxoplasmosis 
HIV encephalopathy 
Conditions where confirmatory diagnostic testing is necessary: 
Extrapulmonary cryptococcosis including meningitis 
Disseminated non-tuberculous mycobacteria infection  
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Progressive multifocal leukoencephalopathy (PML) 
Candida of trachea, bronchi or lungs 
Cryptosporidiosis  
Isosporiasis  
Visceral herpes simplex infection 
Cytomegalovirus (CMV) infection (retinitis or of an organ other 
than liver, spleen or lymph nodes)  
Any disseminated mycosis (e.g. histoplasmosis, coccidiomycosis, 
penicilliosis)  
Recurrent non-typhoidal salmonella septicaemia  
Lymphoma (cerebral or B cell non-Hodgkin) 
Invasive cervical carcinoma  
Visceral leishmaniasis 
Source: Centers for Disease Control (CDC) definition HIV and AIDS staging 
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Annex 3: Kenya PMTCT Guideline: operational guidance, the package of services 
Antenatal Care (ANC) 
• All pregnant women attending ANC with unknown HIV status be offered HIV 
testing and counseling as standard care. 
• Repeat HIV testing (after 3 months) in the third trimester should be offered to all 
women whose first antenatal test was performed before 28 weeks gestation. 
• Offer counseling to attend a minimum of four ANC visits and deliver in a health 
facility.  
• Offer counseling on comprehensive HIV care,  ART use for PMTCT and own 
health 
• HIV disease staged using: 
o WHO clinical staging (Annex 1) 
o Immunological staging (CD4 count) see table 
• Screening and treatment for opportunistic infections (OIs) including TB. 
• Baseline laboratory and other necessary diagnostic evaluations. 
o Routine ANC laboratory investigations (hemoglobin (Hb), rhesus blood group 
and blood group antigens (ABO) typing, urine analysis and screening for 
sexually transmitted infections (STIs) including syphilis. 
o Alanine Transferase (ALT) and creatinine levels for women eligible for 
HAART 
• OI prophylaxis and micronutrient supplementation: 
o Multivitamins 
o Cotrimoxazole (CTX) once daily 
Intrapartum  
• Intrapartum care for all women regardless of HIV status  
• Specifics to management of HIV- positive women.  
o Prophylactic ART  
o No ART during pregnancy  
o Mother received AZT 300mg BD in Pregnancy 
o Mother received HAART in Pregnancy 
• Mode of delivery (C-section) 
Postpartum care 
• Optimal postpartum care 
• Specific to HIV- positive  women 
o  Support exclusive breastfeeding 
o Initiate/continue CTX provision  
o Newly HIV diagnosed conduct CD4 estimation, WHO and refer for ART  
o Continue ART  
o Breast care  
o Family planning education 
• Infants  
o Initiate Nevirapine syrup prophylaxis 
o Feeding options  
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Annex 4: Interview Guide Tool 1: HIV Positive women fully retained 
Experience, opinion with the PMTCT program   
1. Please tell me about your experience with the PMTCT program at (Nyeri, Kayole, 
Kiambu) site?  
• What are your feelings about it? 
• In what ways was it what you expected? 
• In what ways was it different than what you expected? 
 
2. What influenced you to stay in the PMTCT program at site (Nyeri, Kayole, and 
Kiambu)? 
• At what point did you make the decision to stay in the PMTCT program? 
What influenced that decision? 
• Do you know anyone else who has stayed in the PMTCT program like you 
did? 
• Do you know anyone else who has not stayed in the PMTCT program like you 
did? Do you know why they left? 
• Is there anything about the PMTCT program in site (Nyeri, Kayole, and 
Kiambu) that has made you feel like not staying through with the PMTCT 
care? 
• Is there anything you would like to change about the PMTCT program at sites 
(Nyeri, Kayole, and Kiambu)?  
 
3. Thinking back how many visits did you have to make to the PMTCT program at 
(Nyeri, Kayole, and Kiambu) 
• How did that make you feel? 
4. What is your opinion about the PMTCT program at (Nyeri, Kayole, and Kiambu)? 
What has led you to have that opinion? 
Experience and Opinion on the personal and societal factors   
5. And now, let us talk about how your participation in the PMTCT program and your 
home situation. By home situation I mean relationships with your husband, in-laws, 
friends, neighbors.   
6. What ways have these people influenced your decision to stay in the PMTCT 
program?  
• Your partner  
• Your family  
• Friends 
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7. How did the people in your life feel about your decision to stay in the PMTCT 
program? 
8. Let us talk about disclosure of your HIV status 
• Have you disclosed your HIV status to any one? Yes, why and if no why 
not? 
• What are your feelings about disclosure? 
• Have you seen any benefits of your decision to disclose or not?  
 
Knowledge and Opinion on Option B+ 
9. There is a proposed initiative to provide all HIV positive women who are tested 
positive during the PMTCT process with ART for the rest of their lives.  
• Have you heard about this initiative? If yes, what do you know or have 
heard about it? If no, what do you think about that initiative? 
•  If you were offered ARVs for life as explained above, even when you 
were not eligible for ART meaning when your CD4 count is greater than 
350, would  you accept and take ARVs for the  rest of your life? If yes, 
why:  and if no why not? 
Subsequent health seeking behaviors  
10. Can you tell me how your participation in the PMTCT at (Nyeri, Kayole, and 
Kiambu) is influencing when you visit the doctor when sick, how many times you 
visit the doctor, for what illnesses, and the way you take your medications?   
• How different or similar is this behavior from what you did before?   
11. If you had another pregnancy would you use the same PMTCT site? If yes, why and 
if no why not? 
12. Would you recommend the PMTCT program in (Nyeri, Kayole, and Kiambu) to other 
women? If yes, why/if not why not? 
• Would you recommend the PMTCT program to other women in site 
(Nyeri, Kayole, and Kiambu) to other women? If yes, why/if not why not? 
Demographics  
How old are you? 
How old we you when you first entered the PMTCT program?  
How long have you known your HIV status? 
Have you always attended the ANC and PMTCT program at (Nyeri, Kayole or Kiambu)?  
• If not where else were you seen? 
• What services did you receive there? 
• Why did you make the change? 
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How many children have you given birth to? 
How many of your children did you give birth to at a health facility? 
• If not all of your children were born in a health facility, where did 
you give birth to them?  
• What influenced this decision? 
 
Tell me about your family. 
• Structure 
Please describe your general health. 
Is there anything else you would like to share with me? 
Probes  
• Would you give me an example? 
• Can you elaborate on that idea? 
• Would you explain that further? 
• I’m not sure I understand what you’re saying... 
• Is there anything else? 
 
Start with general questions, like Tell me about… 
 
Study Questions (for reference) 
What are the experiences of HIV positive women with PMTCT services?  
i. What are HIV positive women’s perceptions of PMTCT services including 
Option B+?  
ii. What individual, interpersonal, social, cultural, institutional and policy factors 
facilitate/hinder HIV-positive women from “staying” in PMTCT care? 
iii. What service delivery factors facilitate/hinder HIV positive women from 
“staying” in PMTCT care? 
iv. How are women’s experiences in PMTCT services affecting their subsequent 
health care-seeking behavior? 
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Annex 5: Interview Guide Tool 2: HIV Positive women not fully retained 
 
Experience, opinion with the PMTCT program   
1. Please tell me about your experience with the PMTCT program at (Nyeri, Kayole, 
Kiambu) site?  
• What are your feelings about it? 
• In what ways was it what you expected? 
• In what ways was it different than what you expected? 
 
2. What influenced you to leave in the PMTCT program at site (Nyeri, Kayole, and 
Kiambu)? 
• At what point did you make the decision to leave in the PMTCT program? 
What influenced that decision? 
• Do you know anyone else who has left the PMTCT program like you did? 
• Do you know anyone else who has stayed in the PMTCT program? Do you 
know why they stayed? 
• Is there anything about the PMTCT program in site (Nyeri, Kayole, and 
Kiambu) that has made you feel like staying through with the PMTCT care? 
• Is there anything you would like to change about the PMTCT program at sites 
(Nyeri, Kayole, and Kiambu)?  
 
3. Thinking back how many visits did you have to make to the PMTCT program at 
(Nyeri, Kayole, and Kiambu) 
• How did that make you feel? 
 
4. What is your opinion about the PMTCT program at (Nyeri, Kayole, and Kiambu)? 
What has led you to have that opinion? 
Experience and Opinion on the personal and societal factors   
5. And now, let us talk about how your participation in the PMTCT program and your 
home situation. By home situation I mean relationships with your husband, in-laws, 
friends, neighbors.   
6. What ways have these people influenced your decision to leave the PMTCT program?  
• Your partner  
• Your family  
• Friends 
7. How did the people in your life feel about your decision to leave the PMTCT 
program? 
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8. Let us talk about disclosure of your HIV status 
• Have you disclosed your HIV status to any one? If yes, why and if no why 
not? 
• What are your feelings about disclosure? 
• Have you seen any benefits of your decision to disclose or not?  
 
 
Knowledge and Opinion on Option B+ 
9. There is a proposed initiative to provide all HIV positive women who are tested 
positive during the PMTCT process with ART for the rest of their lives.  
• Have you heard about this initiative? If yes, what do you know or have 
heard or about it? If no, what do you think about that initiative? 
•  If you were offered ARVs for life as explained above, even when you 
were not eligible for ART meaning when your CD4 count is greater than 
350, would  you accept and take ARVs for the  rest of your life? If yes, 
why:  and if no why not? 
 
Subsequent health seeking behaviors  
10. Can you tell me how your participation in the PMTCT at (Nyeri, Kayole, Kiambu) 
site is influencing when you visit the doctor when sick, how many times you visit the 
doctor, for what illnesses, and the way you take your medications?   
• How different or similar is this behavior from what you did before?   
11. If you had another pregnancy would you use the same PMTCT site? If yes, why and 
if no why not? 
12. Would you recommend the PMTCT program in (Nyeri, Kayole, and Kiambu) to other 
women? If yes, why/if not why not? 
• Would you recommend the PMTCT program to other women in site 
(Nyeri, Kayole, and Kiambu) to other women? If yes, why/if not why not? 
Demographics  
How old are you? 
How old we you when you first entered the PMTCT program?  
How long have you known your HIV status? 
Have you always attended the ANC and PMTCT program at (Nyeri, Kayole or 
Kiambu)?  
• If not where else were you seen? 
• What services did you receive there? 
• Why did you make the change? 
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How many children have you given birth to? 
How many of your children did you give birth to at a health facility? 
• If not all of your children were born in a health facility, where did you 
give birth to them?  
• What influenced this decision? 
Tell me about your family. 
• Structure 
Please describe your general health. 
Is there anything else you would like to share with me? 
 
Probes  
• Would you give me an example? 
• Can you elaborate on that idea? 
• Would you explain that further? 
• I’m not sure I understand what you’re saying... 
• Is there anything else? 
Start with general questions, like Tell me about… 
Study Questions (for reference) 
 What are the experiences of HIV positive women with PMTCT services?  
i. What are HIV positive women’s perceptions of PMTCT services including 
Option B+?  
ii. What individual, interpersonal, social, cultural, institutional and policy factors 
facilitate/hinder HIV-positive women from “staying” in PMTCT care? 
iii. What service delivery factors facilitate/hinder HIV positive women from 
“staying” in PMTCT care? 
iv. How are women’s experiences in PMTCT services affecting their subsequent 
health care-seeking behavior? 
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Annex 6: Interview Guide Tool 3: Spouses 
 
Experience, opinion with the PMTCT program   
2. Could you begin by telling us how you heard about the PMTCT program in 
(Nyeri, Kayole, and Kiambu)?    
• What are your feelings about it? 
• Would be willing to talk to us about what promoted those feelings? 
 
3. How did you find out that that your wife was part of the PMTCT program (Nyeri, 
Kayole, and Kiambu)? 
• How did that finding make you feel? 
• From what you have heard from your wife or observed, what things about the 
PMTCT program in (Nyeri, Kayole, and Kiambu) have made her stay with the 
program? 
Experience and Opinion on the personal and societal factors   
4. And now, let us talk about your role as a husband of a woman who is participating 
in the PMTCT program at (Nyeri, Kayole, and Kiambu).  
5. In what ways have you supported your wife’s decision to stay in the PMTCT 
program in (Nyeri, Kayole, and Kiambu) starting at antenatal, delivery and 
postnatal care? 
• Emotionally  
• Economically (food, transportation, clothing, money) 
• Accompanying her to the hospital.   
6. Do you remember a time when your wife was considering leaving the PMTCT 
program in (Nyeri, Kayole, and Kiambu) 
• If yes, do you remember the particular reason that made her feel that way?   
• What made her change her mind and stay in the PMTCT program in 
(Nyeri, Kayole, and Kiambu)?  
Knowledge and Opinion on Option B+  
7. There is a proposed initiative to provide all HIV positive women who are tested 
positive during the PMTCT process with ART for the rest of their lives.  
• Have you heard about this initiative? If yes, what do you or know or heard 
have about it? If no, what do you think about that initiative? 
•  If your wife was offered ARVs for life as explained above, even when she 
was not eligible for ART meaning her CD4 count is greater than 350, 
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would you support her decision take ARVs for the rest of your life? If yes, 
why:  and if no why not? 
 
Observations on subsequent health seeking behaviors  
8. Do you think the participation of your wife in the PMTCT program in (Nyeri, 
Kayole, and Kiambu) has changed how your wife visits the doctor when sick, 
how many times she visits the doctor, for what illnesses, and/or the way she take 
her medications?   
• If yes, in what way?   
9. If you and your wife had another pregnancy would you encourage her to use the 
same PMTCT site? If yes, why and if no why not? 
10. If your friend approached you and tells you that his wife was tested HIV positive 
during pregnancy would you recommend the PMTCT program in (Nyeri, Kayole, 
and Kiambu) to him? If yes, why/if not why not? 
 
Opinion and thoughts on the role of spouses  
11. Do you think that husbands have a role in the PMTCT process? 
• Yes, what is that role? If no, why not? 
12. In what ways do you think husbands can support their women through the 
PMTCT process? 
Demographics  
How old are you? 
How many children have you with have? 
Tell me about your family. 
• Structure 
Is there anything else you would like to share with me? 
Probes  
• Would you give me an example? 
• Can you elaborate on that idea? 
• Would you explain that further? 
• I’m not sure I understand what you’re saying... 
• Is there anything else? 
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Start with general questions, like Tell me about… 
 
Study Questions (for reference) 
 What are the experiences of HIV positive women with PMTCT services?  
i. What are HIV positive women’s perceptions of PMTCT services including 
Option B+?  
ii. What individual, interpersonal, social, cultural, institutional and policy factors 
facilitate/hinder HIV-positive women from “staying” in PMTCT care? 
iii. What service delivery factors facilitate/hinder HIV positive women from 
“staying” in PMTCT care? 
iv. How are women’s experiences in PMTCT services affecting their subsequent 
health care-seeking behavior? 
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Annex 7: Failure Modes and Effects Analysis (FMEA) tool.  
Adopted from Institute for Healthcare Improvement (IHI)  
 
 
Healthcare FMEA™ Process Steps 1 and 2 
 
Step 1. Select the process you want to examine. Define the scope (Be specific and 
include a clear definition of the process or product to be studied). 
 












Date Started ____________________________________ Date to be 
Completed_______________________________ 
 
Departments represented.   1. ______________   4. _________________ 
     2. ______________   5. _________________ 
       3. ________________  6. _________________    
 
Team Leader    ____________________________________ 
Are all affected areas represented? YES NO 
 
Are different levels and types of knowledge represented on the team? YES NO 
 
Who will take minutes and maintain records? 
 
  
































1.         
2.         
3         







Failure Mode: What could go wrong? 
Failure Causes: Why would the failure happen? 
Failure Effects: What would be the consequences of failure? 
Likelihood of Occurrence: 1–10, 10 = very likely to occur 
Likelihood of Detection: 1–10, 10 = very unlikely to detect 
Severity: 1–10, 10 = most severe effect 





Annex 8: The Code book: Qualitative Interviews  
High Level Theme   Definition  
Stress    
Situations where stress experienced by the woman at home,  in the 
community or anticipated stress while in the facility influenced the 
woman to not attend/delay attending ANC/PNC, deliver in health 
facilities or not practice behaviors as recommended by the health care 
provider 
  Unwanted pregnancy  Narratives around the stress caused by unwanted pregnancy  
  Discordant relations  
Ways in which being   HIV positive while the male partners is HIV negative 
contributed to stress factor  
Denial    
Commentary by women regarding their refusal and/or difficulty to accept 
their  HIV positive results when presented to then by the health personnel 
      
Acceptance    
Narratives where the woman’s assents to the reality of a situation (HIV 
positive results) and how she deals with the anxiety and negative emotions 
that result from having HIV and being pregnant. 
      
Role of male partners    
Commentary on the influence of male partners as regards the decisions 
their spouses make about their own health. These include: decisions to 
take the medication or not, to breastfeed or not, to return to the health 




Commentary by women showing how an unsupportive spouse impacted their 
decision to leave PMTCT or HIV care. The narratives further explain how  the 
male partners discouraged their spouses from accepting their HIV status, 
returning to the clinic and impressed upon them  that the health personnel do 




Supportive  male 
partners  
Narratives explaining how the male partners encouraged their spouses to stay 
in PMTCT and HIV care accompanied them to the health facility during 
appointments and made the infant feeding decisions especially when they 
opted for replacement feeding.  
   
Lack of PMTCT 
knowledge    
Lack of PMTCT knowledge and/ or the inability to perceive the dangers 
associated with not attending antenatal care or delivering at home. 
Assumptions that everything is okay since the pregnancy is without 
complications 
      
Feelings about 
frequent ANC visits   
Feelings as expressed by the respondents regarding the many visits they 
have to make to the clinic. 
      
Feelings about 
Option B+   
Women's commentary on whether or not they would uptake Option B+ 
and reasons for their choice. 
      
Infant feeding options    
Commentary on how women made infant feeding options and what 
influenced these decisions and the consequences  
      Expectations 
regarding quality of 
care    
The preconceived notions and expectations regarding quality of care and 
whether or not the health facility met this expectations or not 
      Disclosure of HIV 
positive status to the 
male partner, 
immediate family, 
friends and neighbors  
  
The reason why or not women chose to disclose their HIV status and to 
whom, benefits or disadvantages of disclosure. Ways in which disclosure 
of an HIV positive status affects the woman's relationships with her male 
partner and/or immediate family members. 
  Benefits of disclosure  Commentary on the benefits of disclosure (experienced or from others) 
  Fear Fear or being stigmatized, discriminated, talked about, thrown out by spouse  




behavior before and 
after HIV diagnosis  
  
Changes (or not) to the health seeking behavior before and after HIV 
diagnosis and/or acceptance of an HIV positive status 
      
Quality of services    




healthcare providers  
Narratives explaining positive or negative provide attitudes and their impact 
on health seeking behaviors. 
  
Communication 
between providers  
Thoughts on the quality and effectiveness of the communication between 
different healthcare providers who care for them simultaneously, primarily 
mainstream providers  and mentor mothers and/or those in the CCC 
  Waiting and delays 
Commentary on the long lines at the health facility; the amount of time spent 
at the clinic while waiting to see a health provider. 
  
Lack of supplies (test 
kits and drugs) Discussions around the lack of test kits, drugs at the health facilities  
  
Loss of PCR rest 
results  Narratives explaining the loss of PCR test results 
  
Poor services delayed 
results, start of ARVs Opinions regarding services received while at the health facility 
  Side effects of ARV  
Experiences with side effects of HV medications and the resulting reactions 
from the healthcare providers  
  Prescription issues  
Logistical difficulties or other impediments to getting the type or dose of 
medication(s) they need. 
      
Lack of disclosure 
(pregnancy and new 
symptoms)   
Narratives where women that were known HIV positive and enrolled in 
HIV care admitted hiding their pregnancy from the doctors or HIV 
positive women enrolled in PMTCT care refused to disclose new 
symptoms during routine visits.  
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Psychosocial support    
Commentary on how support groups, other HIV positive women 
including mentor mother encouraged women to stay in PMTCT care 
  
Follow up by mentor 
mothers  
The opinions of the mentor mothers by HIV positive women and ways in 
which the mentor mothers encouraged the HIV positive women to stay in 




The role of support groups provides to help the HIV positive women cope with 
the disease 
  Informal support  
Experiences with bonds created with other HIV positive women to help  cope 
with the disease, gain perspective from comparing their own experience with 
others'  and how this help them stay in PMTCT care. 	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F01 Retained  32 30 KP**- 10 Yes  Single  Positive  2 2 
F02 Retained  26 24 2.5 Yes  Married  Positive  2 2 
F03 Retained  25 23 2.8 Yes  Married  Discordant  1 1 
F04 Not Retained  33 32 KP- 7 Yes  Married  Positive  1 1 
F05 Retained  38 29 KP-10 No Widowed  Discordant  5 
 F06 Not Retained  30 27 2.6 No Married  unknown  2 1 
F07 Retained 36 34 2 No Single  unknown 2 2 
F08 Retained  22 20 2 Yes  Single  unknown 1 1 
F09 Not Retained  35 33 2 Yes  Separated unknown 4 4 
F10 Retained  26 25 3 Yes  Married  Discordant  2 2 
F11 Retained  30 27 3 Yes  Married  Discordant  2 2 
F12 Retained  32 30 KP-10 No Married  Positive  2 2 
F13 Reengaged  30 28 2 No Single  unknown 1 1 
F14 Retained 33 31 
 
No Married  Positive  4 4 
F15 Reengaged  31 30 3 No  Married  Discordant  8 5 
F16 Retained  26 24 2 No  Married  Discordant  1 1 
F17 Retained  31 29 KP-6 No  Single  unknown 1 1 
F18 Reengaged 34 31 8 No  Single  unknown 2 2 
F19 Retained  37 35 2 Yes Widowed Discordant  4 4 
F20 Retained  37 35 KP-7 No  Married  Positive  4 4 
F21 Not Retained  38 36 KP-10 Yes Widowed Discordant  4 2 
F22 Retained  32 31 KP-8 Yes Married  Discordant  2 2 
F23 Retained  32 28 KP-4 Yes Married  Discordant  4 4 
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F24 Reengaged 36 29 
 
No  Married  Discordant  3 1 
F25 Retained  32 30 3 Yes Married  Positive  2 2 
F26 Retained  43 40 KP-5 No  Married  Discordant  5 5 
F27 Retained  32 26 7 Yes Married  Positive  3 3 
F28 Reengaged 40 38 6 unknown  Separated  unknown 5 5 
F29 Not retained  29 27 2 No Separated  unknown 2 1 
F30 Retained  33 27 7 No Separated  unknown 
 F31 Reengaged  23 22 2 No Separated  unknown 4 0 
F32 Retained  37 36 KP-8 No Married Discordant  
  F33 Not Retained  24 22 2 No Married unknown  1 1 
F34 Reengaged 26 24 2 No Married unknown  1 
 F34 Reengaged 32 30 2 No Married Positive  3 3 
F36 Retained  30 28 2 Yes Married unknown  2 2 
F37 Reengaged 34 25 KP-11 No Married Discordant  4 4 
F38 Retained  31 30 1 No Separated  unknown 3 3 
F39 Retained  36 34 KP-8 No Single unknown 1 1 
F40 Reengaged  26 24 
 
No single unknown 3 3 
**KP (Known HIV positive); woman diagnosed nosed prior to the current pregnancy. 	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Annex 10: Demographic characteristics of the male interview participants 
	   	   	   	   	   	  Subject 
Code  
Retention status of 
wife  Age  Marital status  Status # of children 
M01 Reengaged  44 Married  Negative  8 
M02 Retained 32 Married  Positive  2 
M03 Retained 39 Married  Positive  4 
M04 Retained 48 Married  Positive  3 
M05 Retained 43 Married  Positive  3 
M06 Retained 48 Married  Positive  1 	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Annex 14: Results of the FMEA process in Kayole Health Center 


















































Step: Antenatal care, labor and delivery, postnatal care and exposed infant diagnosis 
Poor quality of data 
especially the postnatal care 
(PNC) and HIV infant 
diagnosis (HEI) registers. 
Poor coordination among the different 
departments that provide PMTCT 
services and especially between the ANC 
where all PMTCT interventions occurred 
and the CCC where women with a CD4 
count less than 350 were started on 
HAART.  
Mobility between clinics leaves care 
seeking gaps in the registers.  
Staffing challenges; current healthcare 
workers are overwhelmed with the 
clinical workload leaving little time to 
complete the registers.   
Poor data quality  
Follow up of patients is 
compromised  
  
8 10 10 800  
Step 1 & 2: Antenatal care and labor and delivery  
Missed opportunities for 
HIV testing in ANC.  
(History of ANC attendance 
is in the ANC register but 
HIV test was not done.) 
Shortage of test kits in Kayole Level II 
and surrounding facilities  
Private facilities were not vigilant to test 
women seeking ANC services because 
they think that they might scare them 
away.  
Chances of transmitting HIV to 
the child are increased 
significantly.   
Providers are put at risk of 
contracting HIV when assisting a 
client with unknown HIV status 
at delivery.  
4 10 10 400  
HIV positive women refuse Fear of disclosure     400  
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to take HIV medications 
even for PMTCT only.  
Denial of HIV positive status 
   
Woman cannot make informed 
decisions on behalf of the unborn 
child.  
Increased economic costs from 
treating opportunistic infections. 
Step: Antenatal care, postnatal care and comprehensive care center  
Long queues, extended 
waiting times and delays 
Many patients and few health care 
workers 
Different rooms for different procedures 
Women the facility and do not 
return for follow up 
appointments. 
6 10 6 360  
Step:  Postnatal care 
18 months antibody test not 
done and/or not recorded in 
the HEI or PNC registers 
Lack of personnel 
Data entry is not prioritized  
If the infant is breastfeeding and 
seroconverts between the last test 
and 18 months then there is no 
way of knowing until the child is 
symptomatic. 
Hard to tell if PMTCT is working  
7 7 7 329  
Total RPN for Kayole  2,289 
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Annex: 15 Results of the FMEA process in Kiambu County Hospital 


















































PMTCT Steps: ANC; labor and delivery  
Late ANC attendance  Women in the community including own family-
mother and aunties- advice newly pregnant 
women not to start ANC earlier in the pregnancy. 
The common phrase “do not tire yourself this 
early.”  
Fear of being tested for HIV  
HIV associated stigma  
 
Chances of transmitting 
HIV to the child are 
increased  
Health providers are put at 
risk of contracting HIV 
when assisting a client with 
unknown HIV status.  
Woman cannot make 
informed decisions on 
behalf of the unborn child.  
Increased economic costs 
from treating opportunistic 
infections. 
7 10 10 700  
Missed opportunities to 
provided PMTCT 
interventions. 
Denial of HIV positive status,  
Some women are retained in the first pregnancy 
but default in the second pregnancy. 
Inadequate counseling during the testing process 
and/or at the initial ANC visit 
Lack adequate information on PMTCT.  
Shortage of health care staff  
Women come to the ANC late (close to delivery)  
Domestic issues problems 




for HIV testing during 
ANC  
HIV testing is not done during the first visit and 
the woman is told by the healthcare provider that 
it will be done during the second visit but this is 
forgotten and not done during subsequent visits.  
Lack of test kits at the health facility.  
Some private clinics conduct ANC but are 
indifferent about testing women for HIV.  
Women to not want their HIV status to be 
recorded in the ANC book 
2 10 10   
HIV positive women 
refuse to take 
prophylaxis for PMTCT 
but allow their baby to 
receive NVP after birth.  
Women lack adequate information on PMTCT.  2 10 10 200  
Step 3: Post-natal care  
Infant seroconverts HIV 
positive between the 6 
PCR results and the 9 
months antibody test 
Woman not on HAART and reported to be 
breastfeeding 
No intervention during breastfeeding;  
Home deliveries  
 2 10 10 200  
Comprehensive Care Center  
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Women enrolled in 
CCC and on HAART 
conceive and do not 
disclose the pregnancy 
to the clinician  
They are afraid that they will be reprimanded by 
the healthcare provider because they have not 
been using condoms and/or may have low CD4 
count and are encouraged to discuss this with the 
health care providers  before they get pregnant;   
Others are stressed out and they outright lie to 
the health care provider regarding the dates of 
last menstrual period and condom use;  
Provide socially accepted answers that will not 
answer the healthcare provider; 
The setup of triage at the CCC- open space –may 
lead others to lie on question such as “do you use 
condoms?” 
 3 9 9 243  
Step: Antenatal care, labor and delivery, postnatal care and exposed infant diagnosis 
Poor linkage between 
health facilities where 
women attend ANC and 
PNC after delivery at 
Kiambu CH 
The likelihood of failures 2–5 above occurring is 
highest among women who attended ANC in 
surrounding counties (Nairobi, Kajiado, 
Machakos) and those seeking ANC in private 
clinics but deliver at Kiambu CH.  
 7 10 10 700  






Annex 16: Results of the FMEA process in Nyeri County Hospital 
























































PMTCT Steps: ANC, Labor and Delivery 
Pregnant woman does 
not attend the ANC 
clinic throughout 
pregnancy.  
Lack knowledge on the necessity and 
importance of ANC visits.  
Indifference; cases whereby the woman has 
the knowledge on the benefits of ANC visits 
but decides not to seek the service. 
Woman may have HIV symptoms and is afraid 
to seek ANC service HIV testing.  




Chances of transmitting HIV to 
the child are increased 
significantly  
Health providers are put at risk of 
contracting HIV when assisting a 
client with unknown HIV status at 
delivery.  
Woman cannot make informed 
decisions on behalf of the unborn 
child.  
Increased economic costs from 
treating opportunistic infections.  
2 10 10 200  
Missed opportunities 
for HIV testing at the 
ANC or L&D  
Lack of HIV test kits  
Shortage of healthcare  
The woman opts out of the HIV test. Woman 
has “opt in” to be tested for HIV.    
Woman arrives at L&D in active labor. 
3 10 10 300  




during routine HIV 
care visits by HIV 
Lack of knowledge where woman is not well 
informed and thinks that that pregnancy is part 
of the routine process. 
Woman wants to be perceived as a perfect 
patient and does not want to disappoint the 
The chances of transmitting HIV 
to the child though minimal if the 
woman is on HAART and 
adhering are not negligible.  
Care of the woman is 




enrolled in the CCC.   
healthcare provider by not following the rules. 
Family planning method failures. 
The clients fear that the healthcare providers 
will be reprimand them for conceiving while 
HIV positive and possibly with a low CD4 
count.  
Some women do not see the need to disclose 
that they are pregnant.  
compromised because pregnancy 
is not taken into consideration 
when the healthcare provide 
makes prescriptions.  
Woman cannot make informed 
decisions on behalf of the un born 
child.  
Step: Postnatal Care 
Refusal by HIV 
positive women 
enrolled in the PMTCT 
program to disclose 




Negative healthcare provider’s attitude makes 
the clients afraid to disclosure. 
Time with provider is not enough for woman 
to get comfortable enough to disclose.  
Lack of information on why this is important. 
Normal routine appointment so no needs to 
bother the provider. 
Disclosing may require spending more time 
with the healthcare provider or at the health 
facility or it may mean a return visit and they 
don’t want to. 
The clients develop complications 
The clients may come to the clinic 
and end up in wards after 
admission since the illness may 
have developed so much 
This may also lead to lose of lives 
3 9 10 270  
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